Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Extracellular Matrix Organization	49/300	1.1312810390035658E-11	1.773848669157591E-8	0	0	3.4091077116090465	85.92685090487807	APP;SERPINE1;EFEMP1;CAPN6;CTSL;KDR;TIMP2;EMILIN1;PRSS2;ADAMTS9;FGB;ITGA4;ITGA3;ITGA1;HSPG2;MMP11;MMP14;VCAN;COL2A1;MMP16;CEACAM6;MMP15;COL6A1;ITGA8;CD47;COL17A1;COL15A1;HTRA1;PDGFA;LRP4;FBLN1;FURIN;LTBP1;NID2;THBS1;ADAMTS16;SCUBE3;ADAMTS18;JAM3;CRTAP;TGFB2;COL24A1;LAMB3;LAMB2;BMP4;P4HA1;COL9A3;COL9A2;FBN1
Neuronal System	51/411	7.40734573181072E-8	5.807359053739605E-5	0	0	2.4640688575899845	40.455596433888786	GABRB3;ACHE;GABRB2;KCNC3;GRIK5;SLC6A4;NRGN;DLGAP1;CHRNB2;KCNH5;KCNH6;ABCC8;CACNA2D3;KCNK16;KCNK17;PRKAB1;GJD2;SLC5A7;ARHGEF9;EPB41;MAOA;STXBP1;CACNA1B;CACNA1A;SLC1A3;ADCY8;PPM1E;GNG2;SLITRK2;ERBB4;GNG4;SLITRK6;KCNN3;KCNJ3;KCNJ5;GABBR2;SYT2;HOMER2;KCNB2;GAD2;GNG11;SYT7;PTPRD;LRFN2;DLG2;NBEA;DLG4;SYT10;KCNS3;KRAS;KCNK3
Regulation of IGF Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	23/124	3.275927725717378E-7	1.712218224641616E-4	0	0	3.9133731305426975	58.43250955890904	APP;CSF1;GOLM1;LAMB2;APLP2;IGFBP3;KLK13;AFP;F2;PDIA6;LTBP1;PRSS23;F5;BMP4;VCAN;STC2;PENK;GPC3;QSOX1;APOE;IGFBP6;MFGE8;FBN1
Post-translational Protein Phosphorylation	20/107	1.6690912190619012E-6	6.542837578722652E-4	0	0	3.942654585116201	52.45004572353972	APP;CSF1;GOLM1;LAMB2;APLP2;IGFBP3;AFP;PDIA6;LTBP1;PRSS23;F5;BMP4;VCAN;STC2;PENK;GPC3;QSOX1;APOE;MFGE8;FBN1
Degradation of the Extracellular Matrix	23/140	2.9584663619939266E-6	8.968086277274257E-4	0	0	3.3753333176937934	42.97082687793692	COL17A1;COL15A1;LAMB3;HTRA1;FURIN;HSPG2;ADAMTS16;SCUBE3;MMP11;MMP14;COL2A1;CAPN6;MMP16;CTSL;MMP15;ADAMTS18;COL6A1;TIMP2;COL9A3;COL9A2;PRSS2;ADAMTS9;FBN1
TP53 Regulates Transcription of Cell Death Genes	12/44	3.4316656673243333E-6	8.968086277274257E-4	0	0	6.403532608695652	80.57222362768948	PIDD1;STEAP3;CASP6;IGFBP3;TNFRSF10C;TNFRSF10B;BAX;FAS;TNFRSF10A;BID;NDRG1;TNFRSF10D
Signaling by Receptor Tyrosine Kinases	55/536	9.77977761876047E-6	0.002190670186602345	0	0	1.9833111586174734	22.877878605233988	CYFIP2;GABRB3;GABRB2;PTPRU;IRS1;PLAT;AREG;SPRED2;FGF9;AKT3;KDR;ATP6V1E1;TNS3;DUSP4;ITGA3;GAB2;DUSP6;PGF;DNM1;RNF41;TGFBR3;COL2A1;COL6A1;ELMO1;TRIB1;SGK1;TPH1;RALB;PDGFA;FURIN;THBS1;ERBB4;PDGFD;PDGFC;NTF3;POLR2H;APOE;PAK3;NTRK2;EGR2;COL24A1;LAMB3;STAT1;LAMB2;NOS3;FOSL1;DLG4;ID2;FGF19;BAX;SPRY2;COL9A3;KRAS;SPRY1;COL9A2
Regulation of Beta-Cell Development	11/42	1.3423818570647551E-5	0.00263106843984692	0	0	6.0540942928039705	67.91773527957322	KAT2B;ONECUT1;AKT3;PAX4;HNF1B;PAX6;INSM1;NKX6-1;GCK;NKX2-2;NEUROG3
TP53 Regulates Transcription of Death Receptors and Ligands	6/12	2.056909599462505E-5	0.0035835936132857867	0	0	17.00720720720721	183.53703181933722	IGFBP3;TNFRSF10C;FAS;TNFRSF10B;TNFRSF10A;TNFRSF10D
Dissolution of Fibrin Clot	6/13	3.639333859749358E-5	0.0057064754920869935	0	0	14.576833976833976	148.99163934820447	ANXA2;SERPINE1;SERPINF2;PLAT;SERPINB8;S100A10
Regulation of Gene Expression in Endocrine-Committed (NEUROG3+) Progenitor Cells	4/5	4.60802169512152E-5	0.006568525470864129	0	0	67.92446043165468	678.2343525033904	PAX4;INSM1;NEUROG3;NKX2-2
Integrin Cell Surface Interactions	15/85	6.529296863916501E-5	0.008490565700344444	0	0	3.661736084079408	35.28678190468514	FGB;ITGA4;ITGA3;ITGA1;HSPG2;THBS1;COL2A1;COL6A1;KDR;ITGA8;COL9A3;CD47;COL9A2;JAM3;FBN1
Signaling by PDGF	12/58	7.039372072989654E-5	0.008490565700344444	0	0	4.45132325141777	42.56091103835153	COL2A1;STAT1;PDGFD;COL6A1;PDGFC;PDGFA;PLAT;FURIN;COL9A3;KRAS;COL9A2;THBS1
Platelet Degranulation	19/128	8.820445495766263E-5	0.009878898955258215	0	0	2.983323994547264	27.851874522532643	FGB;APP;CD63;TGFB2;HSPA5;APLP2;SERPINE1;SERPINF2;PDGFA;ACTN4;CLU;THBS1;MANF;F5;MMRN1;TMSB4X;PSAP;CD9;QSOX1
Response to Elevated Platelet Cytosolic Ca2+	19/133	1.4836590471301291E-4	0.01550918257266695	0	0	2.851716803403221	25.140247713012428	FGB;APP;CD63;TGFB2;HSPA5;APLP2;SERPINE1;SERPINF2;PDGFA;ACTN4;CLU;THBS1;MANF;F5;MMRN1;TMSB4X;PSAP;CD9;QSOX1
Nervous System Development	53/567	1.668657258180202E-4	0.01635284113016598	0	0	1.781921805623172	15.499728051051779	RET;ROBO2;ROBO3;PLXND1;VLDLR;RPL9;CHL1;DPYSL3;HOXA2;RPL35;NRCAM;PLXNC1;SEMA6A;TRPC3;TRPC4;ITGA1;UNC5C;GAB2;RHOC;DNM1;COL2A1;DOK4;COL6A1;DCX;PABPC1;DSCAML1;EPHA2;ARHGEF28;RPS27L;CRMP1;CACNA1C;RPS4Y1;EFNA5;MYL12A;CACNA1G;EFNB2;CLTCL1;SRGAP2;PAK3;VASP;EGR2;LIMK2;MSN;NFASC;GJB1;DAB1;DLG4;CNTN1;PMP22;RPL22L1;COL9A3;KRAS;COL9A2
Potassium Channels	16/103	1.8155159962547496E-4	0.016583435263387555	0	0	3.142654127481714	27.070730414735152	GABBR2;KCNJ5;KCNH5;KCNH6;ABCC8;KCNC3;KCNB2;KCNK16;KCNK17;GNG11;GNG2;GNG4;KCNS3;KCNN3;KCNK3;KCNJ3
Collagen Degradation	12/64	1.9037106807460205E-4	0.016583435263387555	0	0	3.9364548494983276	33.72177982086576	COL17A1;MMP11;MMP14;COL15A1;COL2A1;CTSL;MMP15;COL6A1;FURIN;COL9A3;COL9A2;PRSS2
Signal Transduction	186/2613	2.1561733351058057E-4	0.017794104154978438	0	0	1.3561598681499794	11.448708829211546	FOXA1;CYFIP2;DGKG;APP;STEAP3;DGKD;PLXND1;IRS1;SERPINE1;IHH;STMN2;PLAT;NR3C1;AMOT;DOCK10;DOCK11;CYSLTR2;CCND1;FGF9;AKT3;KIF5A;MYB;ARHGDIB;EPSTI1;KDR;ATP6V1E1;RGS9;TNS3;CASR;CTNNBIP1;PRKAB1;PGF;RNF41;RUNX1;PYGO1;SFRP1;KEL;MFNG;RRAGD;APLNR;ELMO1;TRIB1;SQSTM1;EPHA2;FKBP5;TPH1;KHDRBS3;PDE1C;ARHGEF28;RHOBTB3;PDGFA;ARHGAP18;GPR83;RASGRP1;LTBP1;GRK5;PDGFD;PDGFC;PENK;PSAP;STAP2;APOE;SRGAP2;EGR2;TGFB2;JAG1;COL24A1;FZD7;TNFRSF10B;TNFRSF10A;GNG11;TNFRSF10D;GNAO1;FOSL1;ARHGAP33;CCDC88A;DLG2;NBEA;DLG4;ID2;FGF19;CNTN1;BCL2;COL9A3;COL9A2;BMPR1B;FBN1;BCL2L1;RET;GABRB3;GLP1R;PTPRU;GABRB2;DOCK5;CXCL6;CDKN1A;PTH1R;CHD3;TNFAIP1;AREG;SMPD3;SPRED2;SHH;GRM4;RASGEF1A;TIMP2;PRLHR;GAST;IFT57;DUSP4;TGIF1;FGB;DUSP5;GPR39;SYK;TRPC3;ITGA3;GAB2;TYK2;AXIN2;F2;RHOC;WNT16;DUSP6;DNM1;GIP;TGFBR3;GREM2;KAT2B;MMP14;ARHGEF9;COL2A1;MMP16;ALDH1A2;ALDH1A1;COL6A1;ITGA8;TFF3;GAS1;RHOU;TFF1;PDE5A;SGK1;PPP1R15A;RALB;PLPPR1;RGS16;FURIN;ADCY8;THBS1;DLL1;NEURL1B;FGD5;PDE11A;ACVR1C;GNG2;CNR1;GNG4;ERBB4;NTF3;P2RY1;STOM;POLR2H;PAK3;DYNC1I1;NTRK2;GABBR2;IL33;TCF7L2;LAMB3;STAT1;LAMB2;NOS3;LIMK2;PTPN13;FMNL3;MT-RNR2;APOC1;NEURL1;FAS;F2RL1;SPRY2;BAX;KRAS;SPRY1;RAMP1
Transmission Across Chemical Synapses	30/269	2.4385091084380548E-4	0.019117911410154353	0	0	2.1550428812501443	17.92770160701836	GABRB3;ACHE;GABRB2;MAOA;STXBP1;GRIK5;CACNA1B;CACNA1A;SLC1A3;ADCY8;PPM1E;SLC6A4;NRGN;GNG2;ERBB4;GNG4;KCNJ3;CHRNB2;GABBR2;KCNJ5;CACNA2D3;GAD2;PRKAB1;GNG11;SLC5A7;ARHGEF9;DLG2;NBEA;DLG4;KRAS
Peptide Hormone Metabolism	14/86	2.7433213346651195E-4	0.02008281029203707	0	0	3.3193184109699536	27.22229795726982	PCSK2;ACHE;ERO1B;TCF7L2;SLC30A8;CDX2;GPR119;PAX6;KLF4;PLA2G7;GIP;ANPEP;KIF5A;CPE
Hemostasis	62/707	2.8474032110814974E-4	0.02008281029203707	0	0	1.6633834929320566	13.579751301535856	DGKG;APP;DOCK5;DGKD;SERPINE1;PLAT;CLU;DOCK10;THBD;DOCK11;KIF19;TMSB4X;MYB;KIF5A;SIRPA;QSOX1;KIF21B;FGB;ANXA2;ITGA4;TRPC3;SYK;ITGA3;APLP2;SERPINF2;ITGA1;ATP1B3;ACTN4;F2;SERPINB8;KIF6;F5;MMRN1;CEACAM6;PDE5A;CD47;CD63;PDGFA;RASGRP1;THBS1;PDE11A;GNG2;GNG4;INPP5D;PSAP;P2RY1;S100A10;JAM3;TGFB2;HSPA5;NOS3;ATP2B4;TNFRSF10B;TNFRSF10A;GNG11;TNFRSF10D;MANF;EHD3;KIF26B;MAFF;CD9;KRAS
Neurofascin Interactions	4/7	2.945820387224825E-4	0.02008281029203707	0	0	22.639088729016787	184.05472787646676	NFASC;CNTN1;DCX;NRCAM
Axon Guidance	50/541	3.292807907230934E-4	0.021513011660575433	0	0	1.7570490212187098	14.089072761372678	RET;ROBO2;ROBO3;PLXND1;VLDLR;RPL9;CHL1;DPYSL3;HOXA2;RPL35;NRCAM;PLXNC1;SEMA6A;TRPC3;TRPC4;ITGA1;UNC5C;GAB2;RHOC;DNM1;COL2A1;DOK4;COL6A1;DCX;PABPC1;DSCAML1;EPHA2;ARHGEF28;RPS27L;CRMP1;CACNA1C;RPS4Y1;EFNA5;MYL12A;CACNA1G;EFNB2;CLTCL1;SRGAP2;PAK3;VASP;LIMK2;MSN;NFASC;DAB1;DLG4;CNTN1;RPL22L1;COL9A3;KRAS;COL9A2
Platelet Activation, Signaling and Aggregation	29/262	3.4833064132802855E-4	0.02184729782409395	0	0	2.1355741478495367	17.004206777393705	DGKG;APP;CD63;DGKD;SERPINE1;PDGFA;CLU;RASGRP1;THBS1;GNG2;GNG4;TMSB4X;PSAP;P2RY1;QSOX1;FGB;TGFB2;SYK;HSPA5;TRPC3;APLP2;SERPINF2;ACTN4;F2;GNG11;MANF;F5;MMRN1;CD9
Transcriptional Regulation by TP53	36/362	5.821105252216554E-4	0.03510574244413676	0	0	1.8975460122699386	14.134536035479936	BTG2;CDKN1A;STEAP3;MRE11;MT-CO1;COX7A2;TXN;CHD3;NDRG1;PIDD1;NUAK1;CASP6;SESN1;AKT3;SESN2;POLR2H;BID;PLK3;SUPT16H;NDUFA4;PLK2;IGFBP3;TNFRSF10C;TNFRSF10B;TNFRSF10A;ARID3A;PRKAB1;DDB2;TNFRSF10D;CCNA1;MSH2;RRAGD;FAS;BAX;MT-CO2;SGK1
Elastic Fibre Formation	9/44	6.126392354595862E-4	0.03557845634076412	0	0	4.378397212543554	32.390219317857415	BMP4;TGFB2;EFEMP1;ITGA8;FBLN1;FURIN;EMILIN1;LTBP1;FBN1
Developmental Biology	105/1385	7.627117494910208E-4	0.042711857971497166	0	0	1.4283660979228487	10.253712269717205	FOXA1;PLXND1;IHH;RPL9;SALL1;CCND1;FGF9;AKT3;DPYSL3;MYB;RPL35;HOXA2;NRCAM;PRSS8;PLXNC1;ATP6V1E1;SEMA6A;EBF1;KRT7;UNC5C;HNF1B;RUNX1;DOK4;CLDN7;DSC3;EPHA2;DLX5;ARHGEF28;GMPR;CACNA1C;RPS4Y1;EFNA5;MYL12A;CACNA1G;EFNB2;CLTCL1;PRDM16;NKX2-5;NKX6-1;SRGAP2;NKX2-2;VASP;EGR2;ST14;JAG1;MSN;SMARCA2;BMP4;GJB1;MAFB;DAB1;DLG4;CNTN1;BCL2;COL9A3;COL9A2;RET;ROBO2;ROBO3;CDKN1A;ONECUT1;CHD3;VLDLR;SHH;CHL1;TRPC3;TRPC4;ITGA1;PAX4;PAX6;GAB2;RHOC;DNM1;KAT2B;ZEB2;COL2A1;COL6A1;ITGA8;DCX;DSG3;PABPC1;DSCAML1;UHRF1;RPS27L;CRMP1;FURIN;DLL1;ACVR1C;POLR2H;CTNNA2;PAK3;TCF7L2;CDX2;LIMK2;LGI2;KLK13;KLF4;GCK;NFASC;MEIS1;PMP22;RPL22L1;KRAS;INSM1;NEUROG3
Molecules Associated With Elastic Fibres	8/37	8.301299167734274E-4	0.0448842658448529	0	0	4.694385659155982	33.30163548134912	BMP4;TGFB2;EFEMP1;ITGA8;FBLN1;EMILIN1;LTBP1;FBN1
ECM Proteoglycans	12/76	9.720545655056208E-4	0.050806051957093784	0	0	3.1963315217391304	22.170070649735266	APP;VCAN;TGFB2;COL2A1;LAMB2;SERPINE1;COL6A1;ITGA8;LRP4;COL9A3;COL9A2;HSPG2
Protein-protein Interactions at Synapses	13/88	0.0011527944641892339	0.05830908773705544	0	0	2.955781202780296	19.99753374106627	SYT2;EPB41;HOMER2;STXBP1;SYT7;PTPRD;LRFN2;DLG2;SLITRK2;DLG4;SYT10;SLITRK6;DLGAP1
Cell-Cell Communication	19/157	0.0012191047169413652	0.05973613113012689	0	0	2.3527538874136313	15.78612813036506	COL17A1;VASP;LAMB3;FBLIM1;CADM2;ACTN4;CLDN1;AMOT;CLDN6;CLDN4;ZEB2;CLDN7;SIRPA;CDH13;CD47;FLNC;CDH17;SKAP2;CRB3
Signaling by FLT3 ITD and TKD Mutants	5/16	0.0013959968820574029	0.06633100336563659	0	0	7.721544881760903	50.76256732177965	CDKN1A;NOX4;KRAS;GAB2;BCL2L1
Biological Oxidations	24/222	0.001499312838090909	0.06723280397452853	0	0	2.074148074148074	13.487663036880289	SLC35B2;GLYATL2;ACSS2;MAOA;GSTO1;SMOX;UGT2B15;CMBL;MAT2B;CYP3A5;TPST1;CYP2B6;GSTA4;GSTA2;FDX1;GSTA1;ALDH1A1;FDXR;CYP1A1;CYP1B1;UGT2A3;UGT3A1;CYP2E1;UGT2B7
Metabolism	153/2181	0.001541827781743066	0.06723280397452853	0	0	1.3205404707920883	8.550217870585769	SLC35B2;SLC46A1;MT-CO1;GLDC;HNMT;MT-ND3;SAT1;RPL9;MT-ND1;NUDT4;HS6ST3;MPC2;FDXR;CYP1B1;RPL35;PLCE1;LRAT;SBF2;ACSL1;UGT2B15;CMBL;HSPG2;CH25H;TPST1;INPP4B;PPP1R3C;GPD1;FDX1;MT-CO2;SUCLG1;CYP2E1;ISCU;TPH1;CEMIP;RETSAT;SAR1B;ABHD3;INSIG2;MAOA;STXBP1;GMPR;CACNA1A;COX7A2;CACNA1C;AK5;TXN;RPS4Y1;ACACB;ACAT1;UGT8;CYP2B6;ARSJ;INPP5D;NEU1;PSAP;PNPO;SLC19A3;ATP5MK;HACL1;UGT3A1;APOE;RIMKLB;IP6K2;GLYATL2;OSBPL6;SLC37A1;NUP155;SRD5A1;SLC10A2;GNG11;EXT2;GLUD2;TCN1;NDUFAF2;CYP1A1;HPSE;LRP10;SERINC2;GLP1R;ACHE;SLC44A3;ACADVL;SLC44A4;ADPGK;GBE1;GADL1;SLC2A3;CROT;HSCB;SMPD3;SPTLC1;CA2;CA4;ANKRD1;PGM2;UGT2A3;AOX1;HMGCS2;AASS;PCYT1B;GSTO1;ABCC8;AMPD3;PTGR1;PLAAT5;PLAAT4;PGM2L1;VCAN;ALDH1A1;SDHAF4;BCAT1;CHST2;ST6GALNAC5;UGT2B7;PRPS2;DDC;ACSS2;LRP1;MRPS36;AKR1D1;RPS27L;NDUFB1;HSD17B4;MAT2B;SAMHD1;ADCY8;CYP3A5;NT5E;GNG2;OXCT1;GNG4;GPC3;CHSY3;GPC4;CRYM;DUOX2;GCH1;NDUFA4;SMOX;NOS3;AKR1C2;PTPN13;HS3ST4;GCK;FABP1;GATM;GSTA4;GLB1;PSAT1;KCNS3;GSTA2;GSTA1;RPL22L1
STAT5 Activation Downstream of FLT3 ITD Mutants	4/10	0.001543610295333563	0.06723280397452853	0	0	11.317745803357314	73.26691300987638	CDKN1A;NOX4;GAB2;BCL2L1
Formation of Lateral Plate Mesoderm	3/5	0.0015915045552430296	0.06744538223300191	0	0	25.447439353099732	163.95977173622245	BMP4;SHH;IHH
GABA Receptor Activation	10/60	0.0016567911127990747	0.06836443328602497	0	0	3.4057866184448464	21.806817861465227	GABRB3;GABRB2;GABBR2;KCNJ5;ARHGEF9;GNG2;GNG4;ADCY8;GNG11;KCNJ3
Activation of Matrix Metalloproteinases	7/33	0.001965558742584071	0.07902554124030317	0	0	4.578136921689672	28.530851903930767	MMP11;MMP14;MMP16;MMP15;TIMP2;FURIN;PRSS2
Interleukin-27 Signaling	4/11	0.0023190243301796343	0.08657690832670635	0	0	9.700411099691674	58.84859865320065	STAT1;EBI3;TYK2;CRLF1
NFE2L2 Regulating Tumorigenic Genes	4/11	0.0023190243301796343	0.08657690832670635	0	0	9.700411099691674	58.84859865320065	BCL2;PDGFA;AREG;BCL2L1
TGFBR3 PTM Regulation	4/11	0.0023190243301796343	0.08657690832670635	0	0	9.700411099691674	58.84859865320065	TGFBR3;MMP14;MMP16;TIMP2
Cell Junction Organization	15/119	0.0025716686578534926	0.0937761966398669	0	0	2.460176063718298	14.670522659808544	COL17A1;VASP;LAMB3;FBLIM1;CADM2;CLDN1;AMOT;CLDN6;CLDN4;ZEB2;CLDN7;CDH13;FLNC;CDH17;CRB3
Retinoid Metabolism and Transport	8/44	0.0026973781245359014	0.09612474771073393	0	0	3.7801845166466106	22.361587165203964	LRP1;RETSAT;GPC3;LRAT;APOE;GPC4;LRP10;HSPG2
Inwardly Rectifying K+ Channels	7/35	0.0028074479238201326	0.0978239632122215	0	0	4.250676284941389	24.974761035272927	GABBR2;KCNJ5;GNG2;GNG4;ABCC8;GNG11;KCNJ3
FASTK Family Proteins Regulate Processing and Stability of Mitochondrial RNAs	5/19	0.0032316083596152486	0.10938590484983063	0	0	6.065963739231066	34.78693915302174	MT-CO1;MT-RNR2;MT-CO2;MT-ND3;MT-ND1
Signaling by NTRKs	16/134	0.0032787866887385455	0.10938590484983063	0	0	2.313220338983051	13.232272290041406	DUSP4;NTRK2;TPH1;EGR2;RALB;IRS1;FURIN;DNM1;DUSP6;FOSL1;ID2;NTF3;BAX;KRAS;TRIB1;SGK1
Kidney Development	8/46	0.0035992668132818887	0.11757604923387502	0	0	3.5808474254227627	20.149518403856092	RET;ROBO2;BMP4;SALL1;JAG1;ITGA8;HNF1B;DLL1
Heparan Sulfate Heparin (HS-GAG) Metabolism	9/57	0.004065346342440975	0.12748926129894897	0	0	3.190379403794038	17.563856435018486	EXT2;VCAN;GLB1;GPC3;GPC4;HPSE;HSPG2;HS3ST4;HS6ST3
Neurexins and Neuroligins	9/57	0.004065346342440975	0.12748926129894897	0	0	3.190379403794038	17.563856435018486	SYT2;DLG2;EPB41;HOMER2;DLG4;STXBP1;SYT10;DLGAP1;SYT7
Defective B3GALTL Causes PpS	7/38	0.004555992822338279	0.13211413175675019	0	0	3.838709677419355	20.695680814537216	ADAMTS16;ADAMTSL1;SEMA5B;ADAMTS18;THBS1;ADAMTS9;THSD4
Mitochondrial Iron-Sulfur Cluster Biogenesis	4/13	0.004593731537886583	0.13211413175675019	0	0	7.54396482813749	40.60963502748675	FDX1;FDXR;HSCB;ISCU
Activation of G Protein Gated Potassium Channels	6/29	0.004675738250518043	0.13211413175675019	0	0	4.432667450058754	23.782893040484073	GABBR2;KCNJ5;GNG2;GNG4;GNG11;KCNJ3
G Protein Gated Potassium Channels	6/29	0.004675738250518043	0.13211413175675019	0	0	4.432667450058754	23.782893040484073	GABBR2;KCNJ5;GNG2;GNG4;GNG11;KCNJ3
Inhibition of Voltage Gated Ca2+ Channels via Gbeta Gamma Subunits	6/29	0.004675738250518043	0.13211413175675019	0	0	4.432667450058754	23.782893040484073	GABBR2;KCNJ5;GNG2;GNG4;GNG11;KCNJ3
Metabolism of Fat-Soluble Vitamins	8/48	0.004718361848455364	0.13211413175675019	0	0	3.4014440433212996	18.219132979154338	LRP1;RETSAT;GPC3;LRAT;APOE;GPC4;LRP10;HSPG2
Formation of the Ureteric Bud	5/21	0.005154164773052634	0.13934017869218157	0	0	5.307155715571557	27.95783199908769	RET;ROBO2;BMP4;SALL1;ITGA8
Regulation of Gene Expression in Beta Cells	5/21	0.005154164773052634	0.13934017869218157	0	0	5.307155715571557	27.95783199908769	AKT3;PAX6;NKX6-1;GCK;NKX2-2
O-glycosylation of TSR Domain-Containing Proteins	7/39	0.005290502643058937	0.14060183295451548	0	0	3.7185527502254283	19.492066059845886	ADAMTS16;ADAMTSL1;SEMA5B;ADAMTS18;THBS1;ADAMTS9;THSD4
Laminin Interactions	6/30	0.005573666149246261	0.14565847536696894	0	0	4.247747747747748	22.044546026939635	LAMB3;ITGA3;LAMB2;ITGA1;NID2;HSPG2
Defective EXT1 Causes Exostoses 1, TRPS2 and CHDS	4/14	0.006150206929187784	0.15554071717687815	0	0	6.7892086330935255	34.565691187068566	EXT2;GPC3;GPC4;HSPG2
Defective EXT2 Causes Exostoses 2	4/14	0.006150206929187784	0.15554071717687815	0	0	6.7892086330935255	34.565691187068566	EXT2;GPC3;GPC4;HSPG2
Assembly of Collagen Fibrils and Other Multimeric Structures	9/61	0.006427316210367193	0.15996875901358348	0	0	2.9443402126328957	14.860668661128718	COL17A1;COL15A1;COL2A1;COL24A1;LAMB3;CTSL;COL6A1;COL9A3;COL9A2
HS-GAG Biosynthesis	6/31	0.006591288494183166	0.16148656810748754	0	0	4.0776216216216215	20.47784199042133	EXT2;GPC3;GPC4;HS3ST4;HSPG2;HS6ST3
Erythrocytes Take up Oxygen and Release Carbon Dioxide	3/8	0.007851223442280958	0.1796694714964008	0	0	10.177358490566037	49.33053090819298	CA2;CA4;AQP1
Ligand-receptor Interactions	3/8	0.007851223442280958	0.1796694714964008	0	0	10.177358490566037	49.33053090819298	SHH;IHH;GAS1
Regulation of Gene Expression in Early Pancreatic Precursor Cells	3/8	0.007851223442280958	0.1796694714964008	0	0	10.177358490566037	49.33053090819298	ONECUT1;HNF1B;NKX6-1
TRAIL Signaling	3/8	0.007851223442280958	0.1796694714964008	0	0	10.177358490566037	49.33053090819298	TNFRSF10B;TNFRSF10A;TNFRSF10D
Constitutive Signaling by NOTCH1 HD Domain Mutants	4/15	0.008020958548946465	0.1796694714964008	0	0	6.171680837148463	29.782663826477584	NEURL1B;JAG1;NEURL1;DLL1
Signaling by NOTCH1 HD Domain Mutants in Cancer	4/15	0.008020958548946465	0.1796694714964008	0	0	6.171680837148463	29.782663826477584	NEURL1B;JAG1;NEURL1;DLL1
Semaphorin Interactions	9/64	0.008800799824405217	0.19336445212471712	0	0	2.7832963784183296	13.173098700714938	SEMA6A;PLXND1;LIMK2;DPYSL3;ITGA1;CRMP1;PLXNC1;RHOC;PAK3
Activation of GABAB Receptors	7/43	0.009139449681803745	0.19336445212471712	0	0	3.3046788898907926	15.515979960907721	GABBR2;KCNJ5;GNG2;GNG4;ADCY8;GNG11;KCNJ3
GABA B Receptor Activation	7/43	0.009139449681803745	0.19336445212471712	0	0	3.3046788898907926	15.515979960907721	GABBR2;KCNJ5;GNG2;GNG4;ADCY8;GNG11;KCNJ3
HS-GAG Degradation	5/24	0.009372256608085779	0.19336445212471712	0	0	4.468473163105784	20.867775831139376	GLB1;GPC3;GPC4;HPSE;HSPG2
Incretin Synthesis, Secretion, and Inactivation	5/24	0.009372256608085779	0.19336445212471712	0	0	4.468473163105784	20.867775831139376	TCF7L2;CDX2;GPR119;PAX6;GIP
Interleukin-6 Family Signaling	5/24	0.009372256608085779	0.19336445212471712	0	0	4.468473163105784	20.867775831139376	STAT1;LIF;LIFR;TYK2;CRLF1
Regulation of Gene Expression in Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells	4/16	0.010229285224041967	0.205591047179252	0	0	5.657074340527578	25.923546401496854	KAT2B;ONECUT1;HNF1B;NEUROG3
Neurotransmitter Receptors and Postsynaptic Signal Transmission	20/204	0.010344796892698932	0.205591047179252	0	0	1.8545699777848301	8.477743072175064	GABRB3;CHRNB2;GABRB2;GABBR2;KCNJ5;GRIK5;ADCY8;PRKAB1;GNG11;PPM1E;NRGN;ARHGEF9;DLG2;GNG2;NBEA;DLG4;ERBB4;GNG4;KRAS;KCNJ3
Collagen Chain Trimerization	7/44	0.010358222402526089	0.205591047179252	0	0	3.2151926498184387	14.693348871228995	COL17A1;COL15A1;COL2A1;COL24A1;COL6A1;COL9A3;COL9A2
Insulin Processing	5/25	0.011188048785558083	0.21025510294229804	0	0	4.244824482448244	19.071610728159097	PCSK2;ERO1B;SLC30A8;KIF5A;CPE
Mitochondrial RNA Degradation	5/25	0.011188048785558083	0.21025510294229804	0	0	4.244824482448244	19.071610728159097	MT-CO1;MT-RNR2;MT-CO2;MT-ND3;MT-ND1
NOTCH2 Activation and Transmission of Signal to the Nucleus	5/25	0.011188048785558083	0.21025510294229804	0	0	4.244824482448244	19.071610728159097	NEURL1B;JAG1;NEURL1;CNTN1;DLL1
Regulation of Insulin Secretion	10/78	0.011237060093388335	0.21025510294229804	0	0	2.501861504095309	11.229700497558966	GLP1R;GNG2;ABCC8;GNG4;STXBP1;KCNS3;CACNA1A;CACNA1C;ADCY8;GNG11
BH3-only Proteins Associate With and Inactivate Anti-Apoptotic BCL-2 Members	3/9	0.01129242194890641	0.21025510294229804	0	0	8.480682839173404	38.02418804455124	BCL2;BID;BCL2L1
Collagen Formation	11/90	0.01139775749368325	0.21025510294229804	0	0	2.3696087977547395	10.602432238681565	COL17A1;COL15A1;CRTAP;COL2A1;COL24A1;LAMB3;P4HA1;CTSL;COL6A1;COL9A3;COL9A2
Collagen Biosynthesis and Modifying Enzymes	9/67	0.011785129724147586	0.21316577877409576	0	0	2.6389122511914773	11.7191895787506	COL17A1;COL15A1;CRTAP;COL2A1;COL24A1;P4HA1;COL6A1;COL9A3;COL9A2
Signaling by NTRK1 (TRKA)	13/115	0.011827437980450467	0.21316577877409576	0	0	2.1702486978472257	9.630116586510326	DUSP4;NTRK2;TPH1;EGR2;RALB;IRS1;DNM1;DUSP6;FOSL1;ID2;KRAS;TRIB1;SGK1
Interleukin-12 Family Signaling	8/56	0.012014922011343356	0.2140840649293907	0	0	2.8333333333333335	12.52788338547481	ANXA2;GSTO1;STAT1;GSTA2;EBI3;MSN;TYK2;CRLF1
SLC-mediated Transmembrane Transport	23/249	0.012434786570002318	0.21808816461917563	0	0	1.7372580135860545	7.621798015922512	SLC35A2;SLC35B2;SLC2A14;SLC44A3;SLC12A4;SLC44A4;SLC30A8;SLC24A3;SLC43A2;SLC1A3;SLC2A3;SLC8B1;RUNX1;SLC2A8;SLC9A2;SLC5A7;SLC9A4;LCN15;SLC17A6;SLC39A8;SLC17A8;SLC38A3;SLC12A7
Transport of Small Molecules	55/724	0.012553459119828667	0.21808816461917563	0	0	1.4114008134582683	6.178772648027685	SLC35B2;RYR2;SLC46A1;SLC44A3;STEAP3;SLC44A4;SLC2A3;VLDLR;ABCA12;AQP1;SLC2A8;UNC80;CA2;CA4;SLC39A8;ATP6V1E1;SLC12A7;SLC2A14;SLC30A8;TRPC3;GLRX3;TRPC4;ATP11B;ATP1B3;RUNX1;SLC9A2;SLC5A7;ANO1;SLC9A4;SCNN1A;SGK1;ABCB1;SLC24A3;SLC43A2;SAR1B;ATP10D;SLC1A3;FURIN;ADCY8;GNG2;LCN15;GNG4;SLC17A6;STOM;SLC17A8;APOE;SLC38A3;TRPM4;SLC35A2;SLC12A4;ATP2B4;CYBRD1;SLC8B1;GNG11;APOC1
IL-6-type Cytokine Receptor Ligand Interactions	4/17	0.012795989250614896	0.21808816461917563	0	0	5.2216380741560595	22.75915440260335	LIF;LIFR;TYK2;CRLF1
Signaling by NTRK3 (TRKC)	4/17	0.012795989250614896	0.21808816461917563	0	0	5.2216380741560595	22.75915440260335	IRS1;NTF3;BAX;KRAS
Attachment and Entry 9694614	5/26	0.013229476961770487	0.22305182662425938	0	0	4.042475676139042	17.484951718417047	CTSL;GPC3;FURIN;GPC4;HSPG2
Phase I - Functionalization of Compounds	12/105	0.014040121441409386	0.23420117468223317	0	0	2.196236559139785	9.368785485273678	CYP2B6;ACSS2;MAOA;SMOX;FDX1;ALDH1A1;FDXR;CYP1A1;CYP1B1;CMBL;CYP2E1;CYP3A5
TGF-beta Receptor Signaling Activates SMADs	7/47	0.014720770996470681	0.24279633649465707	0	0	2.973579801623084	12.544033873113527	PPP1R15A;TGFBR3;TGFB2;ITGA8;FURIN;LTBP1;FBN1
Metabolism of Vitamins and Cofactors	19/198	0.015086577286157263	0.24279633649465707	0	0	1.8098878098216058	7.590578712016229	SLC46A1;RETSAT;GCH1;LRP1;GSTO1;NOS3;SLC2A3;HSPG2;ACACB;NT5E;TCN1;PNPO;SLC19A3;GPC3;AOX1;LRAT;APOE;GPC4;LRP10
Ketone Body Metabolism	3/10	0.015470495806965936	0.24279633649465707	0	0	7.268771659607239	30.302204779281134	OXCT1;HMGCS2;ACAT1
Neurotransmitter Clearance	3/10	0.015470495806965936	0.24279633649465707	0	0	7.268771659607239	30.302204779281134	ACHE;MAOA;SLC6A4
RUNX3 Regulates p14-ARF	3/10	0.015470495806965936	0.24279633649465707	0	0	7.268771659607239	30.302204779281134	CCND1;KRAS;RUNX1
Class B 2 (Secretin Family Receptors)	11/94	0.01548446023562864	0.24279633649465707	0	0	2.2549310363626454	9.398368384470816	GLP1R;SHH;GNG2;GNG4;FZD7;IHH;PTH1R;WNT16;GNG11;RAMP1;GIP
FLT3 Signaling in Disease	5/28	0.018033752600133766	0.27028346544054266	0	0	3.6905647086447777	14.819499982294039	CDKN1A;NOX4;KRAS;GAB2;BCL2L1
Synthesis of PC	5/28	0.018033752600133766	0.27028346544054266	0	0	3.6905647086447777	14.819499982294039	ACHE;SLC44A3;PCYT1B;SLC44A4;ABHD3
Signaling by TGFB Family Members	16/161	0.018110160689805966	0.27028346544054266	0	0	1.8797742946708464	7.540305044426061	TGIF1;PPP1R15A;TGFB2;STAT1;SERPINE1;FURIN;LTBP1;TGFBR3;GREM2;MMP14;ACVR1C;MMP16;TIMP2;ITGA8;BMPR1B;FBN1
Cellular Response to Chemical Stress	19/202	0.018268887936216494	0.27028346544054266	0	0	1.7699488420979224	7.084318966016087	CDKN1A;MT-CO1;NDUFA4;TXNRD2;PDGFA;COX7A2;TXN;AREG;FABP1;SESN1;AKT3;GSTA1;SESN2;BCL2;NOX4;MT-CO2;STAP2;SQSTM1;BCL2L1
Signaling by NOTCH3	7/49	0.018271713862689744	0.27028346544054266	0	0	2.8316801923654946	11.333519932375044	KAT2B;NEURL1B;JAG1;PLXND1;STAT1;NEURL1;DLL1
TP53 Regulates Transcription of Cell Cycle Genes	7/49	0.018271713862689744	0.27028346544054266	0	0	2.8316801923654946	11.333519932375044	CCNA1;PLK3;BTG2;CDKN1A;PLK2;BAX;ARID3A
Other Semaphorin Interactions	4/19	0.019074649129908642	0.2719004530517886	0	0	4.524940047961631	17.916025436583666	SEMA6A;PLXND1;ITGA1;PLXNC1
Phase 4 - Resting Membrane Potential	4/19	0.019074649129908642	0.2719004530517886	0	0	4.524940047961631	17.916025436583666	KCNK5;KCNK16;KCNK17;KCNK3
Scavenging by Class A Receptors	4/19	0.019074649129908642	0.2719004530517886	0	0	4.524940047961631	17.916025436583666	COLEC12;APOE;CALR;MASP1
Signaling by FLT3 Fusion Proteins	4/19	0.019074649129908642	0.2719004530517886	0	0	4.524940047961631	17.916025436583666	CDKN1A;NOX4;KRAS;GAB2
Nuclear Events (Kinase and Transcription Factor Activation)	8/61	0.019538986747893408	0.27601019117744924	0	0	2.5653565833390095	10.095559327177533	DUSP4;FOSL1;TPH1;EGR2;ID2;SGK1;TRIB1;DUSP6
NGF-stimulated Transcription	6/39	0.0200334526701445	0.2781810561018033	0	0	3.087796887796888	12.074372023171453	FOSL1;TPH1;EGR2;ID2;SGK1;TRIB1
CASP8 Activity Is Inhibited	3/11	0.02040230959930318	0.2781810561018033	0	0	6.359838274932614	24.753172142835158	FAS;TNFRSF10B;TNFRSF10A
Dimerization of Procaspase-8	3/11	0.02040230959930318	0.2781810561018033	0	0	6.359838274932614	24.753172142835158	FAS;TNFRSF10B;TNFRSF10A
Regulation by c-FLIP	3/11	0.02040230959930318	0.2781810561018033	0	0	6.359838274932614	24.753172142835158	FAS;TNFRSF10B;TNFRSF10A
Phase II - Conjugation of Compounds	12/111	0.020987824110989997	0.28369748453476135	0	0	2.0624725516029865	7.969007872682479	SLC35B2;TPST1;GLYATL2;GSTA4;GSTO1;GSTA2;UGT2B15;GSTA1;UGT2A3;UGT3A1;MAT2B;UGT2B7
TP53 Regulates Metabolic Genes	10/86	0.021270819893631485	0.28506534695054847	0	0	2.2375559151042164	8.615528040806929	MT-CO1;NDUFA4;SESN1;AKT3;SESN2;RRAGD;MT-CO2;COX7A2;TXN;PRKAB1
ESR-mediated Signaling	18/192	0.02183479614565759	0.2901437318338229	0	0	1.7627661579046543	6.741259234210884	FOXA1;NOS3;GNG11;AREG;RUNX1;KAT2B;GNG2;CCND1;ERBB4;GNG4;AKT3;MYB;BCL2;TFF3;TFF1;KRAS;POLR2H;FKBP5
Defective B3GALT6 Causes EDSP2 and SEMDJL1	4/20	0.022814989728256962	0.2956520982967514	0	0	4.241906474820144	16.035838181127755	VCAN;GPC3;GPC4;HSPG2
Defective B3GAT3 Causes JDSSDHD	4/20	0.022814989728256962	0.2956520982967514	0	0	4.241906474820144	16.035838181127755	VCAN;GPC3;GPC4;HSPG2
Defective B4GALT7 Causes EDS, Progeroid Type	4/20	0.022814989728256962	0.2956520982967514	0	0	4.241906474820144	16.035838181127755	VCAN;GPC3;GPC4;HSPG2
Extra-nuclear Estrogen Signaling	9/75	0.02337885954003015	0.2986087705215195	0	0	2.318058635131806	8.706449982785882	GNG2;CCND1;GNG4;NOS3;AKT3;BCL2;KRAS;AREG;GNG11
Activation of Kainate Receptors Upon Glutamate Binding	5/30	0.02386528427011404	0.2986087705215195	0	0	3.394959495949595	12.681295469718572	GNG2;GNG4;DLG4;GRIK5;GNG11
MET Activates PTK2 Signaling	5/30	0.02386528427011404	0.2986087705215195	0	0	3.394959495949595	12.681295469718572	COL2A1;COL24A1;LAMB3;ITGA3;LAMB2
Signaling by CSF3 (G-CSF)	5/30	0.02386528427011404	0.2986087705215195	0	0	3.394959495949595	12.681295469718572	SYK;STAT1;KRAS;GAB2;TYK2
Glycosaminoglycan Metabolism	13/127	0.02511381349212238	0.2986087705215195	0	0	1.9405608309077318	7.149680547235262	SLC35B2;CEMIP;HSPG2;HS3ST4;HS6ST3;EXT2;VCAN;GLB1;GPC3;CHSY3;HPSE;GPC4;CHST2
MET Promotes Cell Motility	6/41	0.025142349115486143	0.2986087705215195	0	0	2.911042471042471	10.721956400069221	COL2A1;COL24A1;LAMB3;ITGA3;LAMB2;TNS3
Erythrocytes Take up Carbon Dioxide and Release Oxygen	3/12	0.026094455742860276	0.2986087705215195	0	0	5.652890086852351	20.610620471714284	CA2;CA4;AQP1
Interleukin-35 Signalling	3/12	0.026094455742860276	0.2986087705215195	0	0	5.652890086852351	20.610620471714284	STAT1;EBI3;TYK2
O2 CO2 Exchange in Erythrocytes	3/12	0.026094455742860276	0.2986087705215195	0	0	5.652890086852351	20.610620471714284	CA2;CA4;AQP1
Presynaptic Depolarization and Calcium Channel Opening	3/12	0.026094455742860276	0.2986087705215195	0	0	5.652890086852351	20.610620471714284	CACNA1B;CACNA2D3;CACNA1A
Tandem Pore Domain Potassium Channels	3/12	0.026094455742860276	0.2986087705215195	0	0	5.652890086852351	20.610620471714284	KCNK16;KCNK17;KCNK3
Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1)	4/21	0.02697048514667891	0.2986087705215195	0	0	3.9921709691070673	14.42376223067157	TCF7L2;CDX2;GPR119;PAX6
Activated NOTCH1 Transmits Signal to the Nucleus	5/31	0.02718721157158261	0.2986087705215195	0	0	3.2642110364882644	11.76750879037262	NEURL1B;JAG1;NEURL1;CNTN1;DLL1
Antigen Presentation Folding, Assembly and Peptide Loading of Class I MHC	5/31	0.02718721157158261	0.2986087705215195	0	0	3.2642110364882644	11.76750879037262	PDIA3;HSPA5;SAR1B;HLA-B;CALR
Signaling by CSF1 (M-CSF) in Myeloid Cells	5/31	0.02718721157158261	0.2986087705215195	0	0	3.2642110364882644	11.76750879037262	CSF1;STAT1;INPP5D;KRAS;GAB2
Tight Junction Interactions	5/31	0.02718721157158261	0.2986087705215195	0	0	3.2642110364882644	11.76750879037262	CLDN6;CLDN4;CLDN7;CLDN1;CRB3
Sensory Processing of Sound	9/77	0.027234299628348557	0.2986087705215195	0	0	2.249641319942611	8.106083265785406	CLIC5;PCDH15;USH1C;OTOG;MSN;EPS8L2;SLC17A8;ESPN;BSN
Activation of RAS in B Cells	2/5	0.02778638847522445	0.2986087705215195	0	0	11.299222022740874	40.48747406051563	KRAS;RASGRP1
Drug-mediated Inhibition of CDK4 CDK6 Activity	2/5	0.02778638847522445	0.2986087705215195	0	0	11.299222022740874	40.48747406051563	CDK6;CCND1
RUNX1 Regulates Transcription of Genes Involved in Interleukin Signaling	2/5	0.02778638847522445	0.2986087705215195	0	0	11.299222022740874	40.48747406051563	LIFR;RUNX1
Reelin Signalling Pathway	2/5	0.02778638847522445	0.2986087705215195	0	0	11.299222022740874	40.48747406051563	DAB1;VLDLR
Serotonin and Melatonin Biosynthesis	2/5	0.02778638847522445	0.2986087705215195	0	0	11.299222022740874	40.48747406051563	DDC;TPH1
Toxicity of Botulinum Toxin Type E (botE)	2/5	0.02778638847522445	0.2986087705215195	0	0	11.299222022740874	40.48747406051563	SV2B;SV2A
Neutrophil Degranulation	37/478	0.027951841624007077	0.2986087705215195	0	0	1.434079594148441	5.130093052695532	CD63;MVP;SLC2A3;LGALS3;PRDX4;ANPEP;PSAP;NEU1;TIMP2;PGM2;CTSH;SIRPA;STOM;QSOX1;PRSS2;CTSC;GSDMD;SERPINB1;PTPRN2;ANXA2;HLA-B;IRAG2;ATP11B;NBEAL2;TMC6;AMPD3;DDOST;VAMP8;NFASC;TCN1;RAB37;CEACAM6;GLB1;QPCT;S100P;HPSE;CD47
Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion	6/42	0.027994572236392457	0.2986087705215195	0	0	2.83003003003003	10.119464700442968	GLP1R;GNG2;GNG4;KCNS3;ADCY8;GNG11
NCAM1 Interactions	6/42	0.027994572236392457	0.2986087705215195	0	0	2.83003003003003	10.119464700442968	COL2A1;COL6A1;COL9A3;CACNA1C;COL9A2;CACNA1G
Diseases of Signal Transduction by Growth Factor Receptors and Second Messengers	35/451	0.03082263970318088	0.32297510174744337	0	0	1.4373710239806448	5.001340820047319	CDKN1A;IRS1;IHH;PDGFA;AREG;DLL1;FXR1;NEURL1B;SPRED2;SHH;FGF9;ERBB4;AKT3;NTF3;CNTRL;LMNA;KDR;POLR2H;FGB;NTRK2;TCF7L2;JAG1;STAT1;BCL11A;MSN;GAB2;TYK2;DUSP6;KAT2B;FGF19;NEURL1;NOX4;KRAS;SQSTM1;BCL2L1
Aspirin ADME	6/43	0.03105216357731918	0.32297510174744337	0	0	2.7533966398831264	9.560032108130887	GLYATL2;UGT2B15;UGT2A3;UGT3A1;CYP2E1;UGT2B7
Common Pathway of Fibrin Clot Formation	4/22	0.03154872852873353	0.32297510174744337	0	0	3.7701838529176657	13.030592342588298	FGB;THBD;F2;F5
NPAS4 Regulates Expression of Target Genes	4/22	0.03154872852873353	0.32297510174744337	0	0	3.7701838529176657	13.030592342588298	RET;PLK2;SYT10;GEM
Cell-cell Junction Organization	10/92	0.032226673779798896	0.32297510174744337	0	0	2.073170731707317	7.121260176656331	CLDN6;CLDN4;ZEB2;CADM2;CLDN7;CDH13;CLDN1;CDH17;AMOT;CRB3
Sensory Processing of Sound by Outer Hair Cells of the Cochlea	7/55	0.03243833352389992	0.32297510174744337	0	0	2.476931169221521	8.491946543060951	CLIC5;PCDH15;USH1C;OTOG;MSN;EPS8L2;ESPN
Signaling by Non-Receptor Tyrosine Kinases	7/55	0.03243833352389992	0.32297510174744337	0	0	2.476931169221521	8.491946543060951	KHDRBS3;CCND1;ERBB4;ELMO1;STAP2;KRAS;NR3C1
Signaling by PTK6	7/55	0.03243833352389992	0.32297510174744337	0	0	2.476931169221521	8.491946543060951	KHDRBS3;CCND1;ERBB4;ELMO1;STAP2;KRAS;NR3C1
Advanced Glycosylation Endproduct Receptor Signaling	3/13	0.03254468499751024	0.32297510174744337	0	0	5.08733153638814	17.42482889923815	APP;LGALS3;DDOST
Nephron Development	3/13	0.03254468499751024	0.32297510174744337	0	0	5.08733153638814	17.42482889923815	JAG1;HNF1B;DLL1
Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	3/13	0.03254468499751024	0.32297510174744337	0	0	5.08733153638814	17.42482889923815	GPR119;PAX6;GIP
Diseases of Glycosylation	14/146	0.03377780077959149	0.3331043498264117	0	0	1.8047626904251224	6.114448417133415	SEMA5B;HSPG2;THBS1;THSD4;ADAMTS16;ADAMTSL1;EXT2;VCAN;GLB1;ADAMTS18;NEU1;GPC3;GPC4;ADAMTS9
Bile Acid and Bile Salt Metabolism	6/44	0.034319631900886945	0.3335748084310177	0	0	2.680796586059744	9.039747234430234	CH25H;OSBPL6;SLC10A2;AKR1D1;HSD17B4;AKR1C2
Transcriptional Regulation by RUNX2	11/106	0.03432264015786146	0.3335748084310177	0	0	1.9688402000476304	6.6388308693579825	LGALS3;CDKN1A;CCND1;MSX2;DLX5;STAT1;AKT3;IHH;BAX;NR3C1;RUNX1
Glucagon-type Ligand Receptors	5/33	0.034676462866234624	0.3335748084310177	0	0	3.030731644593031	10.18839276634695	GLP1R;GNG2;GNG4;GNG11;GIP
Synthesis of Bile Acids and Bile Salts	5/33	0.034676462866234624	0.3335748084310177	0	0	3.030731644593031	10.18839276634695	CH25H;OSBPL6;AKR1D1;HSD17B4;AKR1C2
Gastrulation	12/120	0.03577816921087017	0.3418512137705337	0	0	1.8896940418679549	6.293469861319796	FOXA1;BMP4;KAT2B;TCF7L2;SHH;ZEB2;DLX5;MYB;CLDN7;IHH;PAX6;DLL1
Transport of Inorganic Cations Anions and Amino Acids Oligopeptides	11/107	0.03640770034250833	0.3418512137705337	0	0	1.9482277526395173	6.454429797579191	SLC9A2;SLC9A4;SLC12A4;SLC24A3;SLC43A2;SLC1A3;SLC17A6;SLC17A8;SLC38A3;SLC12A7;SLC8B1
Long-term Potentiation	4/23	0.0365547871887871	0.3418512137705337	0	0	3.571563801590307	11.818101486505423	DLG2;DLG4;ERBB4;NRGN
RAF-independent MAPK1 3 Activation	4/23	0.0365547871887871	0.3418512137705337	0	0	3.571563801590307	11.818101486505423	DUSP4;DUSP5;TYK2;DUSP6
Signaling by TGF-beta Receptor Complex	10/94	0.03662691576112861	0.3418512137705337	0	0	2.0235942478257125	6.6919693257756325	TGIF1;TGFBR3;PPP1R15A;TGFB2;STAT1;SERPINE1;ITGA8;FURIN;LTBP1;FBN1
Muscle Contraction	18/204	0.0369163778738164	0.3425140858351723	0	0	1.6479816675480345	5.436856289063036	KCNK5;RYR2;ANXA2;TNNC1;TMOD2;ITGA1;ATP2B4;KCNK16;ATP1B3;KCNK17;CACNA1C;MYL12A;CACNA1G;KAT2B;PDE5A;NKX2-5;MYH6;KCNK3
Sensory Processing of Sound by Inner Hair Cells of the Cochlea	8/69	0.0377182446895831	0.34740542930738916	0	0	2.2279694620346806	7.302418013085198	CLIC5;PCDH15;USH1C;MSN;EPS8L2;SLC17A8;ESPN;BSN
G Alpha (Q) Signalling Events	19/219	0.037886689037986955	0.34740542930738916	0	0	1.6180309936189607	5.296066950958227	DGKG;APP;GPR39;CASR;DGKD;TRPC3;RGS16;F2;GNG11;RASGRP1;CYSLTR2;GNG2;GRK5;MT-RNR2;GNG4;P2RY1;F2RL1;GAST;KRAS
Integration of Energy Metabolism	11/108	0.038579956200580585	0.3517056472238974	0	0	1.9280403041470355	6.275814391199392	GLP1R;GNG2;ABCC8;GNG4;STXBP1;KCNS3;CACNA1A;CACNA1C;ADCY8;ACACB;GNG11
Citric Acid Cycle (TCA Cycle)	5/34	0.038853904970283966	0.3521556242393368	0	0	2.926068468915857	9.503714407645388	MRPS36;SDHAF4;SUCLG1;ISCU;ACAT1
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	3/14	0.039743190785223925	0.3537174822207572	0	0	4.624601813281059	14.915805706901523	CCNA1;CDKN1A;ARID3A
Activated NTRK3 Signals Through PI3K	2/6	0.040154152956182895	0.3537174822207572	0	0	8.473967684021543	27.24405530588455	IRS1;NTF3
Toxicity of Botulinum Toxin Type D (botD)	2/6	0.040154152956182895	0.3537174822207572	0	0	8.473967684021543	27.24405530588455	SV2B;SV2A
Toxicity of Botulinum Toxin Type F (botF)	2/6	0.040154152956182895	0.3537174822207572	0	0	8.473967684021543	27.24405530588455	SV2B;SV2A
VLDL Clearance	2/6	0.040154152956182895	0.3537174822207572	0	0	8.473967684021543	27.24405530588455	APOC1;VLDLR
Constitutive Signaling by Aberrant PI3K in Cancer	9/83	0.04143871847053414	0.35979431236701553	0	0	2.066578773895847	6.579035376542058	NTRK2;FGF9;IRS1;ERBB4;FGF19;NTF3;PDGFA;GAB2;AREG
Early SARS-CoV-2 Infection Events	6/46	0.04149960429483476	0.35979431236701553	0	0	2.5464864864864865	8.103101785661993	CTSL;GPC3;FURIN;GPC4;HSPG2;ISCU
Glycosphingolipid Metabolism	7/58	0.04169932113785979	0.35979431236701553	0	0	2.3308580420445906	7.405766333463594	SMPD3;UGT8;GLB1;ARSJ;NEU1;PSAP;ST6GALNAC5
Estrogen-dependent Nuclear Events Downstream of ESR-membrane Signaling	4/24	0.04199130048671163	0.35979431236701553	0	0	3.3928057553956834	10.756187703668356	CCND1;AKT3;BCL2;AREG
Xenobiotics	4/24	0.04199130048671163	0.35979431236701553	0	0	3.3928057553956834	10.756187703668356	CYP2B6;CYP1A1;CYP2E1;CYP3A5
PI3K AKT Signaling in Cancer	11/110	0.04319191173366269	0.36720775711410164	0	0	1.8888888888888888	5.935081611559094	NTRK2;CDKN1A;FGF9;IRS1;ERBB4;FGF19;AKT3;NTF3;PDGFA;GAB2;AREG
Transcriptional Regulation by NPAS4	5/35	0.04332489481256939	0.36720775711410164	0	0	2.8283828382838285	8.878372559945353	RET;PLK2;SYT10;NR3C1;GEM
Activation of BAD and Translocation to Mitochondria	3/15	0.04767376027681058	0.39480668501617555	0	0	4.238993710691824	12.900843802568534	AKT3;BCL2;BID
ADP Signalling Through P2Y Purinoceptor 1	4/25	0.0478585936138448	0.39480668501617555	0	0	3.2310722850291196	9.820859016258847	GNG2;GNG4;P2RY1;GNG11
G Beta Gamma Signalling Through PI3Kgamma	4/25	0.0478585936138448	0.39480668501617555	0	0	3.2310722850291196	9.820859016258847	GNG2;GNG4;AKT3;GNG11
Inflammasomes	4/25	0.0478585936138448	0.39480668501617555	0	0	3.2310722850291196	9.820859016258847	APP;BCL2;TXN;BCL2L1
NOTCH3 Activation and Transmission of Signal to the Nucleus	4/25	0.0478585936138448	0.39480668501617555	0	0	3.2310722850291196	9.820859016258847	NEURL1B;JAG1;NEURL1;DLL1
Signaling by NOTCH2	5/36	0.048091885738577506	0.39480668501617555	0	0	2.736999506402253	8.30581314090791	NEURL1B;JAG1;NEURL1;CNTN1;DLL1
Signaling by Nuclear Receptors	22/270	0.04878366740265243	0.3983999504549948	0	0	1.5111458394763224	4.5642040042208984	FOXA1;NOS3;GNG11;AREG;RUNX1;KAT2B;GNG2;CCND1;ERBB4;GNG4;ALDH1A2;AKT3;MYB;ALDH1A1;APOC1;TFF3;BCL2;TFF1;KRAS;APOE;POLR2H;FKBP5
Visual Phototransduction	10/99	0.04940477179470971	0.40138177292282295	0	0	1.9094012231546011	5.7429218389731735	RETSAT;LRP1;GPC3;LRAT;APOE;GPC4;PPEF1;LRP10;RGS9;HSPG2
A Tetrasaccharide Linker Sequence Is Required for GAG Synthesis	4/26	0.05415480358710733	0.41231221875254065	0	0	3.0840418574231525	8.992784176566813	VCAN;GPC3;GPC4;HSPG2
Glucuronidation	4/26	0.05415480358710733	0.41231221875254065	0	0	3.0840418574231525	8.992784176566813	UGT2B15;UGT2A3;UGT3A1;UGT2B7
Cation-coupled Chloride Cotransporters	2/7	0.0541685695554996	0.41231221875254065	0	0	6.778815080789946	19.76468226277026	SLC12A4;SLC12A7
Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1 M1580 K2555) Translocation Mutant	2/7	0.0541685695554996	0.41231221875254065	0	0	6.778815080789946	19.76468226277026	JAG1;DLL1
Defective Factor VIII Causes Hemophilia A	2/7	0.0541685695554996	0.41231221875254065	0	0	6.778815080789946	19.76468226277026	TPST1;F2
Glycine Degradation	2/7	0.0541685695554996	0.41231221875254065	0	0	6.778815080789946	19.76468226277026	GLDC;MRPS36
NrCAM Interactions	2/7	0.0541685695554996	0.41231221875254065	0	0	6.778815080789946	19.76468226277026	DLG4;NRCAM
RAS Signaling Downstream of NF1 Loss-Of-Function Variants	2/7	0.0541685695554996	0.41231221875254065	0	0	6.778815080789946	19.76468226277026	SPRED2;KRAS
RUNX1 Regulates Transcription of Genes Involved in Differentiation of Myeloid Cells	2/7	0.0541685695554996	0.41231221875254065	0	0	6.778815080789946	19.76468226277026	LGALS3;RUNX1
Release of Apoptotic Factors From the Mitochondria	2/7	0.0541685695554996	0.41231221875254065	0	0	6.778815080789946	19.76468226277026	GSDMD;BAX
SOS-mediated Signalling	2/7	0.0541685695554996	0.41231221875254065	0	0	6.778815080789946	19.76468226277026	IRS1;KRAS
Scavenging by Class F Receptors	2/7	0.0541685695554996	0.41231221875254065	0	0	6.778815080789946	19.76468226277026	HYOU1;CALR
Signaling by NOTCH1 t(7;9)(NOTCH1 M1580 K2555) Translocation Mutant	2/7	0.0541685695554996	0.41231221875254065	0	0	6.778815080789946	19.76468226277026	JAG1;DLL1
Signal Regulatory Protein Family Interactions	3/16	0.05631480397771668	0.4265778388263756	0	0	3.912709931577856	11.256075441783235	SIRPA;CD47;SKAP2
Metabolism of Carbohydrates	23/290	0.05725449502041915	0.4316108086154674	0	0	1.467256734205756	4.1967197886796646	PRPS2;SLC35B2;CEMIP;SLC37A1;NUP155;ADPGK;GBE1;HSPG2;HS3ST4;PGM2L1;GCK;HS6ST3;EXT2;VCAN;PPP1R3C;GLB1;ALDH1A1;GPC3;PGM2;CHSY3;GPC4;HPSE;CHST2
FLT3 Signaling	5/38	0.05851858553701841	0.43486797214239276	0	0	2.570847993890298	7.297122900522151	SOCS2;SYK;AKT3;KRAS;GAB2
Signaling by FGFR1 in Disease	5/38	0.05851858553701841	0.43486797214239276	0	0	2.570847993890298	7.297122900522151	FGF9;STAT1;CNTRL;KRAS;GAB2
rRNA Processing in the Mitochondrion	5/38	0.05851858553701841	0.43486797214239276	0	0	2.570847993890298	7.297122900522151	MT-CO1;MT-RNR2;MT-CO2;MT-ND3;MT-ND1
Ca2+ Pathway	7/63	0.06063202447007683	0.4419147704783431	0	0	2.1221821460775474	5.948332393264345	GNAO1;TCF7L2;GNG2;GNG4;KRAS;AXIN2;GNG11
NCAM Signaling for Neurite Out-Growth	7/63	0.06063202447007683	0.4419147704783431	0	0	2.1221821460775474	5.948332393264345	COL2A1;COL6A1;COL9A3;KRAS;CACNA1C;COL9A2;CACNA1G
Cell Recruitment (Pro-Inflammatory Response)	4/27	0.06087601430058808	0.4419147704783431	0	0	2.9497966843916172	8.256233241987216	GSDMD;APP;NT5E;TXN
Effects of PIP2 Hydrolysis	4/27	0.06087601430058808	0.4419147704783431	0	0	2.9497966843916172	8.256233241987216	DGKG;DGKD;TRPC3;RASGRP1
Purinergic Signaling in Leishmaniasis Infection	4/27	0.06087601430058808	0.4419147704783431	0	0	2.9497966843916172	8.256233241987216	GSDMD;APP;NT5E;TXN
Glycosphingolipid Catabolism	5/39	0.06417816872129997	0.45859195046672907	0	0	2.4951024514216127	6.851781323128476	SMPD3;GLB1;ARSJ;NEU1;PSAP
Diseases of Metabolism	21/264	0.06522668046423692	0.45859195046672907	0	0	1.4711877783415075	4.016175926020996	SEMA5B;MAOA;GBE1;HSPG2;THBS1;THSD4;ACAT1;ADAMTS16;ADAMTSL1;EXT2;VCAN;PPP1R3C;GLB1;ADAMTS18;FDX1;NEU1;FDXR;GPC3;CYP1B1;GPC4;ADAMTS9
Negative Regulation of the PI3K AKT Network	11/118	0.06538754763466505	0.45859195046672907	0	0	1.74691927094346	4.764588570481768	IL33;NTRK2;FGF9;IRS1;ERBB4;FGF19;AKT3;NTF3;PDGFA;GAB2;AREG
Aberrant Regulation of Mitotic G1 S Transition in Cancer Due to RB1 Defects	3/17	0.06564027475086215	0.45859195046672907	0	0	3.633038120908741	9.894818474462241	CDKN1A;CDK6;CCND1
Defective Binding of RB1 Mutants to E2F1,(E2F2, E2F3)	3/17	0.06564027475086215	0.45859195046672907	0	0	3.633038120908741	9.894818474462241	CDKN1A;CDK6;CCND1
Regulation of MITF-M-dependent Genes Involved in Cell Cycle and Proliferation	3/17	0.06564027475086215	0.45859195046672907	0	0	3.633038120908741	9.894818474462241	TCF7L2;CDKN1A;CCND1
Specification of the Neural Plate Border	3/17	0.06564027475086215	0.45859195046672907	0	0	3.633038120908741	9.894818474462241	BMP4;DLX5;MYB
Adrenaline,noradrenaline Inhibits Insulin Secretion	4/28	0.0680163978036939	0.45859195046672907	0	0	2.82673860911271	7.598291638364746	GNG2;GNG4;CACNA1C;GNG11
KEAP1-NFE2L2 Pathway	11/119	0.06860005870351135	0.45859195046672907	0	0	1.730651918887213	4.637215858942509	CDKN1A;SESN1;AKT3;SESN2;GSTA1;BCL2;PDGFA;TXN;SQSTM1;AREG;BCL2L1
Interferon Alpha Beta Signaling	8/78	0.06880304128900563	0.45859195046672907	0	0	1.940587931923672	5.193997824764688	STAT1;MX1;HLA-B;IFI6;ISG15;TYK2;SAMHD1;IP6K2
Cytochrome P450 - Arranged by Substrate Type	7/65	0.06946708489477935	0.45859195046672907	0	0	2.048785796461553	5.463911424190236	CYP2B6;FDX1;FDXR;CYP1A1;CYP1B1;CYP2E1;CYP3A5
Activated NTRK3 Signals Through RAS	2/8	0.06960770676727138	0.45859195046672907	0	0	5.648713345302214	15.053143153860958	NTF3;KRAS
Binding of TCF LEF CTNNB1 to Target Gene Promoters	2/8	0.06960770676727138	0.45859195046672907	0	0	5.648713345302214	15.053143153860958	TCF7L2;AXIN2
RUNX1 Regulates Transcription of Genes Involved in Differentiation of Keratinocytes	2/8	0.06960770676727138	0.45859195046672907	0	0	5.648713345302214	15.053143153860958	CTSL;RUNX1
RUNX3 Regulates WNT Signaling	2/8	0.06960770676727138	0.45859195046672907	0	0	5.648713345302214	15.053143153860958	TCF7L2;CCND1
Release of Hh-Np From the Secreting Cell	2/8	0.06960770676727138	0.45859195046672907	0	0	5.648713345302214	15.053143153860958	SHH;IHH
Synthesis of Ketone Bodies	2/8	0.06960770676727138	0.45859195046672907	0	0	5.648713345302214	15.053143153860958	HMGCS2;ACAT1
Synthesis of Epoxy (EET) and Dihydroxyeicosatrienoic Acids (DHET)	2/8	0.06960770676727138	0.45859195046672907	0	0	5.648713345302214	15.053143153860958	CYP1A1;CYP1B1
TGFBR3 Regulates TGF-beta Signaling	2/8	0.06960770676727138	0.45859195046672907	0	0	5.648713345302214	15.053143153860958	TGFBR3;TGFB2
VEGF Binds to VEGFR Leading to Receptor Dimerization	2/8	0.06960770676727138	0.45859195046672907	0	0	5.648713345302214	15.053143153860958	KDR;PGF
VEGF Ligand-Receptor Interactions	2/8	0.06960770676727138	0.45859195046672907	0	0	5.648713345302214	15.053143153860958	KDR;PGF
Vitamin C (Ascorbate) Metabolism	2/8	0.06960770676727138	0.45859195046672907	0	0	5.648713345302214	15.053143153860958	GSTO1;SLC2A3
EPH-Ephrin Signaling	9/92	0.07091052258793623	0.4652204996564185	0	0	1.8416103438142815	4.873520564722538	EFNB2;ARHGEF28;LIMK2;CLTCL1;EFNA5;PAK3;DNM1;MYL12A;EPHA2
Activation of NMDA Receptors and Postsynaptic Events	9/93	0.07482475396816961	0.4761964757550353	0	0	1.8195896244676733	4.71747991201062	DLG2;NBEA;ERBB4;DLG4;KRAS;ADCY8;PRKAB1;PPM1E;NRGN
Cellular Responses to Mechanical Stimuli	9/93	0.07482475396816961	0.4761964757550353	0	0	1.8195896244676733	4.71747991201062	MMP14;GNG2;ANXA2;GNG4;NOS3;STAT1;KDR;ADCY8;GNG11
Response of Endothelial Cells to Shear Stress	9/93	0.07482475396816961	0.4761964757550353	0	0	1.8195896244676733	4.71747991201062	MMP14;GNG2;ANXA2;GNG4;NOS3;STAT1;KDR;ADCY8;GNG11
Activation of SMO	3/18	0.07562048626467079	0.4761964757550353	0	0	3.3906558849955077	8.754768603528374	SHH;IHH;GAS1
Caspase Activation via Death Receptors in the Presence of Ligand	3/18	0.07562048626467079	0.4761964757550353	0	0	3.3906558849955077	8.754768603528374	TNFRSF10B;FAS;TNFRSF10A
Cell-extracellular Matrix Interactions	3/18	0.07562048626467079	0.4761964757550353	0	0	3.3906558849955077	8.754768603528374	VASP;FBLIM1;FLNC
G Beta Gamma Signalling Through BTK	3/18	0.07562048626467079	0.4761964757550353	0	0	3.3906558849955077	8.754768603528374	GNG2;GNG4;GNG11
MECP2 Regulates Neuronal Receptors and Channels	3/18	0.07562048626467079	0.4761964757550353	0	0	3.3906558849955077	8.754768603528374	TRPC3;SLC2A3;FKBP5
Metabolism of Amine-Derived Hormones	3/18	0.07562048626467079	0.4761964757550353	0	0	3.3906558849955077	8.754768603528374	DDC;TPH1;DUOX2
Signaling by Cytosolic FGFR1 Fusion Mutants	3/18	0.07562048626467079	0.4761964757550353	0	0	3.3906558849955077	8.754768603528374	STAT1;CNTRL;GAB2
Diseases Associated With Glycosaminoglycan Metabolism	5/41	0.07638234144454104	0.4790700455401614	0	0	2.3562356235623563	6.060246841896033	EXT2;VCAN;GPC3;GPC4;HSPG2
FOXO-mediated Transcription	7/67	0.07903050978975759	0.49370453924438207	0	0	1.980282536819958	5.0258012325912125	KAT2B;CDKN1A;AKT3;TXN;NR3C1;KLF4;GCK
RND1 GTPase Cycle	5/42	0.08292123359438734	0.4991518887075521	0	0	2.2924319458972926	5.707844037259278	CCDC88A;STMN2;EPSTI1;PTPN13;EPHA2
tRNA Processing in the Mitochondrion	5/42	0.08292123359438734	0.4991518887075521	0	0	2.2924319458972926	5.707844037259278	MT-CO1;MT-RNR2;MT-CO2;MT-ND3;MT-ND1
Unfolded Protein Response (UPR)	9/95	0.08304410150584814	0.4991518887075521	0	0	1.777084515031197	4.4220677299609985	ACADVL;HSPA5;CREB3L1;LMNA;HYOU1;CALR;PDIA6;ATF3;HERPUD1
Intrinsic Pathway for Apoptosis	6/55	0.08486382286475526	0.4991518887075521	0	0	2.0777716492002205	5.12525468419306	GSDMD;AKT3;BCL2;BAX;BID;BCL2L1
Biosynthesis of Specialized Proresolving Mediators (SPMs)	3/19	0.08622283996608017	0.4991518887075521	0	0	3.1785714285714284	7.79010697403256	CYP1A1;CYP2E1;PTGR1
Ephrin Signaling	3/19	0.08622283996608017	0.4991518887075521	0	0	3.1785714285714284	7.79010697403256	EFNB2;PAK3;MYL12A
Plasma Lipoprotein Assembly	3/19	0.08622283996608017	0.4991518887075521	0	0	3.1785714285714284	7.79010697403256	SAR1B;APOC1;APOE
Prostacyclin Signalling Through Prostacyclin Receptor	3/19	0.08622283996608017	0.4991518887075521	0	0	3.1785714285714284	7.79010697403256	GNG2;GNG4;GNG11
Synthesis, Secretion, and Deacylation of Ghrelin	3/19	0.08622283996608017	0.4991518887075521	0	0	3.1785714285714284	7.79010697403256	ACHE;KLF4;PLA2G7
Activated NTRK2 Signals Through RAS	2/9	0.08626923586718535	0.4991518887075521	0	0	4.841497819953834	11.863036042813683	NTRK2;KRAS
Beta-oxidation of pristanoyl-CoA	2/9	0.08626923586718535	0.4991518887075521	0	0	4.841497819953834	11.863036042813683	HSD17B4;CROT
CD163 Mediating an Anti-Inflammatory Response	2/9	0.08626923586718535	0.4991518887075521	0	0	4.841497819953834	11.863036042813683	PLK2;FURIN
CHL1 Interactions	2/9	0.08626923586718535	0.4991518887075521	0	0	4.841497819953834	11.863036042813683	CHL1;ITGA1
Formyl Peptide Receptors Bind Formyl Peptides and Many Other Ligands	2/9	0.08626923586718535	0.4991518887075521	0	0	4.841497819953834	11.863036042813683	APP;MT-RNR2
ROBO Receptors Bind AKAP5	2/9	0.08626923586718535	0.4991518887075521	0	0	4.841497819953834	11.863036042813683	ROBO2;ROBO3
Serine Biosynthesis	2/9	0.08626923586718535	0.4991518887075521	0	0	4.841497819953834	11.863036042813683	PSAT1;SERINC2
Sodium Proton Exchangers	2/9	0.08626923586718535	0.4991518887075521	0	0	4.841497819953834	11.863036042813683	SLC9A2;SLC9A4
Synthesis of (16-20)-Hydroxyeicosatetraenoic Acids (HETE)	2/9	0.08626923586718535	0.4991518887075521	0	0	4.841497819953834	11.863036042813683	CYP1A1;CYP1B1
Toxicity of Botulinum Toxin Type A (botA)	2/9	0.08626923586718535	0.4991518887075521	0	0	4.841497819953834	11.863036042813683	SV2B;SV2A
Transport of Nucleotide Sugars	2/9	0.08626923586718535	0.4991518887075521	0	0	4.841497819953834	11.863036042813683	SLC35A2;SLC35B2
Apoptosis	14/168	0.08728078477494708	0.5031480534085184	0	0	1.5451245669031513	3.7679793135801565	GSDMD;TNFRSF10B;TNFRSF10A;H1-0;CASP6;AKT3;LMNA;BCL2;BAX;FAS;CLSPN;DSG3;BID;BCL2L1
High Laminar Flow Shear Stress Activates Signaling by PIEZO1 and PECAM1 CDH5 KDR in Endothelial Cell	7/69	0.08931967827962577	0.5117160330107343	0	0	1.9161988423165304	4.628642407943353	MMP14;GNG2;GNG4;NOS3;KDR;ADCY8;GNG11
Vasopressin Regulates Renal Water Homeostasis via Aquaporins	5/43	0.0897461154833877	0.5117160330107343	0	0	2.2319863565303897	5.380806940775442	GNG2;GNG4;ADCY8;GNG11;AQP1
Voltage Gated Potassium Channels	5/43	0.0897461154833877	0.5117160330107343	0	0	2.2319863565303897	5.380806940775442	KCNH5;KCNH6;KCNC3;KCNB2;KCNS3
PI5P, PP2A and IER3 Regulate PI3K AKT Signaling	10/111	0.09122346881339939	0.5182550692007618	0	0	1.681467423415036	4.026178038807778	IL33;NTRK2;FGF9;IRS1;ERBB4;FGF19;NTF3;PDGFA;GAB2;AREG
FGFR1 Mutant Receptor Activation	4/31	0.09186868649859244	0.5200364636454619	0	0	2.5122568611777245	5.997749575091097	FGF9;STAT1;CNTRL;GAB2
MHC Class II Antigen Presentation	11/126	0.09390200769741831	0.5296343455739277	0	0	1.6247019476686997	3.8432381627855348	SAR1B;CTSL;KIF5A;AP1S1;CTSH;CTSF;HLA-DOA;HLA-DRB1;CTSC;DNM1;DYNC1I1
Smooth Muscle Contraction	5/44	0.09685207899328875	0.530356776692326	0	0	2.1746405409771747	5.076851488152642	ANXA2;ITGA1;PDE5A;MYL12A;CACNA1G
Uptake and Actions of Bacterial Toxins	5/44	0.09685207899328875	0.530356776692326	0	0	2.1746405409771747	5.076851488152642	SYT2;SV2B;SV2A;CD9;FURIN
G Beta Gamma Signalling Through CDC42	3/20	0.09741246918838639	0.530356776692326	0	0	2.9914380846678292	6.966464170870842	GNG2;GNG4;GNG11
G Beta Gamma Signalling Through PLC Beta	3/20	0.09741246918838639	0.530356776692326	0	0	2.9914380846678292	6.966464170870842	GNG2;GNG4;GNG11
Maturation of TCA Enzymes and Regulation of TCA Cycle	3/20	0.09741246918838639	0.530356776692326	0	0	2.9914380846678292	6.966464170870842	SDHAF4;ISCU;ACAT1
Ras Activation Upon Ca2+ Influx Through NMDA Receptor	3/20	0.09741246918838639	0.530356776692326	0	0	2.9914380846678292	6.966464170870842	DLG2;DLG4;KRAS
Receptor-type Tyrosine-Protein Phosphatases	3/20	0.09741246918838639	0.530356776692326	0	0	2.9914380846678292	6.966464170870842	PTPRD;SLITRK2;SLITRK6
SHC-mediated Cascade FGFR4	3/20	0.09741246918838639	0.530356776692326	0	0	2.9914380846678292	6.966464170870842	FGF9;FGF19;KRAS
Signaling by PDGFR in Disease	3/20	0.09741246918838639	0.530356776692326	0	0	2.9914380846678292	6.966464170870842	STAT1;KDR;KRAS
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	3/20	0.09741246918838639	0.530356776692326	0	0	2.9914380846678292	6.966464170870842	STEAP3;BAX;BID
Diseases Associated With O-glycosylation of Proteins	7/71	0.10032669891293845	0.5372167883931535	0	0	1.8561203787195673	4.267821073609583	ADAMTSL1;ADAMTS16;SEMA5B;ADAMTS18;ADAMTS9;THBS1;THSD4
G-protein Beta Gamma Signalling	4/32	0.10059435039846107	0.5372167883931535	0	0	2.4224049331963	5.563438532237161	GNG2;GNG4;AKT3;GNG11
Respiratory Syncytial Virus (RSV) Attachment and Entry	4/32	0.10059435039846107	0.5372167883931535	0	0	2.4224049331963	5.563438532237161	GPC3;FURIN;GPC4;HSPG2
Thrombin Signalling Through Proteinase Activated Receptors (PARs)	4/32	0.10059435039846107	0.5372167883931535	0	0	2.4224049331963	5.563438532237161	GNG2;GNG4;F2;GNG11
Signaling by ERBB4	6/58	0.10334191980612421	0.5372167883931535	0	0	1.9575883575883577	4.443162136149091	GABRB3;GABRB2;ERBB4;DLG4;KRAS;APOE
ATF6 (ATF6-alpha) Activates Chaperone Genes	2/10	0.1039689374466463	0.5372167883931535	0	0	4.23608617594255	9.589071976981186	HSPA5;CALR
Activation of Ca-permeable Kainate Receptor	2/10	0.1039689374466463	0.5372167883931535	0	0	4.23608617594255	9.589071976981186	DLG4;GRIK5
Chylomicron Assembly	2/10	0.1039689374466463	0.5372167883931535	0	0	4.23608617594255	9.589071976981186	SAR1B;APOE
Ionotropic Activity of Kainate Receptors	2/10	0.1039689374466463	0.5372167883931535	0	0	4.23608617594255	9.589071976981186	DLG4;GRIK5
Prednisone ADME	2/10	0.1039689374466463	0.5372167883931535	0	0	4.23608617594255	9.589071976981186	ABCB1;UGT2B7
Regulation of FOXO Transcriptional Activity by Acetylation	2/10	0.1039689374466463	0.5372167883931535	0	0	4.23608617594255	9.589071976981186	KAT2B;TXN
Regulation of Commissural Axon Pathfinding by SLIT and ROBO	2/10	0.1039689374466463	0.5372167883931535	0	0	4.23608617594255	9.589071976981186	ROBO2;ROBO3
Removal of Aminoterminal Propeptides From Gamma-Carboxylated Proteins	2/10	0.1039689374466463	0.5372167883931535	0	0	4.23608617594255	9.589071976981186	FURIN;F2
Role of Second Messengers in Netrin-1 Signaling	2/10	0.1039689374466463	0.5372167883931535	0	0	4.23608617594255	9.589071976981186	TRPC3;TRPC4
Tetrahydrobiopterin (BH4) Synthesis, Recycling, Salvage and Regulation	2/10	0.1039689374466463	0.5372167883931535	0	0	4.23608617594255	9.589071976981186	GCH1;NOS3
G Alpha (S) Signalling Events	13/158	0.10415427530071343	0.5372167883931535	0	0	1.5231625347797544	3.445214015938482	GLP1R;GPR39;GPR83;PTH1R;ADCY8;GNG11;GIP;PDE11A;CYSLTR2;GNG2;GRK5;GNG4;RAMP1
Generic Transcription Pathway	79/1230	0.1045253785049098	0.5373632573629461	0	0	1.1736949212751144	2.650585029745062	RET;CDKN1A;BTG2;STEAP3;MRE11;MT-CO1;SERPINE1;IHH;SLC2A3;CHD3;NR3C1;LGALS3;PIDD1;CCND1;CTSL;CASP6;SESN1;AKT3;SESN2;MYB;ZNF248;PITX2;TGIF1;ZNF560;SUPT16H;ITGA4;MSX2;TRPC3;IGFBP3;LIFR;PRKAB1;GEM;DDB2;RUNX1;CCNA1;KAT2B;MSH2;ZNF717;RRAGD;ZNF558;MT-CO2;SGK1;FKBP5;DLX5;FURIN;COX7A2;TXN;NDRG1;THBS1;DLL1;NUAK1;ZNF703;APOE;ZNF589;POLR2H;BID;NKX2-5;PLK3;TCF7L2;JAG1;AUTS2;STAT1;NDUFA4;PLK2;TNFRSF10C;TNFRSF10B;GAD2;TNFRSF10A;ESRRG;ARID3A;KLF4;SMARCA2;GCK;TNFRSF10D;CDK6;SYT10;FAS;BAX;KRAS
Transcriptional Regulation by RUNX3	8/86	0.10665595166658638	0.5420541616077513	0	0	1.740812737202629	3.896194857604943	KAT2B;TCF7L2;CDKN1A;JAG1;CCND1;ITGA4;KRAS;RUNX1
SARS-CoV-2 Infection	23/313	0.10861938453906185	0.5420541616077513	0	0	1.3492191690065305	2.9951389090442175	RPN2;NUP155;SAR1B;STAT1;HLA-B;RPS27L;ISG15;FURIN;TYK2;RPS4Y1;HSPG2;DDOST;ANO1;TRIM4;CTSL;AKT3;GPC3;SNRPG;MGAT1;GPC4;MASP1;ISCU;CRB3
Negative Regulation of NMDA Receptor-Mediated Neuronal Transmission	3/21	0.1091528077262136	0.5420541616077513	0	0	2.825097334531297	6.2576088821647815	DLG2;DLG4;PPM1E
Neurotoxicity of Clostridium Toxins	3/21	0.1091528077262136	0.5420541616077513	0	0	2.825097334531297	6.2576088821647815	SYT2;SV2B;SV2A
Presynaptic Function of Kainate Receptors	3/21	0.1091528077262136	0.5420541616077513	0	0	2.825097334531297	6.2576088821647815	GNG2;GNG4;GNG11
Synaptic Adhesion-Like Molecules	3/21	0.1091528077262136	0.5420541616077513	0	0	2.825097334531297	6.2576088821647815	PTPRD;LRFN2;DLG4
TP53 Regulates Transcription of Additional Cell Cycle Genes With Uncertain Roles in the P53 Pathway	3/21	0.1091528077262136	0.5420541616077513	0	0	2.825097334531297	6.2576088821647815	PLK3;BTG2;PLK2
Cargo Concentration in the ER	4/33	0.10968647791610717	0.5420541616077513	0	0	2.3387496899032496	5.168938942578074	SAR1B;AREG;CTSC;F5
Glucagon Signaling in Metabolic Regulation	4/33	0.10968647791610717	0.5420541616077513	0	0	2.3387496899032496	5.168938942578074	GNG2;GNG4;ADCY8;GNG11
Sialic Acid Metabolism	4/33	0.10968647791610717	0.5420541616077513	0	0	2.3387496899032496	5.168938942578074	ST6GAL2;GLB1;NEU1;ST6GALNAC5
Signal Amplification	4/33	0.10968647791610717	0.5420541616077513	0	0	2.3387496899032496	5.168938942578074	GNG2;GNG4;P2RY1;GNG11
Cytoprotection by HMOX1	6/59	0.1099319026730006	0.5420541616077513	0	0	1.920550739418664	4.240372783631832	FABP1;MT-CO1;NDUFA4;MT-CO2;COX7A2;STAP2
Non-integrin membrane-ECM Interactions	6/59	0.1099319026730006	0.5420541616077513	0	0	1.920550739418664	4.240372783631832	COL2A1;LAMB3;LAMB2;PDGFA;HSPG2;THBS1
Interleukin-12 Signaling	5/46	0.11188394787205254	0.5491011795735129	0	0	2.0683409804395074	4.530273028797869	ANXA2;GSTO1;GSTA2;MSN;TYK2
Platelet Homeostasis	8/87	0.11206146521908425	0.5491011795735129	0	0	1.7186857377873235	3.7617008140839028	PDE11A;GNG2;TRPC3;GNG4;NOS3;ATP2B4;PDE5A;GNG11
Signaling by NOTCH1	7/74	0.11815351331305882	0.5752743810853017	0	0	1.772727884473036	3.7861399906542132	KAT2B;NEURL1B;JAG1;NBEA;NEURL1;CNTN1;DLL1
Metabolic Disorders of Biological Oxidation Enzymes	4/34	0.11913082572308249	0.5752743810853017	0	0	2.260671462829736	4.809653170791295	MAOA;FDX1;FDXR;CYP1B1
ADP Signalling Through P2Y Purinoceptor 12	3/22	0.12140609054948115	0.5752743810853017	0	0	2.676266137040715	5.64321286610522	GNG2;GNG4;GNG11
Cellular Hexose Transport	3/22	0.12140609054948115	0.5752743810853017	0	0	2.676266137040715	5.64321286610522	SLC2A14;SLC2A3;SLC2A8
FRS-mediated FGFR4 Signaling	3/22	0.12140609054948115	0.5752743810853017	0	0	2.676266137040715	5.64321286610522	FGF9;FGF19;KRAS
Activated NTRK2 Signals Through FRS2 and FRS3	2/11	0.12253931331791505	0.5752743810853017	0	0	3.765210452822661	7.904394317056285	NTRK2;KRAS
CYP2E1 Reactions	2/11	0.12253931331791505	0.5752743810853017	0	0	3.765210452822661	7.904394317056285	CYP2B6;CYP2E1
Formation of Annular Gap Junctions	2/11	0.12253931331791505	0.5752743810853017	0	0	3.765210452822661	7.904394317056285	CLTCL1;DNM1
Formation of the Anterior Neural Plate	2/11	0.12253931331791505	0.5752743810853017	0	0	3.765210452822661	7.904394317056285	ZEB2;PAX6
Gamma-carboxylation, Transport, and Amino-Terminal Cleavage of Proteins	2/11	0.12253931331791505	0.5752743810853017	0	0	3.765210452822661	7.904394317056285	FURIN;F2
Interleukin-6 Signaling	2/11	0.12253931331791505	0.5752743810853017	0	0	3.765210452822661	7.904394317056285	STAT1;TYK2
Nef Mediated Downregulation of MHC Class I Complex Cell Surface Expression	2/11	0.12253931331791505	0.5752743810853017	0	0	3.765210452822661	7.904394317056285	PACS1;AP1S1
Sodium Calcium Exchangers	2/11	0.12253931331791505	0.5752743810853017	0	0	3.765210452822661	7.904394317056285	SLC24A3;SLC8B1
Type I Hemidesmosome Assembly	2/11	0.12253931331791505	0.5752743810853017	0	0	3.765210452822661	7.904394317056285	COL17A1;LAMB3
G Alpha (Z) Signalling Events	5/48	0.127963561360896	0.5953912884685013	0	0	1.9719297511146463	4.054306760016518	GNG2;GNG4;RGS16;ADCY8;GNG11
IRS-mediated Signalling	5/48	0.127963561360896	0.5953912884685013	0	0	1.9719297511146463	4.054306760016518	FGF9;IRS1;FGF19;KRAS;GAB2
Inositol Phosphate Metabolism	5/48	0.127963561360896	0.5953912884685013	0	0	1.9719297511146463	4.054306760016518	INPP4B;INPP5D;PLCE1;NUDT4;IP6K2
Nitric Oxide Stimulates Guanylate Cyclase	3/23	0.13413379248880153	0.6204182496237192	0	0	2.542318059299191	5.107307305339911	PDE11A;NOS3;PDE5A
Synthesis of Bile Acids and Bile Salts via 7Alpha-Hydroxycholesterol	3/23	0.13413379248880153	0.6204182496237192	0	0	2.542318059299191	5.107307305339911	AKR1D1;AKR1C2;HSD17B4
Signaling by TGFBR3	5/49	0.13637695950758902	0.6246819358571492	0	0	1.9270108829064725	3.8392463451345415	TGFBR3;MMP14;TGFB2;MMP16;TIMP2
Signaling by Interleukins	31/452	0.13782988804551527	0.6246819358571492	0	0	1.2530030539531727	2.4831200692010627	APP;CDKN1A;CSF1;IRS1;MAOA;PELI2;EBI3;SOCS2;CCND1;INPP5D;GSDMD;DUSP4;IKBIP;IL33;ANXA2;SYK;GSTO1;STAT1;LIF;MSN;LIFR;GAB2;TYK2;PTPN13;DUSP6;GSTA2;BCL2;RHOU;SQSTM1;CRLF1;BCL2L1
Signaling by FGFR in Disease	6/63	0.1383420692350062	0.6246819358571492	0	0	1.7853959222380276	3.5315593729364987	FGF9;STAT1;CNTRL;KRAS;GAB2;POLR2H
Transcriptional Regulation by MECP2	6/63	0.1383420692350062	0.6246819358571492	0	0	1.7853959222380276	3.5315593729364987	TRPC3;GAD2;SLC2A3;SGK1;DLL1;FKBP5
Estrogen-dependent Gene Expression	10/121	0.1384710593848246	0.6246819358571492	0	0	1.5291693139794407	3.0233113727393115	FOXA1;KAT2B;CCND1;ERBB4;MYB;BCL2;TFF3;TFF1;POLR2H;RUNX1
ATF6 (ATF6-alpha) Activates Chaperones	2/12	0.1418282966614446	0.6246819358571492	0	0	3.3885098743267505	6.61822784440176	HSPA5;CALR
Endosomal Vacuolar Pathway	2/12	0.1418282966614446	0.6246819358571492	0	0	3.3885098743267505	6.61822784440176	CTSL;HLA-B
Ethanol Oxidation	2/12	0.1418282966614446	0.6246819358571492	0	0	3.3885098743267505	6.61822784440176	ACSS2;ALDH1A1
Gap Junction Degradation	2/12	0.1418282966614446	0.6246819358571492	0	0	3.3885098743267505	6.61822784440176	CLTCL1;DNM1
Lysine Catabolism	2/12	0.1418282966614446	0.6246819358571492	0	0	3.3885098743267505	6.61822784440176	CRYM;AASS
Organic Anion Transporters	2/12	0.1418282966614446	0.6246819358571492	0	0	3.3885098743267505	6.61822784440176	SLC17A6;SLC17A8
Pregnenolone Biosynthesis	2/12	0.1418282966614446	0.6246819358571492	0	0	3.3885098743267505	6.61822784440176	FDX1;FDXR
Reversible Hydration of Carbon Dioxide	2/12	0.1418282966614446	0.6246819358571492	0	0	3.3885098743267505	6.61822784440176	CA2;CA4
Signaling by PDGFRA Extracellular Domain Mutants	2/12	0.1418282966614446	0.6246819358571492	0	0	3.3885098743267505	6.61822784440176	STAT1;KRAS
Signaling by PDGFRA Transmembrane, Juxtamembrane and Kinase Domain Mutants	2/12	0.1418282966614446	0.6246819358571492	0	0	3.3885098743267505	6.61822784440176	STAT1;KRAS
Specification of Primordial Germ Cells	2/12	0.1418282966614446	0.6246819358571492	0	0	3.3885098743267505	6.61822784440176	BMP4;CBFA2T2
TP53 Regulates Transcription of Caspase Activators and Caspases	2/12	0.1418282966614446	0.6246819358571492	0	0	3.3885098743267505	6.61822784440176	PIDD1;CASP6
Stimuli-sensing Channels	9/107	0.14314031626546597	0.6286947224208702	0	0	1.5584868093578894	3.0295891030880537	UNC80;RYR2;ANO1;TRPC3;TRPC4;SCNN1A;STOM;SGK1;TRPM4
Chondroitin Sulfate Dermatan Sulfate Metabolism	5/50	0.14502805831958512	0.6352066911874567	0	0	1.884088408840884	3.6378507477709543	VCAN;GPC3;CHSY3;GPC4;HSPG2
G-protein Activation	3/24	0.14729701130652137	0.6390913674748551	0	0	2.4211269413425747	4.63719470979243	GNG2;GNG4;GNG11
Growth Hormone Receptor Signaling	3/24	0.14729701130652137	0.6390913674748551	0	0	2.4211269413425747	4.63719470979243	SOCS2;IRS1;STAT1
Thromboxane Signalling Through TP Receptor	3/24	0.14729701130652137	0.6390913674748551	0	0	2.4211269413425747	4.63719470979243	GNG2;GNG4;GNG11
Cellular Responses to Stimuli	57/887	0.14754532846039384	0.6390913674748551	0	0	1.1707771596300216	2.24042239950172	CDKN1A;SLC46A1;ACADVL;MRE11;MT-CO1;NR3C1;AREG;RPL9;HERPUD1;SESN1;CREB3L1;AKT3;SESN2;KDR;RPL35;ATP6V1E1;ANXA2;PDIA6;CCNA1;MMP14;RRAGD;TERF2IP;MT-CO2;SQSTM1;ATF3;FKBP5;PPP1R15A;HSPA4L;PDGFA;RPS27L;COX7A2;TXN;RPS4Y1;ADCY8;GNG2;GNG4;LMNA;STAP2;DYNC1I1;EGLN3;NUP155;HSPA5;STAT1;NDUFA4;TXNRD2;NOS3;H1-0;GNG11;FABP1;CDK6;GSTA1;BCL2;NOX4;HYOU1;RPL22L1;CALR;BCL2L1
Ion Channel Transport	14/184	0.14854531754623057	0.6416502972795856	0	0	1.3985053912672147	2.666761260707215	RYR2;TRPC3;TRPC4;ATP10D;ATP2B4;ATP11B;ATP1B3;UNC80;ANO1;SCNN1A;STOM;ATP6V1E1;SGK1;TRPM4
Gene and Protein Expression by JAK-STAT Signaling After Interleukin-12 Stimulation	4/37	0.14942188124339287	0.6419000268209316	0	0	2.054828864181382	3.9061917719738877	ANXA2;GSTO1;GSTA2;MSN
Glutathione Conjugation	4/37	0.14942188124339287	0.6419000268209316	0	0	2.054828864181382	3.9061917719738877	GSTA4;GSTO1;GSTA2;GSTA1
Signaling by MET	7/79	0.1512035446645509	0.6477791203115187	0	0	1.6491834485522492	3.1155192432316436	COL2A1;COL24A1;LAMB3;ITGA3;LAMB2;KRAS;TNS3
EPH-ephrin Mediated Repulsion of Cells	5/51	0.15390776097708472	0.6487164923171921	0	0	1.8430321292998866	3.449053663964427	EFNB2;CLTCL1;EFNA5;DNM1;EPHA2
IRE1alpha Activates Chaperones	5/51	0.15390776097708472	0.6487164923171921	0	0	1.8430321292998866	3.449053663964427	ACADVL;HSPA5;LMNA;HYOU1;PDIA6
Neurotransmitter Release Cycle	5/51	0.15390776097708472	0.6487164923171921	0	0	1.8430321292998866	3.449053663964427	SLC5A7;MAOA;STXBP1;SLC1A3;GAD2
Signaling by GPCR	46/706	0.15406699156426876	0.6487164923171921	0	0	1.1870631549136221	2.22024465522187	DGKG;GLP1R;APP;CXCL6;PLPPR1;DGKD;PDE1C;RGS16;IHH;GPR83;PTH1R;ADCY8;RASGRP1;SHH;PDE11A;CYSLTR2;GRM4;GNG2;GRK5;CNR1;GNG4;AKT3;PSAP;P2RY1;PENK;PRLHR;GAST;RGS9;GPR39;GABBR2;CASR;TRPC3;FZD7;F2;RHOC;WNT16;GNG11;GIP;ARHGEF9;KEL;NBEA;MT-RNR2;APLNR;F2RL1;KRAS;RAMP1
Drug ADME	9/109	0.15487339310053364	0.6487164923171921	0	0	1.5271544715447154	2.8483680615005182	GLYATL2;ABCB1;GSTA2;UGT2B15;GSTA1;UGT2A3;UGT3A1;CYP2E1;UGT2B7
Metabolism of Steroids	12/155	0.15741254207404748	0.6487164923171921	0	0	1.4245211310428703	2.633776126537072	CH25H;OSBPL6;INSIG2;SAR1B;SRD5A1;SLC10A2;FDX1;AKR1D1;FDXR;HSD17B4;AKR1C2;ACACB
Amyloid Fiber Formation	7/80	0.15828465919137533	0.6487164923171921	0	0	1.6265054288078857	2.9982354156685074	APP;FURIN;APOE;TGFBI;MFGE8;HSPG2;SNCA
Post NMDA Receptor Activation Events	7/80	0.15828465919137533	0.6487164923171921	0	0	1.6265054288078857	2.9982354156685074	DLG2;ERBB4;DLG4;KRAS;ADCY8;PRKAB1;NRGN
Apoptotic Cleavage of Cellular Proteins	4/38	0.16011638986827273	0.6487164923171921	0	0	1.9942869234024545	3.65324305916782	CASP6;LMNA;CLSPN;DSG3
Cooperation of PDCL (PhLP1) and TRiC CCT in G-protein Beta Folding	4/38	0.16011638986827273	0.6487164923171921	0	0	1.9942869234024545	3.65324305916782	GNG2;GNG4;RGS9;GNG11
Inactivation of CSF3 (G-CSF) Signaling	3/25	0.16085680051138304	0.6487164923171921	0	0	2.3109531977456506	4.222667848716651	SYK;STAT1;TYK2
NOTCH3 Intracellular Domain Regulates Transcription	3/25	0.16085680051138304	0.6487164923171921	0	0	2.3109531977456506	4.222667848716651	KAT2B;PLXND1;STAT1
Signaling by NTRK2 (TRKB)	3/25	0.16085680051138304	0.6487164923171921	0	0	2.3109531977456506	4.222667848716651	NTRK2;NTF3;KRAS
Diseases Associated With Visual Transduction	2/13	0.161698053923275	0.6487164923171921	0	0	3.0803003101028237	5.612382778919541	NAPEPLD;LRAT
Diseases of the Neuronal System	2/13	0.161698053923275	0.6487164923171921	0	0	3.0803003101028237	5.612382778919541	NAPEPLD;LRAT
Downregulation of ERBB2 ERBB3 Signaling	2/13	0.161698053923275	0.6487164923171921	0	0	3.0803003101028237	5.612382778919541	AKT3;RNF41
ERKs Are Inactivated	2/13	0.161698053923275	0.6487164923171921	0	0	3.0803003101028237	5.612382778919541	DUSP4;DUSP6
GRB2 Events in EGFR Signaling	2/13	0.161698053923275	0.6487164923171921	0	0	3.0803003101028237	5.612382778919541	KRAS;AREG
Purine Salvage	2/13	0.161698053923275	0.6487164923171921	0	0	3.0803003101028237	5.612382778919541	GMPR;AMPD3
Retinoid Cycle Disease Events	2/13	0.161698053923275	0.6487164923171921	0	0	3.0803003101028237	5.612382778919541	NAPEPLD;LRAT
Synthesis of Bile Acids and Bile Salts via 24-Hydroxycholesterol	2/13	0.161698053923275	0.6487164923171921	0	0	3.0803003101028237	5.612382778919541	AKR1D1;AKR1C2
Alpha-Linolenic (Omega3) and Linoleic (Omega6) Acid Metabolism	2/13	0.161698053923275	0.6487164923171921	0	0	3.0803003101028237	5.612382778919541	ACSL1;HSD17B4
Alpha-Linolenic Acid (ALA) Metabolism	2/13	0.161698053923275	0.6487164923171921	0	0	3.0803003101028237	5.612382778919541	ACSL1;HSD17B4
p38MAPK Events	2/13	0.161698053923275	0.6487164923171921	0	0	3.0803003101028237	5.612382778919541	RALB;KRAS
Apoptotic Execution Phase	5/52	0.16300656758480464	0.6487164923171921	0	0	1.8037229254840377	3.271889872433238	CASP6;LMNA;DSG3;CLSPN;H1-0
Aquaporin-mediated Transport	5/52	0.16300656758480464	0.6487164923171921	0	0	1.8037229254840377	3.271889872433238	GNG2;GNG4;ADCY8;GNG11;AQP1
IRS-related Events Triggered by IGF1R	5/52	0.16300656758480464	0.6487164923171921	0	0	1.8037229254840377	3.271889872433238	FGF9;IRS1;FGF19;KRAS;GAB2
Signaling by FGFR1	5/52	0.16300656758480464	0.6487164923171921	0	0	1.8037229254840377	3.271889872433238	TGFBR3;SPRED2;FGF9;SPRY2;KRAS
Formation of Fibrin Clot (Clotting Cascade)	4/39	0.17108076085719048	0.677410689454734	0	0	1.9372045220966083	3.4203661731850663	FGB;THBD;F2;F5
Platelet Aggregation (Plug Formation)	4/39	0.17108076085719048	0.677410689454734	0	0	1.9372045220966083	3.4203661731850663	FGB;SYK;F2;RASGRP1
IGF1R Signaling Cascade	5/53	0.1723146227074114	0.6805776534136552	0	0	1.766051605160516	3.105483901406424	FGF9;IRS1;FGF19;KRAS;GAB2
Interleukin-4 and Interleukin-13 Signaling	9/112	0.17331774191848792	0.6822001980015384	0	0	1.4824374457336806	2.5981624290477723	CDKN1A;CCND1;MAOA;STAT1;LIF;BCL2;RHOU;TYK2;BCL2L1
Endogenous Sterols	3/26	0.1747744565307386	0.6822001980015384	0	0	2.210359779678894	3.855439841964575	FDX1;FDXR;CYP1B1
MAPK1 MAPK3 Signaling	19/271	0.18172912281970277	0.6822001980015384	0	0	1.28057762150743	2.183689669183884	RET;DUSP4;FGB;DUSP5;IRS1;PDGFA;TYK2;AREG;RASGRP1;DUSP6;SPRED2;DLG2;FGF9;RASGEF1A;DLG4;ERBB4;FGF19;KRAS;BCL2L1
Insulin Receptor Signalling Cascade	5/54	0.18182176197469885	0.6822001980015384	0	0	1.7299178897481584	2.9490401590402238	FGF9;IRS1;FGF19;KRAS;GAB2
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	5/54	0.18182176197469885	0.6822001980015384	0	0	1.7299178897481584	2.9490401590402238	FGF9;IRS1;FGF19;KRAS;GAB2
AKT Phosphorylates Targets in the Cytosol	2/14	0.18202387214773985	0.6822001980015384	0	0	2.8234590065828846	4.810093990226761	CDKN1A;AKT3
FGFR1c Ligand Binding and Activation	2/14	0.18202387214773985	0.6822001980015384	0	0	2.8234590065828846	4.810093990226761	TGFBR3;FGF9
FGFR4 Ligand Binding and Activation	2/14	0.18202387214773985	0.6822001980015384	0	0	2.8234590065828846	4.810093990226761	FGF9;FGF19
Formation of Axial Mesoderm	2/14	0.18202387214773985	0.6822001980015384	0	0	2.8234590065828846	4.810093990226761	FOXA1;SHH
Glutamate and Glutamine Metabolism	2/14	0.18202387214773985	0.6822001980015384	0	0	2.8234590065828846	4.810093990226761	GLUD2;RIMKLB
Glycogen Synthesis	2/14	0.18202387214773985	0.6822001980015384	0	0	2.8234590065828846	4.810093990226761	PPP1R3C;GBE1
LGI-ADAM Interactions	2/14	0.18202387214773985	0.6822001980015384	0	0	2.8234590065828846	4.810093990226761	DLG4;LGI2
Methylation	2/14	0.18202387214773985	0.6822001980015384	0	0	2.8234590065828846	4.810093990226761	GSTO1;MAT2B
PTK6 Regulates RHO GTPases, RAS GTPase and MAP Kinases	2/14	0.18202387214773985	0.6822001980015384	0	0	2.8234590065828846	4.810093990226761	ELMO1;KRAS
Physiological Factors	2/14	0.18202387214773985	0.6822001980015384	0	0	2.8234590065828846	4.810093990226761	KAT2B;NKX2-5
RUNX3 Regulates NOTCH Signaling	2/14	0.18202387214773985	0.6822001980015384	0	0	2.8234590065828846	4.810093990226761	KAT2B;JAG1
Regulation of IFNG Signaling	2/14	0.18202387214773985	0.6822001980015384	0	0	2.8234590065828846	4.810093990226761	IFNGR1;STAT1
Repression of WNT Target Genes	2/14	0.18202387214773985	0.6822001980015384	0	0	2.8234590065828846	4.810093990226761	TCF7L2;AXIN2
SHC1 Events in EGFR Signaling	2/14	0.18202387214773985	0.6822001980015384	0	0	2.8234590065828846	4.810093990226761	KRAS;AREG
SHC1 Events in ERBB4 Signaling	2/14	0.18202387214773985	0.6822001980015384	0	0	2.8234590065828846	4.810093990226761	ERBB4;KRAS
Synthesis of Bile Acids and Bile Salts via 27-Hydroxycholesterol	2/14	0.18202387214773985	0.6822001980015384	0	0	2.8234590065828846	4.810093990226761	AKR1D1;AKR1C2
RHOU GTPase Cycle	4/40	0.18229711923638048	0.6822001980015384	0	0	1.8832933653077537	3.205586405916767	RHOU;PAK3;SRGAP2;EPHA2
O-linked Glycosylation	9/114	0.1861492381892589	0.6949571559065666	0	0	1.454045683313976	2.4445511575078904	ADAMTS16;ADAMTSL1;SEMA5B;GALNT14;GALNT5;ADAMTS18;ADAMTS9;THBS1;THSD4
Downstream Signaling of Activated FGFR4	3/27	0.18901176531340622	0.7006393570009951	0	0	2.1181491464510334	3.5287221308166856	FGF9;FGF19;KRAS
Integrin Signaling	3/27	0.18901176531340622	0.7006393570009951	0	0	2.1181491464510334	3.5287221308166856	FGB;SYK;RASGRP1
Regulation of RUNX1 Expression and Activity	3/27	0.18901176531340622	0.7006393570009951	0	0	2.1181491464510334	3.5287221308166856	CDK6;CCND1;RUNX1
Cardiac Conduction	10/130	0.18999903312007765	0.7026379338025514	0	0	1.4138034960819772	2.347954780897379	KCNK5;RYR2;KAT2B;ATP2B4;ATP1B3;KCNK16;KCNK17;CACNA1C;NKX2-5;KCNK3
Signaling by FGFR4	4/41	0.19374736758480426	0.714813817348172	0	0	1.8322963251020805	3.0071650906361596	FGF9;FGF19;SPRY2;KRAS
Pentose Phosphate Pathway	2/15	0.2026931259738093	0.7353385732794171	0	0	2.6061317497583207	4.1595482135076844	PRPS2;PGM2
Phospholipase C-mediated Cascade; FGFR4	2/15	0.2026931259738093	0.7353385732794171	0	0	2.6061317497583207	4.1595482135076844	FGF9;FGF19
Response of EIF2AK1 (HRI) to Heme Deficiency	2/15	0.2026931259738093	0.7353385732794171	0	0	2.6061317497583207	4.1595482135076844	PPP1R15A;ATF3
YAP1- and WWTR1 (TAZ)-stimulated Gene Expression	2/15	0.2026931259738093	0.7353385732794171	0	0	2.6061317497583207	4.1595482135076844	KAT2B;NKX2-5
Zinc Transporters	2/15	0.2026931259738093	0.7353385732794171	0	0	2.6061317497583207	4.1595482135076844	SLC30A8;SLC39A8
CREB1 Phosphorylation Through NMDA Receptor-Mediated Activation of RAS Signaling	3/28	0.20353121224698154	0.7353385732794171	0	0	2.0333153638814014	3.2369077415260863	DLG2;DLG4;KRAS
Caspase Activation via Extrinsic Apoptotic Signalling Pathway	3/28	0.20353121224698154	0.7353385732794171	0	0	2.0333153638814014	3.2369077415260863	TNFRSF10B;FAS;TNFRSF10A
Peroxisomal Lipid Metabolism	3/28	0.20353121224698154	0.7353385732794171	0	0	2.0333153638814014	3.2369077415260863	HSD17B4;HACL1;CROT
TRP Channels	3/28	0.20353121224698154	0.7353385732794171	0	0	2.0333153638814014	3.2369077415260863	TRPC3;TRPC4;TRPM4
RND3 GTPase Cycle	4/42	0.20541327812555227	0.7404322301169333	0	0	1.7839833396440743	2.8235663387845102	CCDC88A;TNFAIP1;PTPN13;EPHA2
Nuclear Events Mediated by NFE2L2	7/87	0.2117415575844968	0.7613488598598189	0	0	1.483633904418395	2.303176680221361	GSTA1;BCL2;PDGFA;TXN;AREG;SQSTM1;BCL2L1
ADORA2B Mediated Anti-Inflammatory Cytokines Production	4/43	0.21727657816918158	0.7613488598598189	0	0	1.7381479431839144	2.6534291581623353	GNG2;GNG4;ADCY8;GNG11
Negative Regulation of MAPK Pathway	4/43	0.21727657816918158	0.7613488598598189	0	0	1.7381479431839144	2.6534291581623353	DUSP4;DUSP5;KRAS;DUSP6
RND2 GTPase Cycle	4/43	0.21727657816918158	0.7613488598598189	0	0	1.7381479431839144	2.6534291581623353	PLXND1;TNFAIP1;PTPN13;EPHA2
Signaling by SCF-KIT	4/43	0.21727657816918158	0.7613488598598189	0	0	1.7381479431839144	2.6534291581623353	PTPRU;STAT1;KRAS;GAB2
Downregulation of ERBB2 Signaling	3/29	0.2182961589386727	0.7613488598598189	0	0	1.9550072568940493	2.9753306486241407	ERBB4;AKT3;RNF41
Downstream Signal Transduction	3/29	0.2182961589386727	0.7613488598598189	0	0	1.9550072568940493	2.9753306486241407	STAT1;PDGFA;KRAS
EGR2 and SOX10-mediated Initiation of Schwann Cell Myelination	3/29	0.2182961589386727	0.7613488598598189	0	0	1.9550072568940493	2.9753306486241407	EGR2;GJB1;PMP22
The Role of Nef in HIV-1 Replication and Disease Pathogenesis	3/29	0.2182961589386727	0.7613488598598189	0	0	1.9550072568940493	2.9753306486241407	PACS1;ELMO1;AP1S1
VEGFR2 Mediated Vascular Permeability	3/29	0.2182961589386727	0.7613488598598189	0	0	1.9550072568940493	2.9753306486241407	NOS3;AKT3;PAK3
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	5/58	0.22162956073400408	0.7613488598598189	0	0	1.5990183924052783	2.409317662688862	KAT2B;NEURL1B;JAG1;NEURL1;DLL1
Constitutive Signaling by NOTCH1 PEST Domain Mutants	5/58	0.22162956073400408	0.7613488598598189	0	0	1.5990183924052783	2.409317662688862	KAT2B;NEURL1B;JAG1;NEURL1;DLL1
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	5/58	0.22162956073400408	0.7613488598598189	0	0	1.5990183924052783	2.409317662688862	KAT2B;NEURL1B;JAG1;NEURL1;DLL1
Signaling by NOTCH1 PEST Domain Mutants in Cancer	5/58	0.22162956073400408	0.7613488598598189	0	0	1.5990183924052783	2.409317662688862	KAT2B;NEURL1B;JAG1;NEURL1;DLL1
Signaling by NOTCH1 in Cancer	5/58	0.22162956073400408	0.7613488598598189	0	0	1.5990183924052783	2.409317662688862	KAT2B;NEURL1B;JAG1;NEURL1;DLL1
CRMPs in Sema3A Signaling	2/16	0.22360431902460842	0.7613488598598189	0	0	2.4198512439086945	3.624640058964594	DPYSL3;CRMP1
Defects of Contact Activation System (CAS) and Kallikrein Kinin System (KKS)	2/16	0.22360431902460842	0.7613488598598189	0	0	2.4198512439086945	3.624640058964594	TPST1;F2
GRB2 Events in ERBB2 Signaling	2/16	0.22360431902460842	0.7613488598598189	0	0	2.4198512439086945	3.624640058964594	ERBB4;KRAS
Glycogen Storage Diseases	2/16	0.22360431902460842	0.7613488598598189	0	0	2.4198512439086945	3.624640058964594	PPP1R3C;GBE1
Heme Degradation	2/16	0.22360431902460842	0.7613488598598189	0	0	2.4198512439086945	3.624640058964594	FABP1;GSTA1
Rap1 Signalling	2/16	0.22360431902460842	0.7613488598598189	0	0	2.4198512439086945	3.624640058964594	RAP1GAP2;RASGRP1
cGMP Effects	2/16	0.22360431902460842	0.7613488598598189	0	0	2.4198512439086945	3.624640058964594	PDE11A;PDE5A
RAF MAP Kinase Cascade	18/265	0.2267857056765314	0.7613488598598189	0	0	1.2369416605827304	1.8353118613874966	RET;DUSP4;FGB;DUSP5;IRS1;PDGFA;AREG;RASGRP1;DUSP6;SPRED2;DLG2;FGF9;RASGEF1A;DLG4;ERBB4;FGF19;KRAS;BCL2L1
L1CAM Interactions	9/120	0.2269719869031983	0.7613488598598189	0	0	1.3750091554969603	2.039040504838339	NFASC;DLG4;CHL1;ITGA1;CNTN1;DCX;MSN;NRCAM;DNM1
SARS-CoV Infections	32/498	0.22757899864082057	0.7613488598598189	0	0	1.1667484915192499	1.7270886183242815	RPN2;SAR1B;SERPINE1;RPS27L;FURIN;CHD3;RPS4Y1;NR3C1;TRIM4;CTSL;AKT3;GPC3;MGAT1;GPC4;ITGA4;SYK;NUP155;IFNGR1;STAT1;HLA-B;ATP1B3;ISG15;TYK2;HSPG2;DDOST;RUNX1;ANO1;SNRPG;MASP1;ISCU;CRB3;BCL2L1
Interleukin-2 Family Signaling	4/44	0.2293190290127979	0.7613488598598189	0	0	1.6946043165467626	2.495543973516328	SYK;STAT1;INPP5D;GAB2
Netrin-1 Signaling	4/44	0.2293190290127979	0.7613488598598189	0	0	1.6946043165467626	2.495543973516328	TRPC3;TRPC4;UNC5C;DSCAML1
PI3K Cascade	4/44	0.2293190290127979	0.7613488598598189	0	0	1.6946043165467626	2.495543973516328	FGF9;IRS1;FGF19;GAB2
Cargo Recognition for Clathrin-Mediated Endocytosis	8/105	0.23192110703077254	0.7613488598598189	0	0	1.3984145297554802	2.04358428981074	VAMP8;NECAP2;SYT2;TOR1A;SYT11;CLTCL1;AREG;SLC2A8
Adherens Junctions Interactions	5/59	0.23197193702056637	0.7613488598598189	0	0	1.5693235990265693	2.2929997191703495	ZEB2;CADM2;CDH13;CDH17;AMOT
Iron Uptake and Transport	5/59	0.23197193702056637	0.7613488598598189	0	0	1.5693235990265693	2.2929997191703495	SLC46A1;STEAP3;GLRX3;CYBRD1;ATP6V1E1
RHOQ GTPase Cycle	5/59	0.23197193702056637	0.7613488598598189	0	0	1.5693235990265693	2.2929997191703495	ARHGAP33;STEAP3;ARHGEF9;STOM;SRGAP2
Metabolism of Proteins	123/2067	0.23258018390826535	0.7613488598598189	0	0	1.0793766240224782	1.5742926488191549	ERO1B;SEMA5B;APP;GALNT14;CSF1;MT-CO1;NR3C1;FBXO22;RPL9;MT-ND1;ANPEP;KIF5A;RPL35;RGS9;PDIA3;ST6GAL2;SLC30A8;IGFBP3;APLP2;NSMCE1;HLA-B;HSPG2;PDIA6;RAB32;TPST1;RAB37;FDX1;MT-CO2;SQSTM1;PSMD10;CUL9;RPN2;SAR1B;GPR119;NTM;KLHL13;TXN;RPS4Y1;PLA2G7;LTBP1;ACAT1;ADAMTS16;SOCS2;ADAMTS18;ARSJ;STC2;PENK;NEU1;APOE;IGFBP6;CLSPN;TRAPPC3;XRCC4;NUP155;MRPL27;TBCA;GNG11;BMP4;CPE;CALR;TGFBI;FBN1;PCSK2;ACHE;CPM;CDKN1A;PIGZ;CHD3;AREG;PRSS23;ADAMTSL1;TRIM4;SEC61G;TMED3;CTSH;QSOX1;HMGCS2;ADAMTS9;CTSC;CHST8;TMED9;LRRC49;PAX6;AXIN2;F2;DDOST;F5;DDB2;GIP;CCNA1;KAT2B;VCAN;PABPC1;MFGE8;PFDN4;ST6GALNAC5;MRPS36;RPS27L;FURIN;MAT2B;AFP;THBS1;THSD4;GNG2;OXCT1;GNG4;GPC3;RAB29;MGAT1;DYNC1I1;SNCA;IL33;TCF7L2;GALNT5;CDX2;GOLM1;LAMB2;KLK13;KLF4;TTLL5;GLB1;MT-RNR2;RPL22L1
Activation of BH3-only Proteins	3/30	0.23327099089486023	0.7613488598598189	0	0	1.8824997504242786	2.7400808892030573	AKT3;BCL2;BID
Programmed Cell Death	14/202	0.23866569175298738	0.7613488598598189	0	0	1.2633895818048422	1.8100474967613736	GSDMD;TNFRSF10B;TNFRSF10A;H1-0;CASP6;AKT3;LMNA;BCL2;FAS;BAX;CLSPN;DSG3;BID;BCL2L1
GPER1 Signaling	4/45	0.2415224985064908	0.7613488598598189	0	0	1.6531847692577646	2.3488327671227767	GNG2;GNG4;ADCY8;GNG11
DNA Damage Telomere Stress Induced Senescence	5/60	0.2424483608058975	0.7613488598598189	0	0	1.5407086163161772	2.1831325516800444	CCNA1;CDKN1A;MRE11;TERF2IP;H1-0
Acetylcholine Neurotransmitter Release Cycle	2/17	0.24466619420950406	0.7613488598598189	0	0	2.2584081388390187	3.17952354393644	SLC5A7;STXBP1
Biosynthesis of DHA-derived SPMs	2/17	0.24466619420950406	0.7613488598598189	0	0	2.2584081388390187	3.17952354393644	CYP1A1;CYP2E1
FOXO-mediated Transcription of Cell Cycle Genes	2/17	0.24466619420950406	0.7613488598598189	0	0	2.2584081388390187	3.17952354393644	CDKN1A;KLF4
Formation of Senescence-Associated Heterochromatin Foci (SAHF)	2/17	0.24466619420950406	0.7613488598598189	0	0	2.2584081388390187	3.17952354393644	CDKN1A;H1-0
Signaling by Activin	2/17	0.24466619420950406	0.7613488598598189	0	0	2.2584081388390187	3.17952354393644	TGFBR3;ACVR1C
The NLRP3 Inflammasome	2/17	0.24466619420950406	0.7613488598598189	0	0	2.2584081388390187	3.17952354393644	APP;TXN
Signaling by FGFR	7/91	0.24491212712729535	0.7613488598598189	0	0	1.4126840997896002	1.9874428159092041	TGFBR3;SPRED2;FGF9;FGF19;SPRY2;KRAS;POLR2H
Sphingolipid Metabolism	8/107	0.2474304989365447	0.7613488598598189	0	0	1.3700178682128141	1.913401957039577	SMPD3;UGT8;SPTLC1;GLB1;ARSJ;NEU1;PSAP;ST6GALNAC5
Cytokine Signaling in Immune System	48/776	0.2476505869509755	0.7613488598598189	0	0	1.120879120879121	1.5644518449070113	APP;CDKN1A;CSF1;IRS1;MAOA;PELI2;EBI3;IFI6;SAMHD1;EDA2R;SOCS2;CCND1;INPP5D;AKT3;IP6K2;TRIM45;SNCA;DUSP4;IKBIP;GSDMD;IL33;SYK;TNFRSF12A;NUP155;ANXA2;GSTO1;STAT1;IFNGR1;MX1;HLA-B;LIF;MSN;ISG15;LIFR;GAB2;TYK2;PTPN13;DUSP6;PDE12;GSTA2;TRIM35;BCL2;KRAS;RHOU;SQSTM1;HLA-DRB1;CRLF1;BCL2L1
Downregulation of SMAD2 3 SMAD4 Transcriptional Activity	3/31	0.24842123862876642	0.7613488598598189	0	0	1.8151713515594918	2.527861046220724	TGIF1;STAT1;SERPINE1
EGFR Downregulation	3/31	0.24842123862876642	0.7613488598598189	0	0	1.8151713515594918	2.527861046220724	SPRY2;SPRY1;AREG
Negative Regulation of FGFR4 Signaling	3/31	0.24842123862876642	0.7613488598598189	0	0	1.8151713515594918	2.527861046220724	FGF9;FGF19;SPRY2
Signaling by BMP	3/31	0.24842123862876642	0.7613488598598189	0	0	1.8151713515594918	2.527861046220724	TGFBR3;GREM2;BMPR1B
Abacavir Transmembrane Transport	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	ABCB1
Chylomicron Clearance	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	APOE
Diseases of Base Excision Repair	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	NEIL3
Diseases of Mismatch Repair (MMR)	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	MSH2
Electric Transmission Across Gap Junctions	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	GJD2
FasL CD95L Signaling	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	FAS
Ficolins Bind to Repetitive Carbohydrate Structures on the Target Cell Surface	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	MASP1
Fructose Catabolism	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	ALDH1A1
G2 Phase	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	CCNA1
Hyaluronan Biosynthesis and Export	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	CEMIP
IRAK4 Deficiency (TLR5)	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	TLR5
IRS Activation	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	IRS1
Leukotriene Receptors	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	CYSLTR2
MET Interacts With TNS Proteins	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	TNS3
N-glycan Trimming and Elongation in the cis-Golgi	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	MGAT1
NGF-independant TRKA Activation	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	NTRK2
NOSTRIN Mediated eNOS Trafficking	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	NOS3
NTRK2 Activates RAC1	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	NTRK2
PTK6 Expression	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	NR3C1
PTK6 Regulates Proteins Involved in RNA Processing	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	KHDRBS3
RUNX1 Regulates Expression of Components of Tight Junctions	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	RUNX1
RUNX2 Regulates Chondrocyte Maturation	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	IHH
Regulation of NPAS4 Gene Transcription	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	NR3C1
Signaling by Membrane-Tethered Fusions of PDGFRA or PDGFRB	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	KDR
TFAP2 (AP-2) Family Regulates Transcription of Cell Cycle Factors	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	CDKN1A
Transmission Across Electrical Synapses	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	GJD2
VLDL Assembly	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	APOC1
Vitamin B1 (Thiamin) Metabolism	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	SLC19A3
Zinc Efflux and Compartmentalization by the SLC30 Family	1/5	0.24957481758159883	0.7613488598598189	0	0	4.233183856502242	5.875644540404561	SLC30A8
Regulated Necrosis	5/61	0.25304769043348607	0.7704442302906915	0	0	1.5131155972740131	2.079289118580547	GSDMD;TNFRSF10B;BAX;FAS;TNFRSF10A
Signaling by VEGF	8/108	0.2553090134758408	0.7758227386242604	0	0	1.356245487364621	1.8516557204533075	CYFIP2;NOS3;AKT3;KDR;ELMO1;KRAS;PAK3;PGF
Signaling by ALK Fusions and Activated Point Mutants	7/93	0.26207447382765364	0.7893362749383271	0	0	1.3796841906599282	1.8475717501432534	CDKN1A;IRS1;BCL11A;STAT1;MSN;TYK2;SQSTM1
Signaling by ALK in Cancer	7/93	0.26207447382765364	0.7893362749383271	0	0	1.3796841906599282	1.8475717501432534	CDKN1A;IRS1;BCL11A;STAT1;MSN;TYK2;SQSTM1
Regulation of Necroptotic Cell Death	3/32	0.26371367558811415	0.7893362749383271	0	0	1.7524862905474488	2.335873776595107	TNFRSF10B;FAS;TNFRSF10A
Transcriptional Regulation of Pluripotent Stem Cells	3/32	0.26371367558811415	0.7893362749383271	0	0	1.7524862905474488	2.335873776595107	SALL1;CDX2;KLF4
Kinesins	5/62	0.2637587937008063	0.7893362749383271	0	0	1.4864907543385917	1.981076335247731	KIF19;KIF26B;KIF5A;KIF21B;KIF6
FGFR1 Ligand Binding and Activation	2/18	0.26579690890780405	0.7893362749383271	0	0	2.117145421903052	2.8052658748283403	TGFBR3;FGF9
Formation of the Nephric Duct	2/18	0.26579690890780405	0.7893362749383271	0	0	2.117145421903052	2.8052658748283403	RET;BMP4
Gastrin-CREB Signalling Pathway via PKC and MAPK	2/18	0.26579690890780405	0.7893362749383271	0	0	2.117145421903052	2.8052658748283403	GAST;KRAS
Norepinephrine Neurotransmitter Release Cycle	2/18	0.26579690890780405	0.7893362749383271	0	0	2.117145421903052	2.8052658748283403	MAOA;STXBP1
PKA Activation	2/18	0.26579690890780405	0.7893362749383271	0	0	2.117145421903052	2.8052658748283403	NBEA;ADCY8
Pre-NOTCH Processing in Golgi	2/18	0.26579690890780405	0.7893362749383271	0	0	2.117145421903052	2.8052658748283403	MFNG;FURIN
SHC-mediated Cascade FGFR3	2/18	0.26579690890780405	0.7893362749383271	0	0	2.117145421903052	2.8052658748283403	FGF9;KRAS
Factors Involved in Megakaryocyte Development and Platelet Production	11/158	0.26786562791879137	0.7937760303272381	0	0	1.2688583125557915	1.6714287515597446	DOCK10;DOCK11;DOCK5;EHD3;KIF19;KIF26B;KIF5A;MYB;MAFF;KIF21B;KIF6
MITF-M-dependent Gene Expression	7/94	0.27078027812664984	0.7937760303272381	0	0	1.3637532000456039	1.7816720526213408	TCF7L2;CDKN1A;CCND1;BCL2;GMPR;ATP6V1E1;SMARCA2
Metabolism of Amino Acids and Derivatives	23/358	0.2715631362691341	0.7937760303272381	0	0	1.1651541014051425	1.5188490034428728	TPH1;DDC;GLDC;MRPS36;SMOX;GADL1;RPS27L;RPS4Y1;HNMT;RPL9;SAT1;ACAT1;GLUD2;GATM;PSAT1;RPL35;RPL22L1;BCAT1;CRYM;RIMKLB;SERINC2;AASS;DUOX2
Metabolism of Water-Soluble Vitamins and Cofactors	9/127	0.27830247217599574	0.7937760303272381	0	0	1.2929585228055671	1.653754367202094	SLC46A1;NT5E;TCN1;GSTO1;PNPO;SLC19A3;AOX1;SLC2A3;ACACB
Complex IV Assembly	4/48	0.2789206458101034	0.7937760303272381	0	0	1.5402223675604971	1.966598985423189	MT-CO1;NDUFA4;COX7A2;MT-CO2
Gap Junction Trafficking	4/48	0.2789206458101034	0.7937760303272381	0	0	1.5402223675604971	1.966598985423189	GJD2;GJB1;CLTCL1;DNM1
PERK Regulates Gene Expression	3/33	0.279116394956589	0.7937760303272381	0	0	1.693980233602875	2.1617328936797366	HSPA5;ATF3;HERPUD1
Cellular Responses to Stress	48/787	0.28005397418821576	0.7937760303272381	0	0	1.103525870064314	1.4045378543454792	PPP1R15A;CDKN1A;SLC46A1;ACADVL;MRE11;MT-CO1;HSPA4L;PDGFA;RPS27L;COX7A2;TXN;NR3C1;RPS4Y1;AREG;RPL9;HERPUD1;SESN1;CREB3L1;AKT3;SESN2;LMNA;RPL35;STAP2;ATP6V1E1;DYNC1I1;EGLN3;NUP155;HSPA5;NDUFA4;TXNRD2;H1-0;PDIA6;FABP1;CCNA1;CDK6;RRAGD;GSTA1;BCL2;NOX4;TERF2IP;MT-CO2;HYOU1;RPL22L1;CALR;SQSTM1;ATF3;FKBP5;BCL2L1
GPCR Downstream Signalling	39/633	0.28229317321472713	0.7937760303272381	0	0	1.115003329488009	1.410266387489954	DGKG;GLP1R;APP;CXCL6;DGKD;PDE1C;RGS16;GPR83;PTH1R;ADCY8;RASGRP1;PDE11A;CYSLTR2;GRM4;GNG2;GRK5;CNR1;GNG4;AKT3;PSAP;P2RY1;PENK;GAST;RGS9;GPR39;GABBR2;CASR;TRPC3;F2;RHOC;GNG11;GIP;ARHGEF9;NBEA;MT-RNR2;APLNR;F2RL1;KRAS;RAMP1
RNA Polymerase II Transcription	81/1360	0.28264686083709695	0.7937760303272381	0	0	1.07723425230309	1.3611468824065243	RET;CDKN1A;BTG2;STEAP3;MRE11;MT-CO1;SERPINE1;IHH;SLC2A3;CHD3;NR3C1;LGALS3;PIDD1;CCND1;CTSL;CASP6;SESN1;AKT3;SESN2;MYB;ZNF248;PITX2;TGIF1;ZNF560;SUPT16H;ITGA4;MSX2;TRPC3;IGFBP3;LIFR;PRKAB1;GEM;DDB2;RUNX1;CCNA1;KAT2B;MSH2;ZNF717;RRAGD;SNRPG;ZNF558;MT-CO2;SGK1;FKBP5;DLX5;FURIN;COX7A2;TXN;NDRG1;THBS1;DLL1;NUAK1;ZNF703;APOE;ZNF589;POLR2H;BID;NKX2-5;PLK3;TCF7L2;JAG1;AUTS2;STAT1;NDUFA4;PLK2;TNFRSF10C;TNFRSF10B;GAD2;TNFRSF10A;ESRRG;ARID3A;KLF4;POU2F2;SMARCA2;GCK;TNFRSF10D;CDK6;SYT10;FAS;BAX;KRAS
Diseases of Hemostasis	2/19	0.2869232698267648	0.7937760303272381	0	0	1.9925018481360228	2.4877191570615382	TPST1;F2
GABA Synthesis, Release, Reuptake and Degradation	2/19	0.2869232698267648	0.7937760303272381	0	0	1.9925018481360228	2.4877191570615382	STXBP1;GAD2
Glycosphingolipid Biosynthesis	2/19	0.2869232698267648	0.7937760303272381	0	0	1.9925018481360228	2.4877191570615382	UGT8;ST6GALNAC5
Glyoxylate Metabolism and Glycine Degradation	2/19	0.2869232698267648	0.7937760303272381	0	0	1.9925018481360228	2.4877191570615382	GLDC;MRPS36
NFE2L2 Regulating Anti-Oxidant Detoxification Enzymes	2/19	0.2869232698267648	0.7937760303272381	0	0	1.9925018481360228	2.4877191570615382	GSTA1;TXN
RHO GTPases Activate ROCKs	2/19	0.2869232698267648	0.7937760303272381	0	0	1.9925018481360228	2.4877191570615382	LIMK2;RHOC
RHO GTPases Activate CIT	2/19	0.2869232698267648	0.7937760303272381	0	0	1.9925018481360228	2.4877191570615382	DLG4;RHOC
VEGFR2 Mediated Cell Proliferation	2/19	0.2869232698267648	0.7937760303272381	0	0	1.9925018481360228	2.4877191570615382	KDR;KRAS
ER-Phagosome Pathway	6/80	0.28801726720627385	0.7937760303272381	0	0	1.3739956172388605	1.7102602217453342	FGB;PDIA3;VAMP8;SEC61G;HLA-B;CALR
Antigen processing-Cross Presentation	7/96	0.2884126387724848	0.7937760303272381	0	0	1.3329652181842129	1.6573597002534566	FGB;PDIA3;VAMP8;CTSL;SEC61G;HLA-B;CALR
Acrosome Reaction and Sperm Oocyte Membrane Binding	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	CD9
Activated NTRK2 Signals Through CDK5	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	NTRK2
Activation of TRKA Receptors	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	NTRK2
Alpha-oxidation of Phytanate	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	HACL1
Assembly of Viral Components at the Budding Site	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	CALR
Biosynthesis of Lipoxins (LX)	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	PTGR1
Biosynthesis of Maresin-Like SPMs	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	CYP2E1
Conjugation of Benzoate With Glycine	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	GLYATL2
Estrogen-stimulated Signaling Through PRKCZ	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	KRAS
FLT3 Signaling Through SRC Family Kinases	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	SYK
Fibronectin Matrix Formation	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	CEACAM6
LTC4-CYSLTR Mediated IL4 Production	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	CYSLTR2
Maturation of Spike Protein 9683686	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	MGAT1
PTK6 Regulates Cell Cycle	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	CCND1
Protein Repair	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	TXN
RUNX1 Regulates Estrogen Receptor Mediated Transcription	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	RUNX1
RUNX1 Regulates Transcription of Genes Involved in BCR Signaling	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	RUNX1
RUNX1 Regulates Transcription of Genes Involved in WNT Signaling	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	RUNX1
RUNX3 Regulates Immune Response and Cell Migration	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	ITGA4
SARS-CoV-1-mediated Effects on Programmed Cell Death	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	BCL2L1
SARS-CoV-2 Targets PDZ Proteins in Cell-Cell Junction	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	CRB3
Sensing of DNA Double Strand Breaks	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	MRE11
Sensory Perception of Salty Taste	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	SCNN1A
Synthesis of Wybutosine at G37 of tRNA(Phe)	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	TRMT12
TNFR1-mediated Ceramide Production	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	SMPD3
Transport and Synthesis of PAPS	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	SLC35B2
Uptake and Function of Diphtheria Toxin	1/6	0.291458954839839	0.7937760303272381	0	0	3.3863677130044842	4.174904057381884	CD9
XBP1(S) Activates Chaperone Genes	4/49	0.29159119481408746	0.7937760303272381	0	0	1.5059152677857714	1.8558937037834586	ACADVL;LMNA;HYOU1;PDIA6
Diseases of Carbohydrate Metabolism	3/34	0.2945988684559142	0.7991886258458019	0	0	1.6392487609773063	2.0033924903733227	PPP1R3C;GLB1;GBE1
RIPK1-mediated Regulated Necrosis	3/34	0.2945988684559142	0.7991886258458019	0	0	1.6392487609773063	2.0033924903733227	TNFRSF10B;FAS;TNFRSF10A
Mitochondrial Protein Degradation	7/97	0.2973277383016979	0.8051984346408675	0	0	1.3180843602845407	1.5987312152484994	APP;MT-CO1;OXCT1;MT-CO2;HMGCS2;MT-ND1;ACAT1
GPCR Ligand Binding	29/467	0.3016781132434016	0.811617946025081	0	0	1.1235607196716697	1.3464691893552325	GLP1R;APP;CXCL6;PLPPR1;IHH;PTH1R;SHH;CYSLTR2;GRM4;GNG2;CNR1;GNG4;PSAP;P2RY1;PENK;PRLHR;GPR39;GABBR2;CASR;FZD7;F2;WNT16;GNG11;GIP;KEL;MT-RNR2;APLNR;F2RL1;RAMP1
MAPK Family Signaling Cascades	20/314	0.3024964350874817	0.811617946025081	0	0	1.1538557028650875	1.3796488634901984	RET;DUSP4;FGB;DUSP5;IRS1;PDGFA;TYK2;AREG;RASGRP1;DUSP6;SPRED2;DLG2;FGF9;RASGEF1A;DLG4;ERBB4;FGF19;KRAS;PAK3;BCL2L1
Signaling by ERBB2	4/50	0.30433581412336574	0.811617946025081	0	0	1.4730997810447295	1.752434169719442	ERBB4;AKT3;KRAS;RNF41
Oncogenic MAPK Signaling	6/82	0.30768053001361856	0.811617946025081	0	0	1.3376955903271692	1.576732795687054	FGB;FXR1;SPRED2;LMNA;KRAS;DUSP6
Signaling by Insulin Receptor	6/82	0.30768053001361856	0.811617946025081	0	0	1.3376955903271692	1.576732795687054	FGF9;IRS1;FGF19;KRAS;GAB2;ATP6V1E1
Apoptotic Factor-Mediated Response	2/20	0.30798002416130305	0.811617946025081	0	0	1.881707560343108	2.216125295467271	GSDMD;BAX
Chondroitin Sulfate Biosynthesis	2/20	0.30798002416130305	0.811617946025081	0	0	1.881707560343108	2.216125295467271	VCAN;CHSY3
Diseases Associated With N-glycosylation of Proteins	2/20	0.30798002416130305	0.811617946025081	0	0	1.881707560343108	2.216125295467271	GLB1;NEU1
FRS-mediated FGFR3 Signaling	2/20	0.30798002416130305	0.811617946025081	0	0	1.881707560343108	2.216125295467271	FGF9;KRAS
Induction of Cell-Cell Fusion	2/20	0.30798002416130305	0.811617946025081	0	0	1.881707560343108	2.216125295467271	ANO1;FURIN
PI-3K Cascade FGFR4	2/20	0.30798002416130305	0.811617946025081	0	0	1.881707560343108	2.216125295467271	FGF9;FGF19
PKA-mediated Phosphorylation of CREB	2/20	0.30798002416130305	0.811617946025081	0	0	1.881707560343108	2.216125295467271	NBEA;ADCY8
Sema4D Induced Cell Migration and Growth-Cone Collapse	2/20	0.30798002416130305	0.811617946025081	0	0	1.881707560343108	2.216125295467271	LIMK2;RHOC
Signaling by KIT in Disease	2/20	0.30798002416130305	0.811617946025081	0	0	1.881707560343108	2.216125295467271	STAT1;KRAS
Signaling by Phosphorylated Juxtamembrane, Extracellular and Kinase Domain KIT Mutants	2/20	0.30798002416130305	0.811617946025081	0	0	1.881707560343108	2.216125295467271	STAT1;KRAS
Signalling to RAS	2/20	0.30798002416130305	0.811617946025081	0	0	1.881707560343108	2.216125295467271	RALB;KRAS
CaM Pathway	3/35	0.3101319882825365	0.8131888923528717	0	0	1.5879380053908356	1.8590900172583535	PDE1C;NBEA;ADCY8
Calmodulin Induced Events	3/35	0.3101319882825365	0.8131888923528717	0	0	1.5879380053908356	1.8590900172583535	PDE1C;NBEA;ADCY8
Lysosome Vesicle Biogenesis	3/35	0.3101319882825365	0.8131888923528717	0	0	1.5879380053908356	1.8590900172583535	VAMP8;APP;AP1S1
VEGFA-VEGFR2 Pathway	7/99	0.31532713292103587	0.8254306250754329	0	0	1.2892931352177834	1.4880307895492806	CYFIP2;NOS3;AKT3;KDR;ELMO1;KRAS;PAK3
Gap Junction Trafficking and Regulation	4/51	0.31713820002636983	0.8274088147110613	0	0	1.4416806979947956	1.6556515417690671	GJD2;GJB1;CLTCL1;DNM1
Transcriptional Activity of SMAD2 SMAD3 SMAD4 Heterotrimer	4/51	0.31713820002636983	0.8274088147110613	0	0	1.4416806979947956	1.6556515417690671	TGIF1;STAT1;SERPINE1;FURIN
Disease	124/2131	0.32008790933424125	0.827782338561459	0	0	1.0511335326357747	1.1974088590476741	CYFIP2;SEMA5B;APP;MRE11;IRS1;SERPINE1;IHH;NR3C1;ABCA12;RPL9;CYSLTR2;CCND1;FGF9;AKT3;KDR;FDXR;AP1S1;CYP1B1;RPL35;LRAT;SUPT16H;HLA-B;ATP1B3;HSPG2;RUNX1;SLC5A7;TPST1;NEIL3;MSH2;PPP1R3C;FDX1;SNRPG;ELMO1;MASP1;SQSTM1;ISCU;RPN2;SAR1B;MAOA;PDGFA;SLC1A3;TXN;RPS4Y1;ACAT1;ADAMTS16;FXR1;ADAMTS18;NEU1;GSDMD;JAG1;SYT2;XRCC4;NUP155;BCL11A;PLK2;FZD7;MSN;ISG15;GNG11;EXT2;CDK6;FGF19;NAPEPLD;NOX4;CALR;BCL2L1;CDKN1A;GBE1;CHD3;AREG;ADAMTSL1;SPRED2;SHH;TRIM4;CTSL;CNTRL;ADAMTS9;FGB;ITGA4;SYK;IFNGR1;ABCC8;GAB2;TYK2;F2;DUSP6;DDOST;ANO1;KAT2B;VCAN;PACS1;TLR5;RPS27L;FURIN;ADCY8;THBS1;DLL1;THSD4;NEURL1B;NT5E;GNG2;SV2B;GNG4;SV2A;ERBB4;NTF3;LMNA;GPC3;MGAT1;GPC4;SLC17A8;POLR2H;DYNC1I1;SLC35A2;NTRK2;TCF7L2;STAT1;GCK;GLB1;NEURL1;CD9;RPL22L1;KRAS;CRB3
Innate Immune System	68/1149	0.3220330434339633	0.827782338561459	0	0	1.0685998969006645	1.2108317393075305	CYFIP2;APP;MRE11;SLC2A3;CLU;LGALS3;TRIM4;CTSL;ANPEP;TIMP2;PGM2;CTSH;SIRPA;QSOX1;ATP6V1E1;PRSS2;CTSC;IKBIP;DUSP4;FGB;SERPINB1;SYK;ANXA2;HLA-B;IRAG2;ATP11B;TMC6;GAB2;AMPD3;F2;DUSP6;DDOST;DNM1;VAMP8;RAB37;CEACAM6;ELMO1;CD47;MASP1;TLR5;CARD11;CD63;MVP;PELI2;ITLN1;TXN;RASGRP1;PRDX4;NEU1;PSAP;STOM;POLR2H;PAK3;GSDMD;PTPRN2;NOS3;NFATC3;NBEAL2;ISG15;NFASC;GLB1;TCN1;QPCT;BCL2;KRAS;S100P;HPSE;BCL2L1
Immune System	125/2150	0.3228647838743939	0.827782338561459	0	0	1.0501301840016943	1.1871949284776588	CYFIP2;APP;MRE11;CSF1;IRS1;FBXO22;CLU;LGALS3;CCND1;ANPEP;AKT3;KIF5A;AP1S1;SIRPA;HLA-DOA;ATP6V1E1;PRSS2;PDIA3;HLA-B;IRAG2;ATP11B;LIFR;RNF41;RAB37;PDE12;HECW2;ELMO1;MASP1;SQSTM1;CARD11;COL17A1;SAR1B;MAOA;EBI3;KLHL13;TXN;RASGRP1;SOCS2;PRDX4;INPP5D;NEU1;PSAP;SLAMF7;IP6K2;GSDMD;VASP;RAP1GAP2;PTPRN2;NUP155;HSPA5;NFATC3;LIF;MSN;NBEAL2;ISG15;TCN1;RNF182;BCL2;HPSE;CALR;HLA-DRB1;BCL2L1;CDKN1A;SLC2A3;EDA2R;TRIM4;CTSL;SEC61G;TIMP2;PGM2;CTSH;QSOX1;CTSF;CTSC;IKBIP;DUSP4;FGB;SERPINB1;ITGA4;TNFRSF12A;SYK;ANXA2;GSTO1;IFNGR1;TMC6;GAB2;TYK2;AMPD3;F2;DUSP6;DDOST;DNM1;VAMP8;COL2A1;CEACAM6;RHOU;CD47;TLR5;COLEC12;CD63;MVP;PELI2;ITLN1;IFI6;SAMHD1;STOM;POLR2H;PAK3;DYNC1I1;TRIM45;SNCA;IL33;STAT1;NOS3;MX1;PTPN13;NFASC;GLB1;QPCT;GSTA2;TRIM35;TRIM36;KRAS;S100P;CRLF1
Aberrant Regulation of Mitotic Cell Cycle Due to RB1 Defects	3/36	0.32568809527819126	0.827782338561459	0	0	1.5397369925671813	1.7273002368611692	CDKN1A;CDK6;CCND1
Detoxification of Reactive Oxygen Species	3/36	0.32568809527819126	0.827782338561459	0	0	1.5397369925671813	1.7273002368611692	TXNRD2;NOX4;TXN
Metabolism of Steroid Hormones	3/36	0.32568809527819126	0.827782338561459	0	0	1.5397369925671813	1.7273002368611692	SRD5A1;FDX1;FDXR
Regulation of TP53 Degradation	3/36	0.32568809527819126	0.827782338561459	0	0	1.5397369925671813	1.7273002368611692	CCNA1;AKT3;SGK1
SMAD2 SMAD3 SMAD4 Heterotrimer Regulates Transcription	3/36	0.32568809527819126	0.827782338561459	0	0	1.5397369925671813	1.7273002368611692	TGIF1;SERPINE1;FURIN
Striated Muscle Contraction	3/36	0.32568809527819126	0.827782338561459	0	0	1.5397369925671813	1.7273002368611692	TNNC1;TMOD2;MYH6
Transcriptional Regulation by the AP-2 (TFAP2) Family of Transcription Factors	3/36	0.32568809527819126	0.827782338561459	0	0	1.5397369925671813	1.7273002368611692	CDKN1A;APOE;PITX2
Transport of Bile Salts and Organic Acids, Metal Ions and Amine Compounds	6/84	0.32756431215808157	0.827782338561459	0	0	1.3032571032571032	1.4545272893052548	SLC5A7;SLC44A3;SLC44A4;SLC30A8;SLC39A8;RUNX1
Branched-chain Amino Acid Catabolism	2/21	0.32890920242937954	0.827782338561459	0	0	1.7825758291599736	1.9821771671271375	BCAT1;ACAT1
CD209 (DC-SIGN) Signaling	2/21	0.32890920242937954	0.827782338561459	0	0	1.7825758291599736	1.9821771671271375	KRAS;PAK3
SHC-mediated Cascade FGFR1	2/21	0.32890920242937954	0.827782338561459	0	0	1.7825758291599736	1.9821771671271375	FGF9;KRAS
Unblocking of NMDA Receptors, Glutamate Binding and Activation	2/21	0.32890920242937954	0.827782338561459	0	0	1.7825758291599736	1.9821771671271375	DLG2;DLG4
Complex I Biogenesis	5/68	0.32975806696172766	0.827782338561459	0	0	1.3444915920163445	1.4915736262317918	NDUFAF2;NDUFB1;HSCB;MT-ND3;MT-ND1
Activated NTRK2 Signals Through FYN	1/7	0.33100735094262423	0.827782338561459	0	0	2.8218236173393123	3.11984965962499	NTRK2
Activated NTRK2 Signals Through PI3K	1/7	0.33100735094262423	0.827782338561459	0	0	2.8218236173393123	3.11984965962499	NTRK2
Epithelial-Mesenchymal Transition (EMT) During Gastrulation	1/7	0.33100735094262423	0.827782338561459	0	0	2.8218236173393123	3.11984965962499	CLDN7
FGFR3b Ligand Binding and Activation	1/7	0.33100735094262423	0.827782338561459	0	0	2.8218236173393123	3.11984965962499	FGF9
Fructose Metabolism	1/7	0.33100735094262423	0.827782338561459	0	0	2.8218236173393123	3.11984965962499	ALDH1A1
Highly Sodium Permeable Postsynaptic Acetylcholine Nicotinic Receptors	1/7	0.33100735094262423	0.827782338561459	0	0	2.8218236173393123	3.11984965962499	CHRNB2
RUNX3 Regulates CDKN1A Transcription	1/7	0.33100735094262423	0.827782338561459	0	0	2.8218236173393123	3.11984965962499	CDKN1A
STAT5 Activation	1/7	0.33100735094262423	0.827782338561459	0	0	2.8218236173393123	3.11984965962499	GAB2
Signaling by MAPK Mutants	1/7	0.33100735094262423	0.827782338561459	0	0	2.8218236173393123	3.11984965962499	DUSP6
TYSND1 Cleaves Peroxisomal Proteins	1/7	0.33100735094262423	0.827782338561459	0	0	2.8218236173393123	3.11984965962499	HSD17B4
COPI-dependent Golgi-to-ER Retrograde Traffic	7/101	0.333514122831662	0.832723160191156	0	0	1.261727068664505	1.3854647270787075	TMED9;KIF19;KIF26B;KIF5A;TMED3;KIF21B;KIF6
COPII-mediated Vesicle Transport	5/69	0.34094687704916143	0.8452857480477028	0	0	1.3234135913591358	1.4240308734203986	TRAPPC3;SAR1B;AREG;CTSC;F5
Ca-dependent Events	3/37	0.34124099395038004	0.8452857480477028	0	0	1.494371333439036	1.6066977335417179	PDE1C;NBEA;ADCY8
Plasma Lipoprotein Clearance	3/37	0.34124099395038004	0.8452857480477028	0	0	1.494371333439036	1.6066977335417179	APOC1;VLDLR;APOE
RUNX1 Interacts With Co-Factors Whose Precise Effect on RUNX1 Targets Is Not Known	3/37	0.34124099395038004	0.8452857480477028	0	0	1.494371333439036	1.6066977335417179	AUTS2;SMARCA2;RUNX1
Regulation of TP53 Expression and Degradation	3/37	0.34124099395038004	0.8452857480477028	0	0	1.494371333439036	1.6066977335417179	CCNA1;AKT3;SGK1
Signaling by EGFR	4/53	0.34285334574527787	0.8466047970529066	0	0	1.3826897665541036	1.4801036989042469	SPRY2;KRAS;SPRY1;AREG
Synthesis of PIPs at the Plasma Membrane	4/53	0.34285334574527787	0.8466047970529066	0	0	1.3826897665541036	1.4801036989042469	INPP4B;INPP5D;PTPN13;SBF2
SRP-dependent Cotranslational Protein Targeting to Membrane	8/119	0.34606491536488315	0.8486129811865509	0	0	1.221127264448564	1.295773436819854	RPN2;SEC61G;RPL35;RPS27L;RPL22L1;RPS4Y1;RPL9;DDOST
Deregulated CDK5 Triggers Multiple Neurodegenerative Pathways in Alzheimer's Disease Models	2/22	0.3496595102230619	0.8486129811865509	0	0	1.6933572710951525	1.779372074943944	APP;LMNA
ERK MAPK Targets	2/22	0.3496595102230619	0.8486129811865509	0	0	1.6933572710951525	1.779372074943944	DUSP4;DUSP6
Insertion of Tail-Anchored Proteins Into the Endoplasmic Reticulum Membrane	2/22	0.3496595102230619	0.8486129811865509	0	0	1.6933572710951525	1.779372074943944	APP;SEC61G
Nef-mediates Down Modulation of Cell Surface Receptors by Recruiting Them to Clathrin Adapters	2/22	0.3496595102230619	0.8486129811865509	0	0	1.6933572710951525	1.779372074943944	PACS1;AP1S1
Neurodegenerative Diseases	2/22	0.3496595102230619	0.8486129811865509	0	0	1.6933572710951525	1.779372074943944	APP;LMNA
RA Biosynthesis Pathway	2/22	0.3496595102230619	0.8486129811865509	0	0	1.6933572710951525	1.779372074943944	ALDH1A2;ALDH1A1
Regulation of TLR by Endogenous Ligand	2/22	0.3496595102230619	0.8486129811865509	0	0	1.6933572710951525	1.779372074943944	FGB;GSDMD
SHC1 Events in ERBB2 Signaling	2/22	0.3496595102230619	0.8486129811865509	0	0	1.6933572710951525	1.779372074943944	ERBB4;KRAS
Signaling by ERBB2 TMD JMD Mutants	2/22	0.3496595102230619	0.8486129811865509	0	0	1.6933572710951525	1.779372074943944	ERBB4;KRAS
Signaling by FGFR3 in Disease	2/22	0.3496595102230619	0.8486129811865509	0	0	1.6933572710951525	1.779372074943944	FGF9;KRAS
Metabolism of Lipids	45/758	0.35394638992340255	0.8486129811865509	0	0	1.070809810600257	1.1121535827261266	ACHE;SLC44A3;ACADVL;SLC44A4;SAR1B;ABHD3;INSIG2;AKR1D1;HSD17B4;CROT;ACACB;ACAT1;SMPD3;UGT8;SPTLC1;OXCT1;ARSJ;INPP5D;PSAP;NEU1;FDXR;ANKRD1;CYP1B1;HACL1;HMGCS2;SBF2;PCYT1B;OSBPL6;SRD5A1;ACSL1;SLC10A2;AKR1C2;PTGR1;PTPN13;PLAAT5;PLAAT4;FABP1;CH25H;INPP4B;GLB1;FDX1;GPD1;CYP1A1;CYP2E1;ST6GALNAC5
Diseases of Mitotic Cell Cycle	3/38	0.3567659569649542	0.8486129811865509	0	0	1.4515979976896418	1.4961261943770205	CDKN1A;CDK6;CCND1
Maturation of Spike Protein 9694548	3/38	0.3567659569649542	0.8486129811865509	0	0	1.4515979976896418	1.4961261943770205	RPN2;MGAT1;DDOST
CDC42 GTPase Cycle	10/155	0.3648628474446997	0.8486129811865509	0	0	1.1684853775643824	1.1781064015678424	DOCK10;ARHGAP33;FMNL3;DOCK11;STEAP3;ARHGEF9;ARHGDIB;STOM;SRGAP2;PAK3
Biosynthesis of Maresins	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	CYP2E1
ChREBP Activates Metabolic Gene Expression	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	ACACB
Conjugation of Salicylate With Glycine	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	GLYATL2
Defective CHST14 Causes EDS, Musculocontractural Type	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	VCAN
Defective CHST3 Causes SEDCJD	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	VCAN
Defective CHSY1 Causes TPBS	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	VCAN
FGFR1b Ligand Binding and Activation	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	TGFBR3
Formation of Intermediate Mesoderm	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	BMP4
Histidine Catabolism	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	HNMT
IFNG Signaling Activates MAPKs	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	IFNGR1
Inactivation of CDC42 and RAC1	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	SRGAP2
Inhibition of Signaling by Overexpressed EGFR	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	AREG
Lectin Pathway of Complement Activation	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	MASP1
Linoleic Acid (LA) Metabolism	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	ACSL1
MECP2 Regulates Transcription of Neuronal Ligands	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	DLL1
Metabolism of Ingested SeMet, Sec, MeSec Into H2Se	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	HNMT
Netrin Mediated Repulsion Signals	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	UNC5C
RUNX2 Regulates Genes Involved in Cell Migration	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	AKT3
Signaling by Overexpressed Wild-Type EGFR in Cancer	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	AREG
Terminal Pathway of Complement	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	CLU
Toxicity of Botulinum Toxin Type B (botB)	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	SYT2
Transport of RCbl Within the Body	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	TCN1
Transport of Fatty Acids	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	LCN15
rRNA Modification in the Mitochondrion	1/8	0.3683501516430004	0.8486129811865509	0	0	2.4185778347213325	2.415485185147572	MT-RNR2
Amino Acids Regulate mTORC1	4/55	0.3686157346333942	0.8486129811865509	0	0	1.3283255748342502	1.3256696504125884	SESN1;SESN2;RRAGD;ATP6V1E1
Ion Transport by P-type ATPases	4/55	0.3686157346333942	0.8486129811865509	0	0	1.3283255748342502	1.3256696504125884	ATP10D;ATP2B4;ATP11B;ATP1B3
RHOJ GTPase Cycle	4/55	0.3686157346333942	0.8486129811865509	0	0	1.3283255748342502	1.3256696504125884	FMNL3;STEAP3;STOM;PAK3
Azathioprine ADME	2/23	0.3701857647522965	0.8486129811865509	0	0	1.6126357185603146	1.6025572814226146	GSTA2;GSTA1
FRS-mediated FGFR1 Signaling	2/23	0.3701857647522965	0.8486129811865509	0	0	1.6126357185603146	1.6025572814226146	FGF9;KRAS
Nucleotide Salvage	2/23	0.3701857647522965	0.8486129811865509	0	0	1.6126357185603146	1.6025572814226146	GMPR;AMPD3
RNA Polymerase III Transcription Termination	2/23	0.3701857647522965	0.8486129811865509	0	0	1.6126357185603146	1.6025572814226146	NFIB;POLR2H
SHC-mediated Cascade FGFR2	2/23	0.3701857647522965	0.8486129811865509	0	0	1.6126357185603146	1.6025572814226146	FGF9;KRAS
Signaling by NODAL	2/23	0.3701857647522965	0.8486129811865509	0	0	1.6126357185603146	1.6025572814226146	ACVR1C;FURIN
Telomere Extension By Telomerase	2/23	0.3701857647522965	0.8486129811865509	0	0	1.6126357185603146	1.6025572814226146	CCNA1;TERF2IP
Binding and Uptake of Ligands by Scavenger Receptors	8/122	0.37165091950505363	0.8507279442101081	0	0	1.1888023307365887	1.1766768485602292	COLEC12;HPX;AMBP;LRP1;HYOU1;MASP1;APOE;CALR
Aerobic Respiration and Respiratory Electron Transport	16/260	0.37978649824417765	0.8672875366756317	0	0	1.111177347242921	1.0757819383398575	MT-CO1;MRPS36;NDUFA4;NDUFB1;COX7A2;HSCB;MT-ND3;MT-ND1;ACAT1;MPC2;NDUFAF2;ATP5MK;MT-CO2;SUCLG1;SDHAF4;ISCU
Signaling by NOTCH	13/209	0.3840662668196037	0.8672875366756317	0	0	1.1237626510259588	1.0753736239308238	JAG1;PLXND1;STAT1;FURIN;DLL1;RUNX1;KAT2B;NEURL1B;CCND1;NBEA;MFNG;NEURL1;CNTN1
Respiratory Electron Transport	10/158	0.38754577877344526	0.8672875366756317	0	0	1.1446165876545624	1.085006441935557	MT-CO1;NDUFA4;NDUFAF2;NDUFB1;MT-CO2;COX7A2;HSCB;MT-ND3;ISCU;MT-ND1
Class C 3 (Metabotropic Glutamate Pheromone Receptors)	3/40	0.387640467217428	0.8672875366756317	0	0	1.3729875427988636	1.301148715363011	GABBR2;CASR;GRM4
Signaling by FGFR3	3/40	0.387640467217428	0.8672875366756317	0	0	1.3729875427988636	1.301148715363011	FGF9;SPRY2;KRAS
Opioid Signalling	6/90	0.3879487134656761	0.8672875366756317	0	0	1.2097812097812097	1.1455202086126544	GNG2;PDE1C;NBEA;GNG4;ADCY8;GNG11
Cytosolic Sulfonation of Small Molecules	2/24	0.39044837349717987	0.8672875366756317	0	0	1.5392524889831891	1.4476046640217068	SLC35B2;TPST1
Glutamate Neurotransmitter Release Cycle	2/24	0.39044837349717987	0.8672875366756317	0	0	1.5392524889831891	1.4476046640217068	STXBP1;SLC1A3
Metal Ion SLC Transporters	2/24	0.39044837349717987	0.8672875366756317	0	0	1.5392524889831891	1.4476046640217068	SLC30A8;SLC39A8
Other Interleukin Signaling	2/24	0.39044837349717987	0.8672875366756317	0	0	1.5392524889831891	1.4476046640217068	CSF1;TYK2
RAS Processing	2/24	0.39044837349717987	0.8672875366756317	0	0	1.5392524889831891	1.4476046640217068	KRAS;BCL2L1
Sema4D in Semaphorin Signaling	2/24	0.39044837349717987	0.8672875366756317	0	0	1.5392524889831891	1.4476046640217068	LIMK2;RHOC
Leishmania Infection	15/245	0.393435807559981	0.8672875366756317	0	0	1.1049638668404218	1.0307515724909029	CYFIP2;GSDMD;APP;SYK;FZD7;PLK2;FURIN;TXN;ADCY8;GNG11;NT5E;CYSLTR2;GNG2;GNG4;ELMO1
Parasitic Infection Pathways	15/245	0.393435807559981	0.8672875366756317	0	0	1.1049638668404218	1.0307515724909029	CYFIP2;GSDMD;APP;SYK;FZD7;PLK2;FURIN;TXN;ADCY8;GNG11;NT5E;CYSLTR2;GNG2;GNG4;ELMO1
RHOC GTPase Cycle	5/74	0.3970948159881393	0.8672875366756317	0	0	1.227187936184923	1.133406474147237	FMNL3;ARHGEF28;ARHGAP18;STOM;RHOC
Activation of HOX Genes During Differentiation	6/91	0.3980454109850148	0.8672875366756317	0	0	1.1954848966613671	1.1012677543525848	EGR2;MEIS1;MAFB;HOXA2;PAX6;POLR2H
Activation of Anterior HOX Genes in Hindbrain Development During Early Embryogenesis	6/91	0.3980454109850148	0.8672875366756317	0	0	1.1954848966613671	1.1012677543525848	EGR2;MEIS1;MAFB;HOXA2;PAX6;POLR2H
DAG and IP3 Signaling	3/41	0.40294781280656994	0.8672875366756317	0	0	1.3367853596254788	1.2150686760661922	PDE1C;NBEA;ADCY8
Generation of Second Messenger Molecules	3/41	0.40294781280656994	0.8672875366756317	0	0	1.3367853596254788	1.2150686760661922	VASP;PAK3;HLA-DRB1
RET Signaling	3/41	0.40294781280656994	0.8672875366756317	0	0	1.3367853596254788	1.2150686760661922	RET;DOK4;GAB2
Abacavir ADME	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	ABCB1
Amino Acid Conjugation	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	GLYATL2
Atorvastatin ADME	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	ABCB1
CREB3 Factors Activate Genes	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	CREB3L1
Ca2+ Activated K+ Channels	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	KCNN3
Calcineurin Activates NFAT	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	NFATC3
Conjugation of Carboxylic Acids	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	GLYATL2
Downregulation of ERBB4 Signaling	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	ERBB4
EGFR Transactivation by Gastrin	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	KRAS
EGFR Interacts With Phospholipase C-gamma	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	AREG
Highly Calcium Permeable Nicotinic Acetylcholine Receptors	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	CHRNB2
Interleukin-1 Processing	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	GSDMD
Interleukin-23 Signaling	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	TYK2
Interleukin-9 Signaling	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	STAT1
Lipophagy	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	PRKAB1
MAPK1 (ERK2) Activation	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	TYK2
Myoclonic Epilepsy of Lafora	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	PPP1R3C
Nef and Signal Transduction	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	ELMO1
PI3K AKT Activation	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	IRS1
RHO GTPases Activate Rhotekin and Rhophilins	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	RHOC
SHC-related Events Triggered by IGF1R	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	KRAS
Gamma-carboxylated Protein Precursors Transport From the Endoplasmic Reticulum to Golgi Apparatus	1/9	0.40361025748568347	0.8672875366756317	0	0	2.1161434977578475	1.9199887948064691	F2
Regulation of TP53 Activity Through Phosphorylation	6/92	0.40813346940617573	0.8672875366756317	0	0	1.1815210559396605	1.0588331231211137	CCNA1;PLK3;SUPT16H;NUAK1;MRE11;PRKAB1
Plasma Lipoprotein Assembly, Remodeling, and Clearance	5/75	0.4082998251588394	0.8672875366756317	0	0	1.2095923878102095	1.0834966256883833	SAR1B;APOC1;FURIN;VLDLR;APOE
Cellular Response to Starvation	10/161	0.41031718404907497	0.8672875366756317	0	0	1.121696226482881	0.9992348152055065	SESN1;SESN2;RRAGD;RPL35;RPS27L;RPL22L1;ATP6V1E1;RPS4Y1;RPL9;ATF3
Basigin Interactions	2/25	0.41041285217686146	0.8672875366756317	0	0	1.4722504098040747	1.3111739502356157	ITGA3;ATP1B3
Complex III Assembly	2/25	0.41041285217686146	0.8672875366756317	0	0	1.4722504098040747	1.3111739502356157	HSCB;ISCU
Defective Intrinsic Pathway for Apoptosis	2/25	0.41041285217686146	0.8672875366756317	0	0	1.4722504098040747	1.3111739502356157	APP;LMNA
Downstream Signaling of Activated FGFR3	2/25	0.41041285217686146	0.8672875366756317	0	0	1.4722504098040747	1.3111739502356157	FGF9;KRAS
FRS-mediated FGFR2 Signaling	2/25	0.41041285217686146	0.8672875366756317	0	0	1.4722504098040747	1.3111739502356157	FGF9;KRAS
Glycogen Metabolism	2/25	0.41041285217686146	0.8672875366756317	0	0	1.4722504098040747	1.3111739502356157	PPP1R3C;GBE1
Interleukin-7 Signaling	2/25	0.41041285217686146	0.8672875366756317	0	0	1.4722504098040747	1.3111739502356157	SOCS2;IRS1
Metabolism of Cofactors	2/25	0.41041285217686146	0.8672875366756317	0	0	1.4722504098040747	1.3111739502356157	GCH1;NOS3
Regulation of IFNA IFNB Signaling	2/25	0.41041285217686146	0.8672875366756317	0	0	1.4722504098040747	1.3111739502356157	STAT1;TYK2
Signaling by EGFR in Cancer	2/25	0.41041285217686146	0.8672875366756317	0	0	1.4722504098040747	1.3111739502356157	KRAS;AREG
Signaling by ERBB2 KD Mutants	2/25	0.41041285217686146	0.8672875366756317	0	0	1.4722504098040747	1.3111739502356157	ERBB4;KRAS
TRAF6 Mediated NF-kB Activation	2/25	0.41041285217686146	0.8672875366756317	0	0	1.4722504098040747	1.3111739502356157	APP;TRIM4
Deactivation of the Beta-Catenin Transactivating Complex	3/42	0.4181427721991496	0.8715840244221743	0	0	1.3024396986661138	1.1356393000157952	PYGO1;TCF7L2;CTNNBIP1
EPHB-mediated Forward Signaling	3/42	0.4181427721991496	0.8715840244221743	0	0	1.3024396986661138	1.1356393000157952	EFNB2;ARHGEF28;LIMK2
Regulation of RUNX2 Expression and Activity	4/59	0.41984110244412276	0.8715840244221743	0	0	1.231458469587966	1.0687569042463467	MSX2;DLX5;STAT1;NR3C1
Clathrin-mediated Endocytosis	9/145	0.42050107880912346	0.8715840244221743	0	0	1.1207556193208992	0.9709198213569954	VAMP8;NECAP2;SYT2;TOR1A;SYT11;CLTCL1;AREG;DNM1;SLC2A8
Glycerophospholipid Biosynthesis	8/128	0.4231117418039907	0.8715840244221743	0	0	1.1290012033694343	0.9710753519451235	ACHE;SLC44A3;PCYT1B;SLC44A4;ABHD3;GPD1;PLAAT5;PLAAT4
Cell Surface Interactions at the Vascular Wall	14/233	0.4270445741278403	0.8715840244221743	0	0	1.0827553058366275	0.9212806312015398	ITGA4;ITGA3;TNFRSF10B;ATP1B3;TNFRSF10A;F2;TNFRSF10D;THBD;CEACAM6;INPP5D;SIRPA;KRAS;CD47;JAM3
Calnexin Calreticulin Cycle	2/26	0.43004937850159053	0.8715840244221743	0	0	1.4108318372232196	1.1905378430618019	PDIA3;CALR
Constitutive Signaling by AKT1 E17K in Cancer	2/26	0.43004937850159053	0.8715840244221743	0	0	1.4108318372232196	1.1905378430618019	CDKN1A;AKT3
Interleukin-20 Family Signaling	2/26	0.43004937850159053	0.8715840244221743	0	0	1.4108318372232196	1.1905378430618019	STAT1;TYK2
MicroRNA (miRNA) Biogenesis	2/26	0.43004937850159053	0.8715840244221743	0	0	1.4108318372232196	1.1905378430618019	XPO5;POLR2H
Signaling by ERBB2 in Cancer	2/26	0.43004937850159053	0.8715840244221743	0	0	1.4108318372232196	1.1905378430618019	ERBB4;KRAS
Synthesis of IP3 and IP4 in the Cytosol	2/26	0.43004937850159053	0.8715840244221743	0	0	1.4108318372232196	1.1905378430618019	INPP5D;PLCE1
Assembly and Cell Surface Presentation of NMDA Receptors	3/43	0.43320773156507386	0.8715840244221743	0	0	1.269811320754717	1.0622453165484709	DLG2;NBEA;DLG4
Signaling by FGFR2 in Disease	3/43	0.43320773156507386	0.8715840244221743	0	0	1.269811320754717	1.0622453165484709	FGF9;KRAS;POLR2H
Transport of Vitamins, Nucleosides, and Related Molecules	3/43	0.43320773156507386	0.8715840244221743	0	0	1.269811320754717	1.0622453165484709	SLC35A2;SLC35B2;LCN15
AKT Phosphorylates Targets in the Nucleus	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	AKT3
Activation of PPARGC1A (PGC-1alpha) by Phosphorylation	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	PRKAB1
Adenylate Cyclase Activating Pathway	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	ADCY8
Alpha-defensins	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	PRSS2
Calcitonin-like Ligand Receptors	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	RAMP1
Chylomicron Remodeling	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	APOE
Creatine Metabolism	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	GATM
Formation of the Posterior Neural Plate	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	ZEB2
Gamma-carboxylation of Protein Precursors	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	F2
HDL Remodeling	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	APOE
HuR (ELAVL1) Binds and Stabilizes mRNA	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	GPRC5A
Interleukin-21 Signaling	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	STAT1
MAPK3 (ERK1) Activation	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	TYK2
MASTL Facilitates Mitotic Progression	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	ENSA
Organic Cation Transport	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	RUNX1
PI3K Events in ERBB4 Signaling	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	ERBB4
POU5F1 (OCT4), SOX2, NANOG Repress Genes Related to Differentiation	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	CDX2
Protein Lipoylation	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	FDX1
RHOBTB3 ATPase Cycle	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	RHOBTB3
RUNX1 and FOXP3 Control the Development of Regulatory T Lymphocytes (Tregs)	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	RUNX1
Reactions Specific to the Complex N-glycan Synthesis Pathway	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	CHST8
Regulation of CDH11 Gene Transcription	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	ZEB2
SLBP Independent Processing of Histone Pre-mRNAs	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	SNRPG
Signal Attenuation	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	IRS1
Synthesis of Pyrophosphates in the Cytosol	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	NUDT4
Thyroxine Biosynthesis	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	DUOX2
Uptake of Dietary Cobalamins Into Enterocytes	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	TCN1
Virus Assembly and Release	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	CALR
Zinc Influx Into Cells by the SLC39 Gene Family	1/10	0.4369037265279522	0.8715840244221743	0	0	1.8809167912306926	1.5574788795639298	SLC39A8
Asparagine N-linked Glycosylation	18/306	0.44337307417135396	0.88232478646322	0	0	1.0585154826958105	0.8609369092208279	CHST8;PDIA3;TRAPPC3;TMED9;ST6GAL2;RPN2;SAR1B;AREG;DDOST;F5;GLB1;NEU1;TMED3;MGAT1;CALR;CTSC;DYNC1I1;ST6GALNAC5
SARS-CoV-2-host Interactions	13/218	0.44341322176850595	0.88232478646322	0	0	1.0739092939433474	0.8733601302792005	NUP155;SAR1B;STAT1;HLA-B;RPS27L;ISG15;TYK2;RPS4Y1;TRIM4;AKT3;SNRPG;MASP1;CRB3
Gamma Carboxylation, Hypusinylation, Hydroxylation, and Arylsulfatase Activation	4/61	0.44510599097246406	0.8834508782845869	0	0	1.1881231856619967	0.9617178094932446	TPST1;ARSJ;FURIN;F2
Nucleotide-binding Domain, Leucine Rich Repeat Containing Receptor (NLR) Signaling Pathways	4/61	0.44510599097246406	0.8834508782845869	0	0	1.1881231856619967	0.9617178094932446	APP;BCL2;TXN;BCL2L1
Interleukin Receptor SHC Signaling	2/27	0.44933238020694266	0.8879774646799078	0	0	1.354326750448833	1.083451103929337	INPP5D;GAB2
Pyroptosis	2/27	0.44933238020694266	0.8879774646799078	0	0	1.354326750448833	1.083451103929337	GSDMD;BAX
RAC1 GTPase Cycle	11/184	0.45141032786839214	0.8879774646799078	0	0	1.076666753851385	0.8563576256014899	CYFIP2;DOCK10;ARHGAP33;DOCK11;DOCK5;FGD5;JAG1;ARHGDIB;SRGAP2;PAK3;EPHA2
RHO GTPase Cycle	26/450	0.45610378879972596	0.8879774646799078	0	0	1.0385148000692401	0.8152703501215091	CYFIP2;DOCK5;STEAP3;PLXND1;ARHGEF28;STMN2;ARHGAP18;TNFAIP1;DOCK10;DOCK11;FGD5;ARHGDIB;EPSTI1;STOM;SRGAP2;PAK3;JAG1;PTPN13;RHOC;ARHGAP33;FMNL3;CCDC88A;ARHGEF9;RHOU;PDE5A;EPHA2
TP53 Regulates Transcription of DNA Repair Genes	4/62	0.4576126894423381	0.8879774646799078	0	0	1.1675762838005457	0.9127318706094006	SUPT16H;MSH2;POLR2H;DDB2
Protein Folding	6/97	0.4582266235220059	0.8879774646799078	0	0	1.1163053163053163	0.871155075387352	GNG2;GNG4;TBCA;PFDN4;RGS9;GNG11
DAP12 Interactions	3/45	0.462883827931423	0.8879774646799078	0	0	1.2092157617764088	0.931433710883004	SYK;HLA-B;KRAS
G Alpha (12 13) Signalling Events	5/80	0.4637344007312881	0.8879774646799078	0	0	1.1286528652865286	0.8673057355869652	ARHGEF9;GNG2;GNG4;RHOC;GNG11
Late SARS-CoV-2 Infection Events	5/80	0.4637344007312881	0.8879774646799078	0	0	1.1286528652865286	0.8673057355869652	ANO1;RPN2;FURIN;MGAT1;DDOST
Metabolism of Nucleotides	6/98	0.46813480330704893	0.8879774646799078	0	0	1.1041128084606346	0.8380204990547049	NT5E;GMPR;AK5;TXN;AMPD3;SAMHD1
MyD88 Cascade Initiated on Plasma Membrane	6/98	0.46813480330704893	0.8879774646799078	0	0	1.1041128084606346	0.8380204990547049	DUSP4;IKBIP;APP;PELI2;TLR5;DUSP6
Toll Like Receptor 10 (TLR10) Cascade	6/98	0.46813480330704893	0.8879774646799078	0	0	1.1041128084606346	0.8380204990547049	DUSP4;IKBIP;APP;PELI2;TLR5;DUSP6
Toll Like Receptor 5 (TLR5) Cascade	6/98	0.46813480330704893	0.8879774646799078	0	0	1.1041128084606346	0.8380204990547049	DUSP4;IKBIP;APP;PELI2;TLR5;DUSP6
ATF4 Activates Genes in Response to Endoplasmic Reticulum Stress	2/28	0.46824015448414275	0.8879774646799078	0	0	1.3021682088109376	0.9880513336907407	ATF3;HERPUD1
Metabolism of Porphyrins	2/28	0.46824015448414275	0.8879774646799078	0	0	1.3021682088109376	0.9880513336907407	FABP1;GSTA1
Platelet Calcium Homeostasis	2/28	0.46824015448414275	0.8879774646799078	0	0	1.3021682088109376	0.9880513336907407	TRPC3;ATP2B4
Androgen Biosynthesis	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	SRD5A1
Apoptotic Cleavage of Cell Adhesion Proteins	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	DSG3
Attachment and Entry 9678110	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	CTSL
Beta-oxidation of Very Long Chain Fatty Acids	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	HSD17B4
Biotin Transport and Metabolism	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	ACACB
CLEC7A (Dectin-1) Induces NFAT Activation	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	NFATC3
Constitutive Signaling by Overexpressed ERBB2	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	KRAS
Dermatan Sulfate Biosynthesis	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	VCAN
Highly Calcium Permeable Postsynaptic Nicotinic Acetylcholine Receptors	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	CHRNB2
MET Activates RAS Signaling	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	KRAS
Mucopolysaccharidoses	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	GLB1
NOTCH4 Activation and Transmission of Signal to the Nucleus	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	JAG1
OAS Antiviral Response	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	PDE12
Pexophagy	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	SQSTM1
RHO GTPases Activate KTN1	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	KIF5A
Regulation of CDH11 Function	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	AMOT
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	SNRPG
Signaling by FGFR4 in Disease	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	KRAS
Signaling by Leptin	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	IRS1
Signaling by Activated Point Mutants of FGFR1	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	FGF9
Mitochondrial Fatty Acid Beta-Oxidation of Saturated Fatty Acids	1/11	0.46834015515961974	0.8879774646799078	0	0	1.6927354260089686	1.2840420953829286	ACADVL
Beta-catenin Independent WNT Signaling	8/134	0.47423122239800336	0.8980610588406633	0	0	1.0748954214658186	0.8019367632675896	GNAO1;TCF7L2;GNG2;GNG4;FZD7;KRAS;AXIN2;GNG11
Interleukin-10 Signaling	3/46	0.4774662496208136	0.9017322430922302	0	0	1.1810317808562654	0.8730916836945869	CSF1;LIF;TYK2
Interferon Gamma Signaling	6/99	0.47799335877240373	0.9017322430922302	0	0	1.0921825050857308	0.8062037345521532	IFNGR1;STAT1;HLA-B;TRIM35;HLA-DRB1;TRIM45
SLC Transporter Disorders	6/99	0.47799335877240373	0.9017322430922302	0	0	1.0921825050857308	0.8062037345521532	SLC35A2;SLC5A7;NUP155;SLC1A3;SLC17A8;GCK
Synthesis of Substrates in N-glycan Biosythesis	4/64	0.4823256663374422	0.9017322430922302	0	0	1.128537170263789	0.8228567811270026	ST6GAL2;GLB1;NEU1;ST6GALNAC5
Golgi-to-ER Retrograde Transport	8/135	0.48266118474307584	0.9017322430922302	0	0	1.066374825890446	0.7767904539040963	TMED9;KIF19;KIF26B;KIF5A;TMED3;KIF21B;KIF6;DYNC1I1
Acyl Chain Remodelling of PE	2/29	0.4867545160231822	0.9017322430922302	0	0	1.2538732628499236	0.9027829273451774	PLAAT5;PLAAT4
DAP12 Signaling	2/29	0.4867545160231822	0.9017322430922302	0	0	1.2538732628499236	0.9027829273451774	SYK;KRAS
EPHA-mediated Growth Cone Collapse	2/29	0.4867545160231822	0.9017322430922302	0	0	1.2538732628499236	0.9027829273451774	EFNA5;EPHA2
Energy Dependent Regulation of mTOR by LKB1-AMPK	2/29	0.4867545160231822	0.9017322430922302	0	0	1.2538732628499236	0.9027829273451774	RRAGD;PRKAB1
Negative Regulation of FGFR3 Signaling	2/29	0.4867545160231822	0.9017322430922302	0	0	1.2538732628499236	0.9027829273451774	FGF9;SPRY2
PIWI-interacting RNA (piRNA) Biogenesis	2/29	0.4867545160231822	0.9017322430922302	0	0	1.2538732628499236	0.9027829273451774	POLR2H;TDRD6
Nonsense Mediated Decay (NMD) Independent of the Exon Junction Complex (EJC)	6/100	0.48779718519682735	0.9017322430922302	0	0	1.0805060379528464	0.7756472708707222	RPL35;RPS27L;RPL22L1;PABPC1;RPS4Y1;RPL9
MITF-M-regulated Melanocyte Development	8/136	0.49105625319677676	0.9017322430922302	0	0	1.0579873646209386	0.7524370050517678	TCF7L2;CDKN1A;CCND1;AKT3;BCL2;GMPR;ATP6V1E1;SMARCA2
Cyclin D Associated Events in G1	3/47	0.49186115393319196	0.9017322430922302	0	0	1.1541288899779465	0.8189223214947394	CDKN1A;CDK6;CCND1
G1 Phase	3/47	0.49186115393319196	0.9017322430922302	0	0	1.1541288899779465	0.8189223214947394	CDKN1A;CDK6;CCND1
Sensory Perception of Taste	3/47	0.49186115393319196	0.9017322430922302	0	0	1.1541288899779465	0.8189223214947394	GRM4;SCNN1A;TRPM4
Signaling by BRAF and RAF1 Fusions	4/65	0.4945140834836655	0.9017322430922302	0	0	1.1099775916971342	0.7816236298922498	FGB;FXR1;LMNA;KRAS
ALK Mutants Bind TKIs	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	BCL11A
Aspartate and Asparagine Metabolism	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	GADL1
CD28 Dependent Vav1 Pathway	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	PAK3
CREB1 Phosphorylation Through the Activation of Adenylate Cyclase	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	ADCY8
Caspase-mediated Cleavage of Cytoskeletal Proteins	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	CASP6
FGFR3 Mutant Receptor Activation	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	FGF9
HDR Through MMEJ (alt-NHEJ)	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	MRE11
Interleukin-2 Signaling	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	SYK
Killing Mechanisms	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	FZD7
P2Y Receptors	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	P2RY1
PECAM1 Interactions	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	INPP5D
Presynaptic Nicotinic Acetylcholine Receptors	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	CHRNB2
Pyrimidine Catabolism	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	NT5E
Reduction of Cytosolic Ca++ Levels	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	ATP2B4
Regulation of Localization of FOXO Transcription Factors	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	AKT3
Regulation of Signaling by NODAL	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	ACVR1C
Signaling by LTK	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	IRS1
Signaling by Activated Point Mutants of FGFR3	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	FGF9
Unwinding of DNA	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	MCM6
WNT5 FZD7-mediated Leishmania Damping	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	FZD7
Z-decay Degradation of Maternal mRNAs by Zygotically Expressed Factors	1/12	0.498023037320071	0.9017322430922302	0	0	1.5387688544639218	1.072689530193038	PABPC1
G Alpha (I) Signalling Events	18/316	0.498848272441528	0.9021846495828327	0	0	1.0224447133898118	0.7110625425415414	APP;GABBR2;CXCL6;CASR;PDE1C;RGS16;ADCY8;GNG11;GRM4;GNG2;NBEA;MT-RNR2;CNR1;GNG4;PENK;PSAP;APLNR;RGS9
Downstream Signaling of Activated FGFR2	2/30	0.5048604731007332	0.9057165366334801	0	0	1.2090279558861246	0.8263381802334298	FGF9;KRAS
Interconversion of Nucleotide Di- and Triphosphates	2/30	0.5048604731007332	0.9057165366334801	0	0	1.2090279558861246	0.8263381802334298	AK5;TXN
Paracetamol ADME	2/30	0.5048604731007332	0.9057165366334801	0	0	1.2090279558861246	0.8263381802334298	UGT2B15;CYP2E1
Regulation of CDH11 Expression and Function	2/30	0.5048604731007332	0.9057165366334801	0	0	1.2090279558861246	0.8263381802334298	ZEB2;AMOT
Regulation of TP53 Activity Through Acetylation	2/30	0.5048604731007332	0.9057165366334801	0	0	1.2090279558861246	0.8263381802334298	AKT3;CHD3
Interleukin-3, Interleukin-5 and GM-CSF Signaling	3/48	0.5060571808870792	0.9057165366334801	0	0	1.1284216831386642	0.7685743392530159	SYK;INPP5D;GAB2
RMTs Methylate Histone Arginines	3/48	0.5060571808870792	0.9057165366334801	0	0	1.1284216831386642	0.7685743392530159	CCND1;SMARCA2;WDR77
RNA Polymerase I Transcription Initiation	3/48	0.5060571808870792	0.9057165366334801	0	0	1.1284216831386642	0.7685743392530159	KAT2B;CHD3;POLR2H
SARS-CoV-2 Activates Modulates Innate and Adaptive Immune Responses	8/138	0.5077288403827456	0.9057165366334801	0	0	1.041599555678978	0.7060042540359863	NUP155;TRIM4;SAR1B;STAT1;HLA-B;ISG15;MASP1;TYK2
Toll-like Receptor Cascades	10/174	0.5081920041706528	0.9057165366334801	0	0	1.0320645701936224	0.6986003192881894	GSDMD;DUSP4;FGB;IKBIP;APP;CTSL;PELI2;TLR5;DNM1;DUSP6
Signaling by ROBO Receptors	12/210	0.508629449064736	0.9057165366334801	0	0	1.0258014931927975	0.6934782514671693	VASP;ROBO2;ROBO3;HOXA2;RPL35;RPS27L;RPL22L1;PABPC1;RPS4Y1;PAK3;SRGAP2;RPL9
Phospholipid Metabolism	12/211	0.5153475522984786	0.9057165366334801	0	0	1.0205920908892288	0.6765645272332533	INPP4B;ACHE;SLC44A3;PCYT1B;SLC44A4;ABHD3;INPP5D;GPD1;PLAAT5;PTPN13;PLAAT4;SBF2
Glucose Metabolism	5/85	0.5175161950326402	0.9057165366334801	0	0	1.0578307830783078	0.696808432605922	SLC37A1;NUP155;ADPGK;PGM2L1;GCK
PLC Beta Mediated Events	3/49	0.5200440858197163	0.9057165366334801	0	0	1.1038321809445681	0.721731499302965	PDE1C;NBEA;ADCY8
Downstream Signaling of Activated FGFR1	2/31	0.5225459280972455	0.9057165366334801	0	0	1.1672754287129326	0.7576112437770882	FGF9;KRAS
FOXO-mediated Transcription of Oxidative Stress, Metabolic and Neuronal Genes	2/31	0.5225459280972455	0.9057165366334801	0	0	1.1672754287129326	0.7576112437770882	NR3C1;GCK
Interaction Between L1 and Ankyrins	2/31	0.5225459280972455	0.9057165366334801	0	0	1.1672754287129326	0.7576112437770882	NFASC;NRCAM
MAPK Targets Nuclear Events Mediated by MAP Kinases	2/31	0.5225459280972455	0.9057165366334801	0	0	1.1672754287129326	0.7576112437770882	DUSP4;DUSP6
Transcriptional Regulation of Brown and Beige Adipocyte Differentiation	2/31	0.5225459280972455	0.9057165366334801	0	0	1.1672754287129326	0.7576112437770882	PRDM16;CHD3
Transcriptional Regulation of Brown and Beige Adipocyte Differentiation by EBF2	2/31	0.5225459280972455	0.9057165366334801	0	0	1.1672754287129326	0.7576112437770882	PRDM16;CHD3
Transferrin Endocytosis and Recycling	2/31	0.5225459280972455	0.9057165366334801	0	0	1.1672754287129326	0.7576112437770882	STEAP3;ATP6V1E1
Turbulent Flow Shear Stress Activates Signaling by PIEZO1 and Integrins in Endothelial Cells	2/31	0.5225459280972455	0.9057165366334801	0	0	1.1672754287129326	0.7576112437770882	ANXA2;STAT1
2-LTR Circle Formation	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	XRCC4
Activation of RAC1	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	PAK3
Apoptosis Induced DNA Fragmentation	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	H1-0
Diseases of Branched-Chain Amino Acid Catabolism	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	ACAT1
ERBB2 Activates PTK6 Signaling	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	ERBB4
FGFR2c Ligand Binding and Activation	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	FGF9
FGFR3 Ligand Binding and Activation	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	FGF9
FGFR3c Ligand Binding and Activation	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	FGF9
FGFRL1 Modulation of FGFR1 Signaling	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	SPRED2
IRF3-mediated Induction of Type I IFN	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	MRE11
NF-kB Activation Through FADD RIP-1 Pathway Mediated by Caspase-8 and -10	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	TRIM4
NF-kB Is Activated and Signals Survival	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	SQSTM1
POU5F1 (OCT4), SOX2, NANOG Activate Genes Related to Proliferation	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	SALL1
Passive Transport by Aquaporins	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	AQP1
Phospholipase C-mediated Cascade; FGFR3	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	FGF9
Telomere C-strand Synthesis Initiation	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	TERF2IP
The Activation of Arylsulfatases	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	ARSJ
Trafficking and Processing of Endosomal TLR	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	CTSL
Transcriptional Regulation of Testis Differentiation	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	FGF9
eNOS Activation	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	NOS3
p75NTR Recruits Signalling Complexes	1/13	0.5260501041316356	0.9057165366334801	0	0	1.4104633781763827	0.9060235853033188	SQSTM1
Intracellular Signaling by Second Messengers	18/321	0.526216686781314	0.9057165366334801	0	0	1.0053021695612183	0.6454464156222982	IL33;NTRK2;CDKN1A;PDE1C;IRS1;PDGFA;GAB2;CHD3;ADCY8;AREG;FGF9;NBEA;ERBB4;FGF19;AKT3;RRAGD;NTF3;SGK1
Downstream Signaling Events of B Cell Receptor (BCR)	4/68	0.5303115691133274	0.9117637504053699	0	0	1.0577787769784173	0.6709391128084403	NFATC3;KRAS;RASGRP1;CARD11
SCF(Skp2)-mediated Degradation of P27 P21	3/50	0.5338126913816668	0.9167779847606281	0	0	1.0802890405459655	0.6781085218161137	CCNA1;CDKN1A;CCND1
Regulation of TP53 Activity	9/160	0.5388502936952205	0.9206538115199822	0	0	1.0086146556829807	0.6236440872199871	PLK3;CCNA1;SUPT16H;NUAK1;MRE11;AKT3;CHD3;SGK1;PRKAB1
Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC)	2/32	0.5398014017084561	0.9206538115199822	0	0	1.1283064033512866	0.6956618055451759	NUP155;GCK
Nuclear Signaling by ERBB4	2/32	0.5398014017084561	0.9206538115199822	0	0	1.1283064033512866	0.6956618055451759	ERBB4;APOE
Pausing and Recovery of Tat-mediated HIV Elongation	2/32	0.5398014017084561	0.9206538115199822	0	0	1.1283064033512866	0.6956618055451759	SUPT16H;POLR2H
Regulation of Glucokinase by Glucokinase Regulatory Protein	2/32	0.5398014017084561	0.9206538115199822	0	0	1.1283064033512866	0.6956618055451759	NUP155;GCK
Tat-mediated HIV Elongation Arrest and Recovery	2/32	0.5398014017084561	0.9206538115199822	0	0	1.1283064033512866	0.6956618055451759	SUPT16H;POLR2H
Response of EIF2AK4 (GCN2) to Amino Acid Deficiency	6/106	0.5452098771345745	0.9206538115199822	0	0	1.0153513513513515	0.6158963540019773	RPL35;RPS27L;RPL22L1;RPS4Y1;RPL9;ATF3
Diseases of DNA Repair	3/51	0.5473548393062251	0.9206538115199822	0	0	1.057726864330638	0.63744754193616	NEIL3;MRE11;MSH2
Acetylcholine Binding and Downstream Events	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	CHRNB2
Adenylate Cyclase Inhibitory Pathway	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	ADCY8
CS DS Degradation	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	VCAN
Carnitine Shuttle	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	ACACB
Erythropoietin Activates RAS	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	KRAS
IRAK1 Recruits IKK Complex	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	PELI2
IRAK1 Recruits IKK Complex Upon TLR7 8 or 9 Stimulation	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	PELI2
Interleukin-15 Signaling	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	GAB2
Lysosphingolipid and LPA Receptors	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	PLPPR1
Mismatch Repair (MMR) Directed by MSH2 MSH3 (MutSbeta)	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	MSH2
Mismatch Repair (MMR) Directed by MSH2 MSH6 (MutSalpha)	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	MSH2
Postsynaptic Nicotinic Acetylcholine Receptors	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	CHRNB2
Regulation of NPAS4 Gene Expression	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	NR3C1
Regulation of TP53 Activity Through Association With Co-factors	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	AKT3
Retrograde Neurotrophin Signalling	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	DNM1
Synthesis of IP2, IP, and Ins in the Cytosol	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	INPP4B
TP53 Regulates Transcription of Cell Death Genes With Uncertain Role in P53-Dependent Apoptosis	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	NDRG1
Uptake and Function of Anthrax Toxins	1/14	0.5525136444421833	0.9206538115199822	0	0	1.3018972059330804	0.7723858640229507	FURIN
Activation of the Pre-Replicative Complex	2/33	0.5566197789036627	0.9206538115199822	0	0	1.091851508658134	0.6396862046166651	GMNN;MCM6
Amino Acid Transport Across the Plasma Membrane	2/33	0.5566197789036627	0.9206538115199822	0	0	1.091851508658134	0.6396862046166651	SLC43A2;SLC38A3
FGFR2 Mutant Receptor Activation	2/33	0.5566197789036627	0.9206538115199822	0	0	1.091851508658134	0.6396862046166651	FGF9;POLR2H
HIV Elongation Arrest and Recovery	2/33	0.5566197789036627	0.9206538115199822	0	0	1.091851508658134	0.6396862046166651	SUPT16H;POLR2H
Inactivation, Recovery and Regulation of the Phototransduction Cascade	2/33	0.5566197789036627	0.9206538115199822	0	0	1.091851508658134	0.6396862046166651	PPEF1;RGS9
Negative Regulation of FGFR1 Signaling	2/33	0.5566197789036627	0.9206538115199822	0	0	1.091851508658134	0.6396862046166651	FGF9;SPRY2
Pausing and Recovery of HIV Elongation	2/33	0.5566197789036627	0.9206538115199822	0	0	1.091851508658134	0.6396862046166651	SUPT16H;POLR2H
Regulation of Expression and Function of Type II Classical Cadherins	2/33	0.5566197789036627	0.9206538115199822	0	0	1.091851508658134	0.6396862046166651	ZEB2;AMOT
Regulation of Homotypic Cell-Cell Adhesion	2/33	0.5566197789036627	0.9206538115199822	0	0	1.091851508658134	0.6396862046166651	ZEB2;AMOT
Pre-NOTCH Expression and Processing	5/89	0.5588373596432958	0.9233477132989335	0	0	1.0072435815010072	0.5861118137942662	KAT2B;CCND1;MFNG;FURIN;RUNX1
Regulation of Expression of SLITs and ROBOs	9/164	0.5689903037506253	0.9287397602611587	0	0	0.9823760818253344	0.553953901405291	ROBO2;ROBO3;HOXA2;RPL35;RPS27L;RPL22L1;PABPC1;RPS4Y1;RPL9
tRNA Processing	8/146	0.5724230994571646	0.9287397602611587	0	0	0.9807984094595301	0.5471647533105387	NUP155;MT-CO1;MT-RNR2;TRMT12;CDKAL1;MT-CO2;MT-ND3;MT-ND1
Negative Regulation of FGFR2 Signaling	2/34	0.5729960751369904	0.9287397602611587	0	0	1.0576750448833034	0.5889942840190275	FGF9;SPRY2
Plasma Lipoprotein Remodeling	2/34	0.5729960751369904	0.9287397602611587	0	0	1.0576750448833034	0.5889942840190275	FURIN;APOE
Signalling to ERKs	2/34	0.5729960751369904	0.9287397602611587	0	0	1.0576750448833034	0.5889942840190275	RALB;KRAS
The Phototransduction Cascade	2/34	0.5729960751369904	0.9287397602611587	0	0	1.0576750448833034	0.5889942840190275	PPEF1;RGS9
Intraflagellar Transport	3/53	0.5737319332656935	0.9287397602611587	0	0	1.0153099730458222	0.5640991209257801	DYNLT5;IFT20;IFT57
Transcriptional Regulation by RUNX1	11/202	0.5771018219524658	0.9287397602611587	0	0	0.9742626329629718	0.5355877885642139	LGALS3;KAT2B;CDK6;CCND1;AUTS2;CTSL;MYB;LIFR;SMARCA2;THBS1;RUNX1
Anchoring Fibril Formation	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	LAMB3
Constitutive Signaling by EGFRvIII	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	KRAS
Degradation of Cysteine and Homocysteine	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	GADL1
Depolymerization of the Nuclear Lamina	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	LMNA
ERBB2 Regulates Cell Motility	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	ERBB4
Eicosanoid Ligand-Binding Receptors	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	CYSLTR2
Fatty Acids	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	CYP2B6
GRB2 SOS Provides Linkage to MAPK Signaling for Integrins	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	FGB
Integration of Provirus	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	XRCC4
Keratan Sulfate Degradation	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	GLB1
Mismatch Repair	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	MSH2
Negative Regulation of FLT3	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	SOCS2
Negative Regulation of TCF-dependent Signaling by WNT Ligand Antagonists	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	SFRP1
Organic Cation Anion Zwitterion Transport	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	RUNX1
Phase 2 - Plateau Phase	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	CACNA1C
SARS-CoV-2 Targets Host Intracellular Signalling and Regulatory Pathways	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	AKT3
Signaling by EGFRvIII in Cancer	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	KRAS
p130Cas Linkage to MAPK Signaling for Integrins	1/15	0.5775008075603506	0.9287397602611587	0	0	1.2088404868673928	0.6637083548432527	FGB
Chaperonin-mediated Protein Folding	5/91	0.5788224243852349	0.9290483363202614	0	0	0.9837146505348209	0.5378553718681596	GNG2;GNG4;PFDN4;RGS9;GNG11
Post-translational Protein Modification	80/1457	0.578877694250571	0.9290483363202614	0	0	0.9817660798052955	0.5366962310631185	SEMA5B;CPM;APP;CDKN1A;GALNT14;CSF1;PIGZ;CHD3;NR3C1;AREG;FBXO22;PRSS23;ADAMTSL1;TRIM4;TMED3;QSOX1;ADAMTS9;CTSC;CHST8;PDIA3;TMED9;ST6GAL2;LRRC49;IGFBP3;APLP2;NSMCE1;HLA-B;AXIN2;F2;PDIA6;DDOST;F5;DDB2;RAB32;TPST1;CCNA1;KAT2B;VCAN;RAB37;FDX1;MFGE8;SQSTM1;ST6GALNAC5;PSMD10;CUL9;RPN2;SAR1B;NTM;FURIN;KLHL13;MAT2B;AFP;LTBP1;THBS1;THSD4;ADAMTS16;SOCS2;ADAMTS18;ARSJ;STC2;PENK;NEU1;GPC3;RAB29;MGAT1;APOE;CLSPN;DYNC1I1;IL33;TRAPPC3;GALNT5;XRCC4;NUP155;GOLM1;LAMB2;BMP4;TTLL5;GLB1;CALR;FBN1
Formation of the Cornified Envelope	7/129	0.5849230218234319	0.9337086777086291	0	0	0.970701710298748	0.5205630859335492	ST14;KLK13;KRT7;FURIN;PRSS8;DSG3;DSC3
G-protein Mediated Events	3/54	0.5865552225990375	0.9337086777086291	0	0	0.9953490830294381	0.5310072486137075	PDE1C;NBEA;ADCY8
Ion Homeostasis	3/54	0.5865552225990375	0.9337086777086291	0	0	0.9953490830294381	0.5310072486137075	RYR2;ATP2B4;ATP1B3
Metabolism of Non-Coding RNA	3/54	0.5865552225990375	0.9337086777086291	0	0	0.9953490830294381	0.5310072486137075	NUP155;SNRPG;WDR77
snRNP Assembly	3/54	0.5865552225990375	0.9337086777086291	0	0	0.9953490830294381	0.5310072486137075	NUP155;SNRPG;WDR77
Cyclin E Associated Events During G1 S Transition	4/73	0.5870250629966067	0.9337086777086291	0	0	0.9808674799291002	0.5224961039850843	CCNA1;CDKN1A;CCND1;AKT3
CD28 Co-Stimulation	2/35	0.5889272208251494	0.9337086777086291	0	0	1.025569881943311	0.5429907091172519	AKT3;PAK3
Diseases Associated With the TLR Signaling Cascade	2/35	0.5889272208251494	0.9337086777086291	0	0	1.025569881943311	0.5429907091172519	FGB;TLR5
Diseases of Immune System	2/35	0.5889272208251494	0.9337086777086291	0	0	1.025569881943311	0.5429907091172519	FGB;TLR5
N-glycan Trimming in the ER and Calnexin Calreticulin Cycle	2/35	0.5889272208251494	0.9337086777086291	0	0	1.025569881943311	0.5429907091172519	PDIA3;CALR
Negative Regulators of DDX58 IFIH1 Signaling	2/35	0.5889272208251494	0.9337086777086291	0	0	1.025569881943311	0.5429907091172519	TRIM4;ISG15
Nucleotide Catabolism	2/35	0.5889272208251494	0.9337086777086291	0	0	1.025569881943311	0.5429907091172519	NT5E;SAMHD1
Transport to the Golgi and Subsequent Modification	10/186	0.5940000487032089	0.9364800420759327	0	0	0.961080059181325	0.5006034192964213	CHST8;TRAPPC3;TMED9;SAR1B;TMED3;MGAT1;AREG;CTSC;DYNC1I1;F5
Glycolysis	4/74	0.5978782127256888	0.9364800420759327	0	0	0.966803699897225	0.4972930821777721	NUP155;ADPGK;PGM2L1;GCK
SARS-CoV-2 Modulates Host Translation Machinery	3/55	0.5991286458432835	0.9364800420759327	0	0	0.976155919552146	0.5000641160735461	SNRPG;RPS27L;RPS4Y1
Elevation of Cytosolic Ca2+ Levels	1/16	0.6010938894395472	0.9364800420759327	0	0	1.1281913303437967	0.5742540517864416	TRPC3
NRIF Signals Cell Death From the Nucleus	1/16	0.6010938894395472	0.9364800420759327	0	0	1.1281913303437967	0.5742540517864416	SQSTM1
Nucleotide-like (Purinergic) Receptors	1/16	0.6010938894395472	0.9364800420759327	0	0	1.1281913303437967	0.5742540517864416	P2RY1
PI3K Events in ERBB2 Signaling	1/16	0.6010938894395472	0.9364800420759327	0	0	1.1281913303437967	0.5742540517864416	ERBB4
Phospholipase C-mediated Cascade FGFR1	1/16	0.6010938894395472	0.9364800420759327	0	0	1.1281913303437967	0.5742540517864416	FGF9
Platelet Adhesion to Exposed Collagen	1/16	0.6010938894395472	0.9364800420759327	0	0	1.1281913303437967	0.5742540517864416	ITGA1
STING Mediated Induction of Host Immune Responses	1/16	0.6010938894395472	0.9364800420759327	0	0	1.1281913303437967	0.5742540517864416	MRE11
Sema3A PAK Dependent Axon Repulsion	1/16	0.6010938894395472	0.9364800420759327	0	0	1.1281913303437967	0.5742540517864416	PAK3
Signaling by ERBB2 ECD Mutants	1/16	0.6010938894395472	0.9364800420759327	0	0	1.1281913303437967	0.5742540517864416	KRAS
Spry Regulation of FGF Signaling	1/16	0.6010938894395472	0.9364800420759327	0	0	1.1281913303437967	0.5742540517864416	SPRY2
Synthesis of PIPs at the Early Endosome Membrane	1/16	0.6010938894395472	0.9364800420759327	0	0	1.1281913303437967	0.5742540517864416	INPP4B
VLDLR Internalisation and Degradation	1/16	0.6010938894395472	0.9364800420759327	0	0	1.1281913303437967	0.5742540517864416	VLDLR
p75NTR Signals via NF-kB	1/16	0.6010938894395472	0.9364800420759327	0	0	1.1281913303437967	0.5742540517864416	SQSTM1
Interferon Signaling	15/280	0.602368654243449	0.9364800420759327	0	0	0.9572258495707162	0.485204036081164	NUP155;IFNGR1;STAT1;MX1;HLA-B;IFI6;ISG15;TYK2;SAMHD1;PDE12;TRIM35;HLA-DRB1;IP6K2;SNCA;TRIM45
Cleavage of the Damaged Purine	2/36	0.6044118638908443	0.9364800420759327	0	0	0.9953532579997888	0.5011597876722824	NEIL3;TERF2IP
Depurination	2/36	0.6044118638908443	0.9364800420759327	0	0	0.9953532579997888	0.5011597876722824	NEIL3;TERF2IP
Keratan Sulfate Keratin Metabolism	2/36	0.6044118638908443	0.9364800420759327	0	0	0.9953532579997888	0.5011597876722824	GLB1;CHST2
ROS and RNS Production in Phagocytes	2/36	0.6044118638908443	0.9364800420759327	0	0	0.9953532579997888	0.5011597876722824	NOS3;ATP6V1E1
Recognition and Association of DNA Glycosylase With Site Containing an Affected Purine	2/36	0.6044118638908443	0.9364800420759327	0	0	0.9953532579997888	0.5011597876722824	NEIL3;TERF2IP
Signaling by High-Kinase Activity BRAF Mutants	2/36	0.6044118638908443	0.9364800420759327	0	0	0.9953532579997888	0.5011597876722824	FGB;KRAS
Influenza Infection	9/169	0.6054141569238468	0.9371070069660333	0	0	0.9514227642276423	0.4774643768962707	NUP155;RPL35;RPS27L;ISG15;RPL22L1;CALR;POLR2H;RPS4Y1;RPL9
Peptide Chain Elongation	5/94	0.6078691603016495	0.9373477474196302	0	0	0.9504040291669617	0.47310696014257747	RPL35;RPS27L;RPL22L1;RPS4Y1;RPL9
RAC3 GTPase Cycle	5/94	0.6078691603016495	0.9373477474196302	0	0	0.9504040291669617	0.47310696014257747	DOCK10;JAG1;ARHGDIB;SRGAP2;EPHA2
PIP3 Activates AKT Signaling	15/281	0.6079368918068098	0.9373477474196302	0	0	0.9535760381881133	0.4745797265353213	IL33;NTRK2;CDKN1A;IRS1;PDGFA;GAB2;CHD3;AREG;FGF9;ERBB4;FGF19;AKT3;RRAGD;NTF3;SGK1
Cyclin A Cdk2-associated Events at S Phase Entry	4/75	0.6085586778527956	0.9373477474196302	0	0	0.9531360826831493	0.4733864167468442	CCNA1;CDKN1A;CCND1;AKT3
Signaling by FGFR2	4/75	0.6085586778527956	0.9373477474196302	0	0	0.9531360826831493	0.4733864167468442	FGF9;SPRY2;KRAS;POLR2H
Gene Expression (Transcription)	88/1615	0.6114074489549741	0.9390314618116387	0	0	0.9730276552534279	0.4787215167884608	RET;CDKN1A;BTG2;STEAP3;MRE11;MT-CO1;SERPINE1;IHH;SLC2A3;CHD3;NR3C1;LGALS3;PIDD1;CCND1;CTSL;CASP6;SESN1;AKT3;SESN2;MYB;XPO5;ZNF248;PITX2;PHLDA1;TGIF1;ZNF560;SUPT16H;ITGA4;MSX2;TRPC3;ACSL1;IGFBP3;LIFR;PRKAB1;GEM;DDB2;RUNX1;CCNA1;KAT2B;MSH2;ZNF717;RRAGD;SNRPG;ZNF558;MT-CO2;SGK1;FKBP5;DLX5;UHRF1;FURIN;COX7A2;TXN;NDRG1;THBS1;DLL1;NUAK1;ZNF703;APOE;ZNF589;POLR2H;BID;NKX2-5;PLK3;TCF7L2;JAG1;AUTS2;NUP155;STAT1;NDUFA4;PLK2;TNFRSF10C;TNFRSF10B;GAD2;TNFRSF10A;ESRRG;ARID3A;TDRD6;KLF4;POU2F2;SMARCA2;GCK;TNFRSF10D;CDK6;NFIB;SYT10;FAS;BAX;KRAS
HSP90 Chaperone Cycle for Steroid Hormone Receptors (SHR) in the Presence of Ligand	3/56	0.6114484199679101	0.9390314618116387	0	0	0.9576870263947516	0.47110988153254746	NR3C1;DYNC1I1;FKBP5
Regulation of Cholesterol Biosynthesis by SREBP (SREBF)	3/56	0.6114484199679101	0.9390314618116387	0	0	0.9576870263947516	0.47110988153254746	INSIG2;SAR1B;ACACB
ISG15 Antiviral Mechanism	4/76	0.619063256717115	0.9416619506414871	0	0	0.9398481215027977	0.4507021175442019	NUP155;STAT1;MX1;ISG15
Activation of ATR in Response to Replication Stress	2/37	0.619450187609185	0.9416619506414871	0	0	0.9668632982816107	0.4630530603384357	CLSPN;MCM6
Gap Junction Assembly	2/37	0.619450187609185	0.9416619506414871	0	0	0.9668632982816107	0.4630530603384357	GJD2;GJB1
RHOH GTPase Cycle	2/37	0.619450187609185	0.9416619506414871	0	0	0.9668632982816107	0.4630530603384357	ARHGDIB;STOM
Activated Point Mutants of FGFR2	1/17	0.6233706025292497	0.9416619506414871	0	0	1.0576233183856503	0.4998476604316944	FGF9
GAB1 Signalosome	1/17	0.6233706025292497	0.9416619506414871	0	0	1.0576233183856503	0.4998476604316944	AREG
Germ Layer Formation at Gastrulation	1/17	0.6233706025292497	0.9416619506414871	0	0	1.0576233183856503	0.4998476604316944	BMP4
Hyaluronan Metabolism	1/17	0.6233706025292497	0.9416619506414871	0	0	1.0576233183856503	0.4998476604316944	CEMIP
Metabolism of Angiotensinogen to Angiotensins	1/17	0.6233706025292497	0.9416619506414871	0	0	1.0576233183856503	0.4998476604316944	ANPEP
Metabolism of Folate and Pterines	1/17	0.6233706025292497	0.9416619506414871	0	0	1.0576233183856503	0.4998476604316944	SLC46A1
Metabolism of Nitric Oxide NOS3 Activation and Regulation	1/17	0.6233706025292497	0.9416619506414871	0	0	1.0576233183856503	0.4998476604316944	NOS3
PKA Activation in Glucagon Signalling	1/17	0.6233706025292497	0.9416619506414871	0	0	1.0576233183856503	0.4998476604316944	ADCY8
Purine Catabolism	1/17	0.6233706025292497	0.9416619506414871	0	0	1.0576233183856503	0.4998476604316944	NT5E
Regulation of MITF-M-dependent Genes Involved in Lysosome Biogenesis and Autophagy	1/17	0.6233706025292497	0.9416619506414871	0	0	1.0576233183856503	0.4998476604316944	ATP6V1E1
Removal of the Flap Intermediate From the C-strand	1/17	0.6233706025292497	0.9416619506414871	0	0	1.0576233183856503	0.4998476604316944	TERF2IP
TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway	1/17	0.6233706025292497	0.9416619506414871	0	0	1.0576233183856503	0.4998476604316944	TNFRSF12A
Translation of Replicase and Assembly of the Replication Transcription Complex 9694676	1/17	0.6233706025292497	0.9416619506414871	0	0	1.0576233183856503	0.4998476604316944	ISCU
MyD88 MAL(TIRAP) Cascade Initiated on Plasma Membrane	6/115	0.6254212217260436	0.9429427650638812	0	0	0.9310686833622613	0.43697837344245005	DUSP4;FGB;IKBIP;APP;PELI2;DUSP6
Toll Like Receptor TLR6 TLR2 Cascade	6/115	0.6254212217260436	0.9429427650638812	0	0	0.9310686833622613	0.43697837344245005	DUSP4;FGB;IKBIP;APP;PELI2;DUSP6
L13a-mediated Translational Silencing of Ceruloplasmin Expression	6/116	0.633816097067056	0.9546816908752582	0	0	0.9225552825552825	0.42068191932698534	RPL35;RPS27L;RPL22L1;PABPC1;RPS4Y1;RPL9
Transcriptional Regulation of Granulopoiesis	3/58	0.635315521654594	0.9560218214533622	0	0	0.9227640284244057	0.4185966934210055	CDKN1A;MYB;RUNX1
ER to Golgi Anterograde Transport	8/155	0.6402138865768621	0.9564310875219416	0	0	0.9203074731697733	0.4104138423994049	TRAPPC3;TMED9;SAR1B;TMED3;AREG;CTSC;DYNC1I1;F5
ABC Transporters in Lipid Homeostasis	1/18	0.6444043309379541	0.9564310875219416	0	0	0.9953574254814033	0.43738882537190477	ABCA12
Formation of Definitive Endoderm	1/18	0.6444043309379541	0.9564310875219416	0	0	0.9953574254814033	0.43738882537190477	TCF7L2
PI-3K Cascade FGFR3	1/18	0.6444043309379541	0.9564310875219416	0	0	0.9953574254814033	0.43738882537190477	FGF9
Phospholipase C-mediated Cascade; FGFR2	1/18	0.6444043309379541	0.9564310875219416	0	0	0.9953574254814033	0.43738882537190477	FGF9
RNA Polymerase III Chain Elongation	1/18	0.6444043309379541	0.9564310875219416	0	0	0.9953574254814033	0.43738882537190477	POLR2H
Recycling of Bile Acids and Salts	1/18	0.6444043309379541	0.9564310875219416	0	0	0.9953574254814033	0.43738882537190477	SLC10A2
Regulation of NF-kappa B Signaling	1/18	0.6444043309379541	0.9564310875219416	0	0	0.9953574254814033	0.43738882537190477	IKBIP
Serotonin Neurotransmitter Release Cycle	1/18	0.6444043309379541	0.9564310875219416	0	0	0.9953574254814033	0.43738882537190477	STXBP1
Synthesis of Glycosylphosphatidylinositol (GPI)	1/18	0.6444043309379541	0.9564310875219416	0	0	0.9953574254814033	0.43738882537190477	PIGZ
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	1/18	0.6444043309379541	0.9564310875219416	0	0	0.9953574254814033	0.43738882537190477	BAX
TRAF3-dependent IRF Activation Pathway	1/18	0.6444043309379541	0.9564310875219416	0	0	0.9953574254814033	0.43738882537190477	TRIM4
Tie2 Signaling	1/18	0.6444043309379541	0.9564310875219416	0	0	0.9953574254814033	0.43738882537190477	KRAS
Eukaryotic Translation Termination	5/98	0.644737027749166	0.9564310875219416	0	0	0.909332868770748	0.39911779395155095	RPL35;RPS27L;RPL22L1;RPS4Y1;RPL9
Selenocysteine Synthesis	5/98	0.644737027749166	0.9564310875219416	0	0	0.909332868770748	0.39911779395155095	RPL35;RPS27L;RPL22L1;RPS4Y1;RPL9
Arachidonate Metabolism	3/59	0.6468587845898596	0.9577663590527855	0	0	0.9062379668848671	0.394781971614263	CYP1A1;CYP1B1;PTGR1
Formation of Paraxial Mesoderm	3/59	0.6468587845898596	0.9577663590527855	0	0	0.9062379668848671	0.394781971614263	BMP4;KAT2B;DLL1
Biosynthesis of the N-glycan Precursor (Dolichol LLO) and Transfer to a Nascent Protein	4/79	0.6494956569114292	0.9600964008247802	0	0	0.9021103117505995	0.38931394104355377	ST6GAL2;GLB1;NEU1;ST6GALNAC5
Toll Like Receptor 2 (TLR2) Cascade	6/118	0.6502693735178039	0.9600964008247802	0	0	0.905984555984556	0.38990728789782503	DUSP4;FGB;IKBIP;APP;PELI2;DUSP6
Toll Like Receptor TLR1 TLR2 Cascade	6/118	0.6502693735178039	0.9600964008247802	0	0	0.905984555984556	0.38990728789782503	DUSP4;FGB;IKBIP;APP;PELI2;DUSP6
Eukaryotic Translation Elongation	5/99	0.6536063648963424	0.9633397105442489	0	0	0.8996112377195167	0.3825596763845214	RPL35;RPS27L;RPL22L1;RPS4Y1;RPL9
Fatty Acid Metabolism	9/176	0.6536948035835976	0.9633397105442489	0	0	0.9112019862713597	0.3873653568757158	ACADVL;ACSL1;CYP1A1;CYP1B1;HSD17B4;HACL1;CROT;PTGR1;ACACB
Formation of the Beta-Catenin TCF Transactivating Complex	3/60	0.658140184104203	0.964203946911792	0	0	0.8902917671537334	0.3724422759816275	PYGO1;TCF7L2;AXIN2
Translation Initiation Complex Formation	3/60	0.658140184104203	0.964203946911792	0	0	0.8902917671537334	0.3724422759816275	RPS27L;PABPC1;RPS4Y1
Processing of DNA Double-Strand Break Ends	4/80	0.6592725569764958	0.964203946911792	0	0	0.890193108670958	0.3708706846056559	CCNA1;MRE11;TIMELESS;CLSPN
MAP2K and MAPK Activation	2/40	0.6619087004080789	0.964203946911792	0	0	0.8903902485117642	0.36739963346471627	FGB;KRAS
Mitotic G1 Phase and G1 S Transition	7/139	0.6632841029564328	0.964203946911792	0	0	0.8966855206710933	0.36813591671669155	CCNA1;CDKN1A;CDK6;CCND1;GMNN;AKT3;MCM6
Aflatoxin Activation and Detoxification	1/19	0.6642643711517244	0.964203946911792	0	0	0.9400099651220728	0.3845346323388576	CYP3A5
Assembly of Active LPL and LIPC Lipase Complexes	1/19	0.6642643711517244	0.964203946911792	0	0	0.9400099651220728	0.3845346323388576	FURIN
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	1/19	0.6642643711517244	0.964203946911792	0	0	0.9400099651220728	0.3845346323388576	KRAS
Initiation of Nuclear Envelope (NE) Reformation	1/19	0.6642643711517244	0.964203946911792	0	0	0.9400099651220728	0.3845346323388576	LMNA
MyD88 Deficiency (TLR2 4)	1/19	0.6642643711517244	0.964203946911792	0	0	0.9400099651220728	0.3845346323388576	FGB
Processive Synthesis on the C-strand of the Telomere	1/19	0.6642643711517244	0.964203946911792	0	0	0.9400099651220728	0.3845346323388576	TERF2IP
Regulation of MITF-M-dependent Genes Involved in Apoptosis	1/19	0.6642643711517244	0.964203946911792	0	0	0.9400099651220728	0.3845346323388576	BCL2
SARS-CoV-1 Targets Host Intracellular Signalling and Regulatory Pathways	1/19	0.6642643711517244	0.964203946911792	0	0	0.9400099651220728	0.3845346323388576	SERPINE1
Signaling by FGFR2 IIIa TM	1/19	0.6642643711517244	0.964203946911792	0	0	0.9400099651220728	0.3845346323388576	POLR2H
Signaling by Ligand-Responsive EGFR Variants in Cancer	1/19	0.6642643711517244	0.964203946911792	0	0	0.9400099651220728	0.3845346323388576	KRAS
Nonsense Mediated Decay (NMD) Enhanced by the Exon Junction Complex (EJC)	6/120	0.666263591857426	0.964203946911792	0	0	0.889995258416311	0.3614002884101605	RPL35;RPS27L;RPL22L1;PABPC1;RPS4Y1;RPL9
Nonsense-Mediated Decay (NMD)	6/120	0.666263591857426	0.964203946911792	0	0	0.889995258416311	0.3614002884101605	RPL35;RPS27L;RPL22L1;PABPC1;RPS4Y1;RPL9
Anti-inflammatory Response Favouring Leishmania Parasite Infection	8/159	0.6683114420318875	0.964203946911792	0	0	0.8957372032419251	0.3609829738734794	CYSLTR2;GNG2;SYK;GNG4;PLK2;FURIN;ADCY8;GNG11
Leishmania Parasite Growth and Survival	8/159	0.6683114420318875	0.964203946911792	0	0	0.8957372032419251	0.3609829738734794	CYSLTR2;GNG2;SYK;GNG4;PLK2;FURIN;ADCY8;GNG11
mRNA Activation Upon Binding of the Cap-Binding Complex and eIFs, and Subsequent Binding to 43S	3/61	0.6691591842729405	0.964203946911792	0	0	0.8748954363788456	0.3514746339183527	RPS27L;PABPC1;RPS4Y1
Interleukin-1 Family Signaling	7/140	0.6706030387768012	0.964203946911792	0	0	0.8898960656826919	0.35558281318449936	GSDMD;IKBIP;APP;IL33;PELI2;PTPN13;SQSTM1
Peptide Ligand-Binding Receptors	10/198	0.672160557173313	0.964203946911792	0	0	0.8991574006386827	0.3571975089956373	APP;CXCL6;KEL;MT-RNR2;PENK;PSAP;APLNR;F2RL1;PRLHR;F2
G1 S Transition	6/121	0.6740852438727841	0.964203946911792	0	0	0.8822091656874266	0.3479421493794337	CCNA1;CDKN1A;CCND1;GMNN;AKT3;MCM6
Cleavage of the Damaged Pyrimidine	2/41	0.6751887332328748	0.964203946911792	0	0	0.8675136951618101	0.3407273008871378	NEIL3;TERF2IP
Depyrimidination	2/41	0.6751887332328748	0.964203946911792	0	0	0.8675136951618101	0.3407273008871378	NEIL3;TERF2IP
MTOR Signalling	2/41	0.6751887332328748	0.964203946911792	0	0	0.8675136951618101	0.3407273008871378	RRAGD;PRKAB1
RNA Polymerase III Abortive And Retractive Initiation	2/41	0.6751887332328748	0.964203946911792	0	0	0.8675136951618101	0.3407273008871378	NFIB;POLR2H
RNA Polymerase III Transcription	2/41	0.6751887332328748	0.964203946911792	0	0	0.8675136951618101	0.3407273008871378	NFIB;POLR2H
Recognition and Association of DNA Glycosylase With Site Containing an Affected Pyrimidine	2/41	0.6751887332328748	0.964203946911792	0	0	0.8675136951618101	0.3407273008871378	NEIL3;TERF2IP
SARS-CoV-1 Modulates Host Translation Machinery	2/41	0.6751887332328748	0.964203946911792	0	0	0.8675136951618101	0.3407273008871378	RPS27L;RPS4Y1
Sensory Perception of Sweet, Bitter, and Umami (Glutamate) Taste	2/41	0.6751887332328748	0.964203946911792	0	0	0.8675136951618101	0.3407273008871378	GRM4;TRPM4
Signaling by RAF1 Mutants	2/41	0.6751887332328748	0.964203946911792	0	0	0.8675136951618101	0.3407273008871378	FGB;KRAS
Signaling by Retinoic Acid	2/41	0.6751887332328748	0.964203946911792	0	0	0.8675136951618101	0.3407273008871378	ALDH1A2;ALDH1A1
Transcriptional Regulation by VENTX	2/41	0.6751887332328748	0.964203946911792	0	0	0.8675136951618101	0.3407273008871378	TCF7L2;CCND1
TRAF6 Mediated Induction of NFkB and MAP Kinases Upon TLR7 8 or 9 Activation	5/102	0.6793539259882413	0.9665788255707949	0	0	0.8716490205721603	0.33699087878286166	DUSP4;IKBIP;APP;PELI2;DUSP6
Viral mRNA Translation	5/102	0.6793539259882413	0.9665788255707949	0	0	0.8716490205721603	0.33699087878286166	RPL35;RPS27L;RPL22L1;RPS4Y1;RPL9
Selenoamino Acid Metabolism	6/122	0.681788466731522	0.9665788255707949	0	0	0.8745573159366263	0.3349867920563155	RPL35;RPS27L;RPL22L1;HNMT;RPS4Y1;RPL9
Class I Peroxisomal Membrane Protein Import	1/20	0.6830161599058934	0.9665788255707949	0	0	0.890488553221619	0.339486970408216	GDAP1
FGFR2 Ligand Binding and Activation	1/20	0.6830161599058934	0.9665788255707949	0	0	0.890488553221619	0.339486970408216	FGF9
Formation of ATP by Chemiosmotic Coupling	1/20	0.6830161599058934	0.9665788255707949	0	0	0.890488553221619	0.339486970408216	ATP5MK
IRAK4 Deficiency (TLR2 4)	1/20	0.6830161599058934	0.9665788255707949	0	0	0.890488553221619	0.339486970408216	FGB
NOTCH4 Intracellular Domain Regulates Transcription	1/20	0.6830161599058934	0.9665788255707949	0	0	0.890488553221619	0.339486970408216	KAT2B
Signaling by Hippo	1/20	0.6830161599058934	0.9665788255707949	0	0	0.890488553221619	0.339486970408216	AMOT
Synthesis of Leukotrienes (LT) and Eoxins (EX)	1/20	0.6830161599058934	0.9665788255707949	0	0	0.890488553221619	0.339486970408216	PTGR1
MyD88 Dependent Cascade Initiated on Endosome	5/103	0.6876458434547368	0.971060591114174	0	0	0.862708719851577	0.32306831399309016	DUSP4;IKBIP;APP;PELI2;DUSP6
NS1 Mediated Effects on Host Pathways	2/42	0.6880410183213311	0.971060591114174	0	0	0.8457809694793537	0.31624327539810093	NUP155;ISG15
RHOF GTPase Cycle	2/42	0.6880410183213311	0.971060591114174	0	0	0.8457809694793537	0.31624327539810093	STEAP3;SRGAP2
Peroxisomal Protein Import	3/63	0.6904104382874428	0.9726536992225608	0	0	0.8456424079065589	0.31328431424524894	HSD17B4;HACL1;CROT
Translation of Structural Proteins 9694635	3/63	0.6904104382874428	0.9726536992225608	0	0	0.8456424079065589	0.31328431424524894	RPN2;MGAT1;DDOST
PI Metabolism	4/84	0.6965103585598772	0.9786195403221848	0	0	0.8455035971223022	0.3057954957529311	INPP4B;INPP5D;PTPN13;SBF2
Cap-dependent Translation Initiation	6/124	0.696836131349455	0.9786195403221848	0	0	0.8596426935409986	0.31050724043676997	RPL35;RPS27L;RPL22L1;PABPC1;RPS4Y1;RPL9
Eukaryotic Translation Initiation	6/124	0.696836131349455	0.9786195403221848	0	0	0.8596426935409986	0.31050724043676997	RPL35;RPS27L;RPL22L1;PABPC1;RPS4Y1;RPL9
Base-Excision Repair, AP Site Formation	2/43	0.70047189724738	0.9786195403221848	0	0	0.8251083767570171	0.2937394337557266	NEIL3;TERF2IP
tRNA Modification in the Nucleus and Cytosol	2/43	0.70047189724738	0.9786195403221848	0	0	0.8251083767570171	0.2937394337557266	TRMT12;CDKAL1
CTLA4 Inhibitory Signaling	1/21	0.7007214885310422	0.9786195403221848	0	0	0.8459192825112107	0.30084677445472646	AKT3
Interleukin-37 Signaling	1/21	0.7007214885310422	0.9786195403221848	0	0	0.8459192825112107	0.30084677445472646	PTPN13
PI-3K Cascade FGFR1	1/21	0.7007214885310422	0.9786195403221848	0	0	0.8459192825112107	0.30084677445472646	FGF9
RHO GTPases Activate PAKs	1/21	0.7007214885310422	0.9786195403221848	0	0	0.8459192825112107	0.30084677445472646	PAK3
Disorders of Transmembrane Transporters	8/164	0.7015104357921784	0.9786195403221848	0	0	0.8667962602980653	0.30729617953637783	SLC35A2;SLC5A7;NUP155;ABCC8;SLC1A3;SLC17A8;ABCA12;GCK
Potential Therapeutics for SARS	8/164	0.7015104357921784	0.9786195403221848	0	0	0.8667962602980653	0.30729617953637783	ITGA4;SYK;IFNGR1;ATP1B3;FURIN;CHD3;TYK2;NR3C1
Vesicle-mediated Transport	39/752	0.707181098026801	0.9856532992942435	0	0	0.9228650568237312	0.3197436681740861	COLEC12;APP;LRP1;SAR1B;RHOBTB3;AREG;SLC2A8;HPX;KIF19;AKT3;CLTCL1;KIF5A;TMED3;AP1S1;KIF21B;APOE;SBF2;CTSC;DYNC1I1;TRAPPC3;TMED9;TOR1A;SYT2;AMBP;SYTL1;PRKAB1;KIF6;DNM1;F5;GJD2;VAMP8;RAB32;NECAP2;GJB1;SYT11;KIF26B;HYOU1;CALR;MASP1
RAB Geranylgeranylation	3/65	0.7106181280640107	0.9869096379744275	0	0	0.8182766715937745	0.2795397459353209	RAB32;RAB37;RAB29
RUNX1 Regulates Genes Involved in Megakaryocyte Differentiation and Platelet Function	3/65	0.7106181280640107	0.9869096379744275	0	0	0.8182766715937745	0.2795397459353209	KAT2B;THBS1;RUNX1
Formation of a Pool of Free 40S Subunits	5/106	0.7116395483044873	0.9869096379744275	0	0	0.836950031636827	0.28471679876852757	RPL35;RPS27L;RPL22L1;RPS4Y1;RPL9
Formation of HIV-1 Elongation Complex Containing HIV-1 Tat	2/44	0.712488335578477	0.9869096379744275	0	0	0.8054201932119347	0.27303079119071755	SUPT16H;POLR2H
HIV Transcription Elongation	2/44	0.712488335578477	0.9869096379744275	0	0	0.8054201932119347	0.27303079119071755	SUPT16H;POLR2H
NR1H3 & NR1H2 Regulate Gene Expression Linked to Cholesterol Transport and Efflux	2/44	0.712488335578477	0.9869096379744275	0	0	0.8054201932119347	0.27303079119071755	APOC1;APOE
Tat-mediated Elongation of the HIV-1 Transcript	2/44	0.712488335578477	0.9869096379744275	0	0	0.8054201932119347	0.27303079119071755	SUPT16H;POLR2H
Chaperone Mediated Autophagy	1/22	0.7174387060349772	0.988527145046436	0	0	0.8055947042494128	0.26751203062099577	RNASE1
Cobalamin (Cbl, Vitamin B12) Transport and Metabolism	1/22	0.7174387060349772	0.988527145046436	0	0	0.8055947042494128	0.26751203062099577	TCN1
Early Phase of HIV Life Cycle	1/22	0.7174387060349772	0.988527145046436	0	0	0.8055947042494128	0.26751203062099577	XRCC4
Post-chaperonin Tubulin Folding Pathway	1/22	0.7174387060349772	0.988527145046436	0	0	0.8055947042494128	0.26751203062099577	TBCA
Regulation of Signaling by CBL	1/22	0.7174387060349772	0.988527145046436	0	0	0.8055947042494128	0.26751203062099577	SYK
The Canonical Retinoid Cycle in Rods (Twilight Vision)	1/22	0.7174387060349772	0.988527145046436	0	0	0.8055947042494128	0.26751203062099577	LRAT
Reproduction	6/127	0.7185012125789939	0.9891219502404411	0	0	0.8381952200134019	0.2770971856811545	BMP4;MRE11;LMNA;TERF2IP;CD9;CBFA2T2
Toll Like Receptor 7 8 (TLR7 8) Cascade	5/107	0.7193422487963743	0.9894110930813289	0	0	0.8287005171105346	0.27298889002104104	DUSP4;IKBIP;APP;PELI2;DUSP6
Carboxyterminal Post-Translational Modifications of Tubulin	2/45	0.7240978340980646	0.9898739353668399	0	0	0.7866477391340654	0.253952518709359	TTLL5;LRRC49
Formation of HIV Elongation Complex in the Absence of HIV Tat	2/45	0.7240978340980646	0.9898739353668399	0	0	0.7866477391340654	0.253952518709359	SUPT16H;POLR2H
Paradoxical Activation of RAF Signaling by Kinase Inactive BRAF	2/45	0.7240978340980646	0.9898739353668399	0	0	0.7866477391340654	0.253952518709359	FGB;KRAS
Signaling by RAS Mutants	2/45	0.7240978340980646	0.9898739353668399	0	0	0.7866477391340654	0.253952518709359	FGB;KRAS
Signaling by Moderate Kinase Activity BRAF Mutants	2/45	0.7240978340980646	0.9898739353668399	0	0	0.7866477391340654	0.253952518709359	FGB;KRAS
Signaling Downstream of RAS Mutants	2/45	0.7240978340980646	0.9898739353668399	0	0	0.7866477391340654	0.253952518709359	FGB;KRAS
TAK1-dependent IKK and NF-kappa-B Activation	2/45	0.7240978340980646	0.9898739353668399	0	0	0.7866477391340654	0.253952518709359	IKBIP;APP
Toll Like Receptor 4 (TLR4) Cascade	7/148	0.7255151529172726	0.990947525935787	0	0	0.8390473815142387	0.2692279195350698	DUSP4;FGB;IKBIP;APP;PELI2;DNM1;DUSP6
Influenza Viral RNA Transcription and Replication	7/149	0.731915660840509	0.9945445712590034	0	0	0.8330941464839533	0.2600003430870051	NUP155;RPL35;RPS27L;RPL22L1;POLR2H;RPS4Y1;RPL9
Abortive Elongation of HIV-1 Transcript in the Absence of Tat	1/23	0.7332229109537041	0.9945445712590034	0	0	0.7689359967386873	0.23860508094197966	POLR2H
Dopamine Neurotransmitter Release Cycle	1/23	0.7332229109537041	0.9945445712590034	0	0	0.7689359967386873	0.23860508094197966	STXBP1
Intrinsic Pathway of Fibrin Clot Formation	1/23	0.7332229109537041	0.9945445712590034	0	0	0.7689359967386873	0.23860508094197966	F2
Mitochondrial Calcium Ion Transport	1/23	0.7332229109537041	0.9945445712590034	0	0	0.7689359967386873	0.23860508094197966	SLC8B1
Nephrin Family Interactions	1/23	0.7332229109537041	0.9945445712590034	0	0	0.7689359967386873	0.23860508094197966	ACTN4
PI-3K Cascade FGFR2	1/23	0.7332229109537041	0.9945445712590034	0	0	0.7689359967386873	0.23860508094197966	FGF9
RHOBTB1 GTPase Cycle	1/23	0.7332229109537041	0.9945445712590034	0	0	0.7689359967386873	0.23860508094197966	PDE5A
RSV-host Interactions	5/109	0.7343045212060322	0.9947916204697326	0	0	0.8126774215883127	0.2509803524879942	GPC3;ISG15;TYK2;GPC4;HSPG2
Hh Mutants Abrogate Ligand Secretion	2/46	0.735308347018125	0.9947916204697326	0	0	0.7687285784233719	0.23635739987522836	SHH;IHH
Metabolism of Polyamines	2/46	0.735308347018125	0.9947916204697326	0	0	0.7687285784233719	0.23635739987522836	SMOX;SAT1
Adipogenesis	5/110	0.7415645426815871	0.9999956227936566	0	0	0.8048947751918049	0.24065796613293572	EGR2;PRDM16;EBF1;CHD3;KLF4
Toll Like Receptor 9 (TLR9) Cascade	5/110	0.7415645426815871	0.9999956227936566	0	0	0.8048947751918049	0.24065796613293572	DUSP4;IKBIP;APP;PELI2;DUSP6
Inhibition of DNA Recombination at Telomere	2/47	0.7461282084312194	0.9999956227936566	0	0	0.751605824855376	0.2201136526690428	TERF2IP;POLR2H
RAB GEFs Exchange GTP for GDP on RABs	4/90	0.7467332432133711	0.9999956227936566	0	0	0.786264012046177	0.2296262517371161	RAB32;TRAPPC3;AKT3;SBF2
Assembly Of The HIV Virion	1/24	0.748126131736283	0.9999956227936566	0	0	0.7354650029245466	0.21341994834641936	FURIN
CD28 Dependent PI3K Akt Signaling	1/24	0.748126131736283	0.9999956227936566	0	0	0.7354650029245466	0.21341994834641936	AKT3
Impaired BRCA2 Binding to PALB2	1/24	0.748126131736283	0.9999956227936566	0	0	0.7354650029245466	0.21341994834641936	MRE11
Maturation of hRSV A Proteins	1/24	0.748126131736283	0.9999956227936566	0	0	0.7354650029245466	0.21341994834641936	FURIN
Synthesis of Very Long-Chain Fatty acyl-CoAs	1/24	0.748126131736283	0.9999956227936566	0	0	0.7354650029245466	0.21341994834641936	ACSL1
Triglyceride Catabolism	1/24	0.748126131736283	0.9999956227936566	0	0	0.7354650029245466	0.21341994834641936	FABP1
mTORC1-mediated Signalling	1/24	0.748126131736283	0.9999956227936566	0	0	0.7354650029245466	0.21341994834641936	RRAGD
SARS-CoV-1-host Interactions	5/112	0.7556445732493222	0.9999956227936566	0	0	0.7897658924770982	0.22127988888262293	SERPINE1;RPS27L;RPS4Y1;RUNX1;BCL2L1
DNA Damage Bypass	2/48	0.7565660652670709	0.9999956227936566	0	0	0.7352275388338146	0.20510305872919	USP1;ISG15
NOTCH1 Intracellular Domain Regulates Transcription	2/48	0.7565660652670709	0.9999956227936566	0	0	0.7352275388338146	0.20510305872919	KAT2B;NBEA
Recycling Pathway of L1	2/48	0.7565660652670709	0.9999956227936566	0	0	0.7352275388338146	0.20510305872919	MSN;DNM1
Respiratory Syncytial Virus Infection Pathway	6/133	0.7585433898209394	0.9999956227936566	0	0	0.7983400723558204	0.22062549188069194	GPC3;ISG15;FURIN;TYK2;GPC4;HSPG2
Cyclin A B1 B2 Associated Events During G2 M Transition	1/25	0.7621974983022931	0.9999956227936566	0	0	0.7047832585949177	0.1913835927557268	CCNA1
Deadenylation of mRNA	1/25	0.7621974983022931	0.9999956227936566	0	0	0.7047832585949177	0.1913835927557268	PABPC1
Defective HDR Through Homologous Recombination Repair Due to PALB2 Loss of BRCA1 Binding Function	1/25	0.7621974983022931	0.9999956227936566	0	0	0.7047832585949177	0.1913835927557268	MRE11
Defective HDR Through Homologous Recomb Repair Due to PALB2 Loss of BRCA2 RAD51 RAD51C Binding Fnc	1/25	0.7621974983022931	0.9999956227936566	0	0	0.7047832585949177	0.1913835927557268	MRE11
Defective Homologous Recombination Repair (HRR) Due to BRCA1 Loss of Function	1/25	0.7621974983022931	0.9999956227936566	0	0	0.7047832585949177	0.1913835927557268	MRE11
Defective Homologous Recombination Repair (HRR) Due to PALB2 Loss of Function	1/25	0.7621974983022931	0.9999956227936566	0	0	0.7047832585949177	0.1913835927557268	MRE11
Signaling by Erythropoietin	1/25	0.7621974983022931	0.9999956227936566	0	0	0.7047832585949177	0.1913835927557268	KRAS
TCR Signaling	5/113	0.7624658753453657	0.9999956227936566	0	0	0.7824115744907824	0.21218808264863293	VASP;INPP5D;PAK3;CARD11;HLA-DRB1
Viral Messenger RNA Synthesis	2/49	0.766630816295366	0.9999956227936566	0	0	0.7195462011535964	0.19121935127892004	NUP155;POLR2H
trans-Golgi Network Vesicle Budding	3/72	0.7733530140997004	0.9999956227936566	0	0	0.7349896480331263	0.18890678506550065	VAMP8;APP;AP1S1
Downregulation of TGF-beta Receptor Signaling	1/26	0.7754834028643272	0.9999956227936566	0	0	0.6765560538116592	0.17202702722835317	PPP1R15A
Fertilization	1/26	0.7754834028643272	0.9999956227936566	0	0	0.6765560538116592	0.17202702722835317	CD9
Gluconeogenesis	1/26	0.7754834028643272	0.9999956227936566	0	0	0.6765560538116592	0.17202702722835317	SLC37A1
N-glycan Antennae Elongation in the Medial trans-Golgi	1/26	0.7754834028643272	0.9999956227936566	0	0	0.6765560538116592	0.17202702722835317	CHST8
Polymerase Switching on the C-strand of the Telomere	1/26	0.7754834028643272	0.9999956227936566	0	0	0.6765560538116592	0.17202702722835317	TERF2IP
Translocation of ZAP-70 to Immunological Synapse	1/26	0.7754834028643272	0.9999956227936566	0	0	0.6765560538116592	0.17202702722835317	HLA-DRB1
WNT Ligand Biogenesis and Trafficking	1/26	0.7754834028643272	0.9999956227936566	0	0	0.6765560538116592	0.17202702722835317	WNT16
rRNA Processing	11/237	0.7761915601550264	0.9999956227936566	0	0	0.821839586753694	0.20821793560124674	MT-CO1;MT-RNR2;KRR1;RPL35;RPS27L;MT-CO2;RPL22L1;RPS4Y1;MT-ND3;RPL9;MT-ND1
Death Receptor Signaling	7/157	0.7793798677717207	0.9999956227936566	0	0	0.7883258190562068	0.19649550545008784	SMPD3;ARHGEF9;TNFRSF10B;FAS;TNFRSF10A;SQSTM1;TNFRSF10D
SARS-CoV-1 Infection	7/157	0.7793798677717207	0.9999956227936566	0	0	0.7883258190562068	0.19649550545008784	CTSL;SERPINE1;RPS27L;MGAT1;RPS4Y1;RUNX1;BCL2L1
Hedgehog 'On' State	3/73	0.781338486371776	0.9999956227936566	0	0	0.7244512899499422	0.17875605333635866	SHH;IHH;GAS1
Pre-NOTCH Transcription and Translation	3/73	0.781338486371776	0.9999956227936566	0	0	0.7244512899499422	0.17875605333635866	KAT2B;CCND1;RUNX1
Extension of Telomeres	2/51	0.7856775315217217	0.9999956227936566	0	0	0.6901036895907375	0.16645910766773703	CCNA1;TERF2IP
Nonhomologous End-Joining (NHEJ)	2/51	0.7856775315217217	0.9999956227936566	0	0	0.6901036895907375	0.16645910766773703	MRE11;XRCC4
Cardiogenesis	1/27	0.7880276525635496	0.9999956227936566	0	0	0.6505001724732666	0.15496351561103167	NKX2-5
G0 and Early G1	1/27	0.7880276525635496	0.9999956227936566	0	0	0.6505001724732666	0.15496351561103167	CCNA1
Postmitotic Nuclear Pore Complex (NPC) Reformation	1/27	0.7880276525635496	0.9999956227936566	0	0	0.6505001724732666	0.15496351561103167	NUP155
Prefoldin Mediated Transfer of Substrate to CCT TriC	1/27	0.7880276525635496	0.9999956227936566	0	0	0.6505001724732666	0.15496351561103167	PFDN4
RNA Pol II CTD Phosphorylation and Interaction With CE	1/27	0.7880276525635496	0.9999956227936566	0	0	0.6505001724732666	0.15496351561103167	POLR2H
RNA Pol II CTD Phosphorylation and Interaction With CE During HIV Infection	1/27	0.7880276525635496	0.9999956227936566	0	0	0.6505001724732666	0.15496351561103167	POLR2H
RNA Polymerase III Transcription Initiation From Type 2 Promoter	1/27	0.7880276525635496	0.9999956227936566	0	0	0.6505001724732666	0.15496351561103167	POLR2H
Resolution of D-loop Structures Through Synthesis-Dependent Strand Annealing (SDSA)	1/27	0.7880276525635496	0.9999956227936566	0	0	0.6505001724732666	0.15496351561103167	MRE11
Syndecan Interactions	1/27	0.7880276525635496	0.9999956227936566	0	0	0.6505001724732666	0.15496351561103167	THBS1
GTP Hydrolysis and Joining of the 60S Ribosomal Subunit	5/117	0.7883137240165438	0.9999956227936566	0	0	0.7543075736145043	0.17941895183500164	RPL35;RPS27L;RPL22L1;RPS4Y1;RPL9
PPARA Activates Gene Expression	5/117	0.7883137240165438	0.9999956227936566	0	0	0.7543075736145043	0.17941895183500164	FABP1;ACSL1;CYP1A1;ANKRD1;HMGCS2
RHOG GTPase Cycle	3/74	0.7890903175259757	0.9999956227936566	0	0	0.7142097870240309	0.1691780817722197	DOCK5;ARHGDIB;EPHA2
Hedgehog Ligand Biogenesis	2/52	0.7946780847160946	0.9999956227936566	0	0	0.6762657091561939	0.15541814853534164	SHH;IHH
Positive Epigenetic Regulation of rRNA Expression	3/75	0.7966124577012482	0.9999956227936566	0	0	0.7042527702905061	0.1601379033858835	KAT2B;CHD3;POLR2H
Mitochondrial Biogenesis	4/97	0.7969967913399872	0.9999956227936566	0	0	0.7268120987081302	0.1649170275184964	GLUD2;ACSS2;ATP5MK;PRKAB1
Activation of AMPK Downstream of NMDARs	1/28	0.7998716135528471	0.9999956227936566	0	0	0.6263743564191995	0.13987192888323322	PRKAB1
BMAL1 CLOCK,NPAS2 Activates Circadian Gene Expression	1/28	0.7998716135528471	0.9999956227936566	0	0	0.6263743564191995	0.13987192888323322	SERPINE1
FGFR2 Alternative Splicing	1/28	0.7998716135528471	0.9999956227936566	0	0	0.6263743564191995	0.13987192888323322	POLR2H
Keratan Sulfate Biosynthesis	1/28	0.7998716135528471	0.9999956227936566	0	0	0.6263743564191995	0.13987192888323322	CHST2
Notch-HLH Transcription Pathway	1/28	0.7998716135528471	0.9999956227936566	0	0	0.6263743564191995	0.13987192888323322	KAT2B
RNA Polymerase III Transcription Initiation From Type 1 Promoter	1/28	0.7998716135528471	0.9999956227936566	0	0	0.6263743564191995	0.13987192888323322	POLR2H
RNA Polymerase III Transcription Initiation From Type 3 Promoter	1/28	0.7998716135528471	0.9999956227936566	0	0	0.6263743564191995	0.13987192888323322	POLR2H
Sulfur Amino Acid Metabolism	1/28	0.7998716135528471	0.9999956227936566	0	0	0.6263743564191995	0.13987192888323322	GADL1
TGFBR3 Expression	1/28	0.7998716135528471	0.9999956227936566	0	0	0.6263743564191995	0.13987192888323322	TGFBR3
Membrane Trafficking	31/633	0.8000657264438503	0.9999956227936566	0	0	0.8676791646891314	0.19354572630594066	APP;SAR1B;RHOBTB3;AREG;SLC2A8;KIF19;AKT3;CLTCL1;KIF5A;TMED3;AP1S1;KIF21B;SBF2;CTSC;DYNC1I1;TRAPPC3;TMED9;TOR1A;SYT2;SYTL1;PRKAB1;KIF6;DNM1;F5;GJD2;VAMP8;RAB32;NECAP2;GJB1;SYT11;KIF26B
Regulation of Lipid Metabolism by PPARalpha	5/119	0.8003910444337651	0.9999956227936566	0	0	0.7409951521467937	0.16498617571399857	FABP1;ACSL1;CYP1A1;ANKRD1;HMGCS2
Formation of the Ternary Complex, and Subsequently, the 43S Complex	2/53	0.8033426251992936	0.9999956227936566	0	0	0.6629703946210441	0.14517326234853106	RPS27L;RPS4Y1
Nuclear Envelope Breakdown	2/53	0.8033426251992936	0.9999956227936566	0	0	0.6629703946210441	0.14517326234853106	NUP155;LMNA
Nuclear Receptor Transcription Pathway	2/53	0.8033426251992936	0.9999956227936566	0	0	0.6629703946210441	0.14517326234853106	ESRRG;NR3C1
mRNA Splicing - Minor Pathway	2/53	0.8033426251992936	0.9999956227936566	0	0	0.6629703946210441	0.14517326234853106	SNRPG;POLR2H
p53-Dependent G1 DNA Damage Response	2/53	0.8033426251992936	0.9999956227936566	0	0	0.6629703946210441	0.14517326234853106	CCNA1;CDKN1A
p53-Dependent G1 S DNA Damage Checkpoint	2/53	0.8033426251992936	0.9999956227936566	0	0	0.6629703946210441	0.14517326234853106	CCNA1;CDKN1A
Intra-Golgi and Retrograde Golgi-to-ER Traffic	9/204	0.8093412415278959	0.9999956227936566	0	0	0.7791953304148426	0.16482680703868535	TMED9;KIF19;KIF26B;KIF5A;TMED3;RHOBTB3;KIF21B;KIF6;DYNC1I1
SUMOylation of DNA Damage Response and Repair Proteins	3/77	0.8109841055595185	0.9999956227936566	0	0	0.6851460625045531	0.14354277527727222	NUP155;XRCC4;NSMCE1
G1 S-Specific Transcription	1/29	0.8110543464726452	0.9999956227936566	0	0	0.6039718129404228	0.12648390718065944	CCNA1
Myogenesis	1/29	0.8110543464726452	0.9999956227936566	0	0	0.6039718129404228	0.12648390718065944	CTNNA2
Phosphorylation of CD3 and TCR Zeta Chains	1/29	0.8110543464726452	0.9999956227936566	0	0	0.6039718129404228	0.12648390718065944	HLA-DRB1
Processing of Capped Intronless Pre-mRNA	1/29	0.8110543464726452	0.9999956227936566	0	0	0.6039718129404228	0.12648390718065944	SNRPG
TNFs Bind Their Physiological Receptors	1/29	0.8110543464726452	0.9999956227936566	0	0	0.6039718129404228	0.12648390718065944	EDA2R
TRAF6 Mediated IRF7 Activation	1/29	0.8110543464726452	0.9999956227936566	0	0	0.6039718129404228	0.12648390718065944	TRIM4
mRNA Capping	1/29	0.8110543464726452	0.9999956227936566	0	0	0.6039718129404228	0.12648390718065944	POLR2H
NR1H2 and NR1H3-mediated Signaling	2/54	0.8116805877189887	0.9999956227936566	0	0	0.6501864383372462	0.13566034776366595	APOC1;APOE
Protein Localization	7/164	0.8155437951522468	0.9999956227936566	0	0	0.7528961077001717	0.15351563300386087	APP;SEC61G;HSD17B4;HACL1;CROT;HSCB;GDAP1
Costimulation by the CD28 Family	3/78	0.8178420995067811	0.9999956227936566	0	0	0.6759748427672956	0.13592907277149852	AKT3;PAK3;HLA-DRB1
G1 S DNA Damage Checkpoints	2/55	0.819701401099985	0.9999956227936566	0	0	0.63788489549812	0.12682118120718486	CCNA1;CDKN1A
Regulation of RAS by GAPs	2/55	0.819701401099985	0.9999956227936566	0	0	0.63788489549812	0.12682118120718486	SPRED2;KRAS
Dectin-2 Family	1/30	0.8216127352194507	0.9999956227936566	0	0	0.5831142724601824	0.1145738608991406	SYK
Insulin Receptor Recycling	1/30	0.8216127352194507	0.9999956227936566	0	0	0.5831142724601824	0.1145738608991406	ATP6V1E1
PD-1 Signaling	1/30	0.8216127352194507	0.9999956227936566	0	0	0.5831142724601824	0.1145738608991406	HLA-DRB1
Recognition of DNA Damage by PCNA-containing Replication Complex	1/30	0.8216127352194507	0.9999956227936566	0	0	0.5831142724601824	0.1145738608991406	USP1
Respiratory Syncytial Virus (RSV) Genome Replication, Transcription and Translation	1/30	0.8216127352194507	0.9999956227936566	0	0	0.5831142724601824	0.1145738608991406	FURIN
SUMOylation of Intracellular Receptors	1/30	0.8216127352194507	0.9999956227936566	0	0	0.5831142724601824	0.1145738608991406	NR3C1
Signaling by ALK	1/30	0.8216127352194507	0.9999956227936566	0	0	0.5831142724601824	0.1145738608991406	IRS1
Surfactant Metabolism	1/30	0.8216127352194507	0.9999956227936566	0	0	0.5831142724601824	0.1145738608991406	CTSH
Rab Regulation of Trafficking	5/123	0.8229075799926261	0.9999956227936566	0	0	0.7157241147843598	0.1395027756963714	RAB32;TRAPPC3;AKT3;SYTL1;SBF2
RNA Polymerase I Promoter Clearance	3/79	0.8244873422032726	0.9999956227936566	0	0	0.6670449709178606	0.12873533638310336	KAT2B;CHD3;POLR2H
Switching of Origins to a Post-Replicative State	3/79	0.8244873422032726	0.9999956227936566	0	0	0.6670449709178606	0.12873533638310336	CCNA1;GMNN;MCM6
Golgi Associated Vesicle Biogenesis	2/56	0.8274144598375077	0.9999956227936566	0	0	0.6260389653567392	0.11860279956295593	VAMP8;AP1S1
Transcriptional Activation of Mitochondrial Biogenesis	2/56	0.8274144598375077	0.9999956227936566	0	0	0.6260389653567392	0.11860279956295593	GLUD2;ACSS2
Interleukin-1 Signaling	4/102	0.8277286313255137	0.9999956227936566	0	0	0.6895463221259727	0.13037246676110495	IKBIP;APP;PELI2;SQSTM1
Cellular Senescence	7/167	0.8295633871387298	0.9999956227936566	0	0	0.7386609558160505	0.13802305146759178	CCNA1;CDKN1A;MRE11;CDK6;TERF2IP;TXN;H1-0
PKR-mediated Signaling	3/80	0.8309242701324225	0.9999956227936566	0	0	0.6583470437917878	0.12193681376889415	STAT1;ISG15;SNCA
Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	1/31	0.8315816081542163	0.9999956227936566	0	0	0.5636472346786248	0.10395111441464099	DLG4
Metalloprotease DUBs	1/31	0.8315816081542163	0.9999956227936566	0	0	0.5636472346786248	0.10395111441464099	KAT2B
Nicotinate Metabolism	1/31	0.8315816081542163	0.9999956227936566	0	0	0.5636472346786248	0.10395111441464099	NT5E
RUNX2 Regulates Bone Development	1/31	0.8315816081542163	0.9999956227936566	0	0	0.5636472346786248	0.10395111441464099	IHH
Trafficking of AMPA Receptors	1/31	0.8315816081542163	0.9999956227936566	0	0	0.5636472346786248	0.10395111441464099	DLG4
RNA Polymerase I Transcription	3/81	0.8371573713965091	0.9999956227936566	0	0	0.6498721404381782	0.115510358882508	KAT2B;CHD3;POLR2H
Senescence-Associated Secretory Phenotype (SASP)	3/81	0.8371573713965091	0.9999956227936566	0	0	0.6498721404381782	0.115510358882508	CCNA1;CDKN1A;CDK6
Class A 1 (Rhodopsin-like Receptors)	15/333	0.8372014642487356	0.9999956227936566	0	0	0.795417544941991	0.14133817263173187	APP;GPR39;CXCL6;PLPPR1;F2;KEL;CYSLTR2;MT-RNR2;CNR1;PENK;PSAP;P2RY1;APLNR;F2RL1;PRLHR
Cooperation of Prefoldin and TriC CCT in Actin and Tubulin Folding	1/32	0.840993852179567	0.9999956227936566	0	0	0.545436134818458	0.09445368226788926	PFDN4
DNA Strand Elongation	1/32	0.840993852179567	0.9999956227936566	0	0	0.545436134818458	0.09445368226788926	MCM6
PINK1-PRKN Mediated Mitophagy	1/32	0.840993852179567	0.9999956227936566	0	0	0.545436134818458	0.09445368226788926	SQSTM1
Packaging Of Telomere Ends	1/32	0.840993852179567	0.9999956227936566	0	0	0.545436134818458	0.09445368226788926	TERF2IP
Phase 0 - Rapid Depolarisation	1/32	0.840993852179567	0.9999956227936566	0	0	0.545436134818458	0.09445368226788926	CACNA1C
Termination of Translesion DNA Synthesis	1/32	0.840993852179567	0.9999956227936566	0	0	0.545436134818458	0.09445368226788926	ISG15
Formation of RNA Pol II Elongation Complex	2/58	0.8419545684310029	0.9999956227936566	0	0	0.6036163118748397	0.10383964507867675	SUPT16H;POLR2H
Orc1 Removal From Chromatin	2/58	0.8419545684310029	0.9999956227936566	0	0	0.6036163118748397	0.10383964507867675	CCNA1;MCM6
RNA Polymerase II Transcription Elongation	2/58	0.8419545684310029	0.9999956227936566	0	0	0.6036163118748397	0.10383964507867675	SUPT16H;POLR2H
SUMOylation of Chromatin Organization Proteins	2/58	0.8419545684310029	0.9999956227936566	0	0	0.6036163118748397	0.10383964507867675	NUP155;CHD3
B-WICH Complex Positively Regulates rRNA Expression	2/59	0.8488000197884135	0.9999956227936566	0	0	0.592995054962361	0.09721066869452563	KAT2B;POLR2H
Meiotic Synapsis	2/59	0.8488000197884135	0.9999956227936566	0	0	0.592995054962361	0.09721066869452563	LMNA;TERF2IP
S Phase	6/150	0.84895022630977	0.9999956227936566	0	0	0.7034534534534534	0.11519382375637209	CCNA1;CDKN1A;CCND1;GMNN;AKT3;MCM6
Regulation of HSF1-mediated Heat Shock Response	3/83	0.8490302248397819	0.9999956227936566	0	0	0.6335579514824797	0.10368840654841119	HSPA5;NUP155;HSPA4L
Toll Like Receptor 3 (TLR3) Cascade	4/106	0.8494431635742625	0.9999956227936566	0	0	0.662364226266046	0.10808078309764091	DUSP4;IKBIP;APP;DUSP6
Cristae Formation	1/33	0.8498805212090684	0.9999956227936566	0	0	0.5283632286995515	0.08594330000471802	ATP5MK
DNA Methylation	1/33	0.8498805212090684	0.9999956227936566	0	0	0.5283632286995515	0.08594330000471802	UHRF1
Formation of the Early Elongation Complex	1/33	0.8498805212090684	0.9999956227936566	0	0	0.5283632286995515	0.08594330000471802	POLR2H
Formation of the HIV-1 Early Elongation Complex	1/33	0.8498805212090684	0.9999956227936566	0	0	0.5283632286995515	0.08594330000471802	POLR2H
RNA Polymerase I Transcription Termination	1/33	0.8498805212090684	0.9999956227936566	0	0	0.5283632286995515	0.08594330000471802	POLR2H
Transcriptional Regulation of White Adipocyte Differentiation	3/84	0.8546790969172231	0.9999956227936566	0	0	0.6257029716149213	0.09825364066218588	EGR2;EBF1;KLF4
Ribosomal Scanning and Start Codon Recognition	2/60	0.85537448202162	0.9999956227936566	0	0	0.5827400482882437	0.09103327000592644	RPS27L;RPS4Y1
Late Endosomal Microautophagy	1/34	0.8582709382826473	0.9999956227936566	0	0	0.5123250441636091	0.0783014289054697	RNASE1
RAF Activation	1/34	0.8582709382826473	0.9999956227936566	0	0	0.5123250441636091	0.0783014289054697	KRAS
Signaling by WNT in Cancer	1/34	0.8582709382826473	0.9999956227936566	0	0	0.5123250441636091	0.0783014289054697	TCF7L2
Telomere C-strand (Lagging Strand) Synthesis	1/34	0.8582709382826473	0.9999956227936566	0	0	0.5123250441636091	0.0783014289054697	TERF2IP
Regulation of PTEN Gene Transcription	2/61	0.8616868502718124	0.9999956227936566	0	0	0.5728326689590116	0.08527379413999028	RRAGD;CHD3
C-type Lectin Receptors (CLRs)	5/131	0.8617652979595991	0.9999956227936566	0	0	0.66999557098567	0.09967679651791442	SYK;NFATC3;KRAS;PAK3;CARD11
DDX58 IFIH1-mediated Induction of Interferon-Alpha Beta	3/86	0.8654245828261424	0.9999956227936566	0	0	0.6105608417497483	0.08824743890757006	APP;TRIM4;ISG15
GPVI-mediated Activation Cascade	1/35	0.8661927915422543	0.9999956227936566	0	0	0.4972302822474281	0.07142602229956933	SYK
Impaired BRCA2 Binding to RAD51	1/35	0.8661927915422543	0.9999956227936566	0	0	0.4972302822474281	0.07142602229956933	MRE11
Nuclear Import of Rev Protein	1/35	0.8661927915422543	0.9999956227936566	0	0	0.4972302822474281	0.07142602229956933	NUP155
Oncogene Induced Senescence	1/35	0.8661927915422543	0.9999956227936566	0	0	0.4972302822474281	0.07142602229956933	CDK6
RHOBTB GTPase Cycle	1/35	0.8661927915422543	0.9999956227936566	0	0	0.4972302822474281	0.07142602229956933	PDE5A
Resolution of D-loop Structures Through Holliday Junction Intermediates	1/35	0.8661927915422543	0.9999956227936566	0	0	0.4972302822474281	0.07142602229956933	MRE11
SUMOylation of SUMOylation Proteins	1/35	0.8661927915422543	0.9999956227936566	0	0	0.4972302822474281	0.07142602229956933	NUP155
Translation of Structural Proteins 9683701	1/35	0.8661927915422543	0.9999956227936566	0	0	0.4972302822474281	0.07142602229956933	MGAT1
Transport of the SLBP Independent Mature mRNA	1/35	0.8661927915422543	0.9999956227936566	0	0	0.4972302822474281	0.07142602229956933	NUP155
MyD88-independent TLR4 Cascade	4/110	0.868795462537887	0.9999956227936566	0	0	0.6372336093389439	0.08962534752011544	DUSP4;IKBIP;APP;DUSP6
TRIF (TICAM1)-mediated TLR4 Signaling	4/110	0.868795462537887	0.9999956227936566	0	0	0.6372336093389439	0.08962534752011544	DUSP4;IKBIP;APP;DUSP6
CLEC7A (Dectin-1) Signaling	3/87	0.8705303174264598	0.9999956227936566	0	0	0.6032601719933256	0.08364364729356052	SYK;NFATC3;CARD11
MAP Kinase Activation	2/63	0.8735601329042099	0.9999956227936566	0	0	0.5539924066280131	0.0748877575271521	DUSP4;DUSP6
Nuclear Pore Complex (NPC) Disassembly	1/36	0.8736722259174724	0.9999956227936566	0	0	0.4829980781550288	0.06522889104477107	NUP155
RHO GTPases Activate WASPs and WAVEs	1/36	0.8736722259174724	0.9999956227936566	0	0	0.4829980781550288	0.06522889104477107	CYFIP2
RNA Polymerase III Transcription Initiation	1/36	0.8736722259174724	0.9999956227936566	0	0	0.4829980781550288	0.06522889104477107	POLR2H
Resolution of D-Loop Structures	1/36	0.8736722259174724	0.9999956227936566	0	0	0.4829980781550288	0.06522889104477107	MRE11
Rev-mediated Nuclear Export of HIV RNA	1/36	0.8736722259174724	0.9999956227936566	0	0	0.4829980781550288	0.06522889104477107	NUP155
Transport of the SLBP Dependant Mature mRNA	1/36	0.8736722259174724	0.9999956227936566	0	0	0.4829980781550288	0.06522889104477107	NUP155
Cytosolic Sensors of Pathogen-Associated DNA	2/64	0.8791380544492925	0.9999956227936566	0	0	0.5450280882608444	0.07020688577082568	MRE11;POLR2H
Meiosis	3/89	0.880230421599363	0.9999956227936566	0	0	0.5891681815332539	0.0751611058223308	MRE11;LMNA;TERF2IP
Selective Autophagy	3/89	0.880230421599363	0.9999956227936566	0	0	0.5891681815332539	0.0751611058223308	PRKAB1;SQSTM1;DYNC1I1
Evasion by RSV of Host Interferon Responses	1/37	0.8807339285025264	0.9999956227936566	0	0	0.4695565520677628	0.05963354567859725	TYK2
Fatty acyl-CoA Biosynthesis	1/37	0.8807339285025264	0.9999956227936566	0	0	0.4695565520677628	0.05963354567859725	ACSL1
HDR Through Single Strand Annealing (SSA)	1/37	0.8807339285025264	0.9999956227936566	0	0	0.4695565520677628	0.05963354567859725	MRE11
RHOV GTPase Cycle	1/37	0.8807339285025264	0.9999956227936566	0	0	0.4695565520677628	0.05963354567859725	EPHA2
Sphingolipid De Novo Biosynthesis	1/37	0.8807339285025264	0.9999956227936566	0	0	0.4695565520677628	0.05963354567859725	SPTLC1
Transport of Ribonucleoproteins Into the Host Nucleus	1/37	0.8807339285025264	0.9999956227936566	0	0	0.4695565520677628	0.05963354567859725	NUP155
Antiviral Mechanism by IFN-stimulated Genes	6/158	0.8807843984149469	0.9999956227936566	0	0	0.6661450924608819	0.08456206124955493	NUP155;PDE12;STAT1;MX1;ISG15;SNCA
Signaling by Hedgehog	5/136	0.8822190320108685	0.9999956227936566	0	0	0.6442514480455679	0.0807343175071015	SHH;IHH;GAS1;IFT57;ADCY8
Signaling by WNT	12/287	0.882503863041185	0.9999956227936566	0	0	0.7355335968379446	0.09193589830451623	PYGO1;GNAO1;TCF7L2;SFRP1;GNG2;GNG4;FZD7;CTNNBIP1;KRAS;AXIN2;WNT16;GNG11
ABC Transporter Disorders	2/65	0.88448787854882	0.9999956227936566	0	0	0.5363483514291414	0.0658348667068969	ABCC8;ABCA12
O-linked Glycosylation of Mucins	2/65	0.88448787854882	0.9999956227936566	0	0	0.5363483514291414	0.0658348667068969	GALNT14;GALNT5
DNA Damage Recognition in GG-NER	1/38	0.8874012101403069	0.9999956227936566	0	0	0.4568415949581869	0.054573418128647806	DDB2
Fanconi Anemia Pathway	1/38	0.8874012101403069	0.9999956227936566	0	0	0.4568415949581869	0.054573418128647806	USP1
Interactions of Rev With Host Cellular Proteins	1/38	0.8874012101403069	0.9999956227936566	0	0	0.4568415949581869	0.054573418128647806	NUP155
Mitochondrial Fatty Acid Beta-Oxidation	1/38	0.8874012101403069	0.9999956227936566	0	0	0.4568415949581869	0.054573418128647806	ACADVL
NEP NS2 Interacts With the Cellular Export Machinery	1/38	0.8874012101403069	0.9999956227936566	0	0	0.4568415949581869	0.054573418128647806	NUP155
Triglyceride Metabolism	1/38	0.8874012101403069	0.9999956227936566	0	0	0.4568415949581869	0.054573418128647806	FABP1
Downstream TCR Signaling	3/91	0.8892785381578219	0.9999956227936566	0	0	0.5757167360940946	0.06755735159675323	INPP5D;CARD11;HLA-DRB1
Mitochondrial Translation Elongation	3/91	0.8892785381578219	0.9999956227936566	0	0	0.5757167360940946	0.06755735159675323	MRPS36;MT-RNR2;MRPL27
Mitochondrial Translation Initiation	3/91	0.8892785381578219	0.9999956227936566	0	0	0.5757167360940946	0.06755735159675323	MRPS36;MT-RNR2;MRPL27
Mitochondrial Translation Termination	3/91	0.8892785381578219	0.9999956227936566	0	0	0.5757167360940946	0.06755735159675323	MRPS36;MT-RNR2;MRPL27
Regulation of Endogenous Retroelements by Piwi-interacting RNAs (piRNAs)	2/66	0.889617664871576	0.9999956227936566	0	0	0.5279398563734291	0.06174969264554664	CHD3;SMARCA2
Class I MHC Mediated Antigen Processing & Presentation	16/373	0.8904438029292121	0.9999956227936566	0	0	0.754856124267889	0.08758994594095963	PDIA3;FGB;HSPA5;SAR1B;HLA-B;KLHL13;FBXO22;RNF41;VAMP8;TRIM4;CTSL;HECW2;SEC61G;RNF182;TRIM36;CALR
Scavenging of Heme From Plasma	3/92	0.8935691313269404	0.9999956227936566	0	0	0.5692177231291075	0.06405496746907675	HPX;LRP1;AMBP
Telomere Maintenance	3/92	0.8935691313269404	0.9999956227936566	0	0	0.5692177231291075	0.06405496746907675	CCNA1;TERF2IP;POLR2H
Chromatin Modifications During the Maternal to Zygotic Transition (MZT)	1/39	0.8936960818877531	0.9999956227936566	0	0	0.444795846117536	0.04999038930862512	UHRF1
Export of Viral Ribonucleoproteins From Nucleus	1/39	0.8936960818877531	0.9999956227936566	0	0	0.444795846117536	0.04999038930862512	NUP155
Mitophagy	1/39	0.8936960818877531	0.9999956227936566	0	0	0.444795846117536	0.04999038930862512	SQSTM1
Ovarian Tumor Domain Proteases	1/39	0.8936960818877531	0.9999956227936566	0	0	0.444795846117536	0.04999038930862512	TRIM4
SUMOylation of Ubiquitinylation Proteins	1/39	0.8936960818877531	0.9999956227936566	0	0	0.444795846117536	0.04999038930862512	NUP155
Synthesis of PA	1/39	0.8936960818877531	0.9999956227936566	0	0	0.444795846117536	0.04999038930862512	GPD1
Translesion Synthesis by Y Family DNA Polymerases Bypasses Lesions on DNA Template	1/39	0.8936960818877531	0.9999956227936566	0	0	0.444795846117536	0.04999038930862512	ISG15
Ubiquitin-dependent Degradation of Cyclin D	1/39	0.8936960818877531	0.9999956227936566	0	0	0.444795846117536	0.04999038930862512	CCND1
HDR Through Homologous Recombination (HRR) or Single Strand Annealing (SSA)	4/116	0.8937960461087839	0.9999956227936566	0	0	0.6029033915724563	0.06769258573735164	CCNA1;MRE11;TIMELESS;CLSPN
Adaptive Immune System	40/854	0.8953004192926522	0.9999956227936566	0	0	0.8252422750564015	0.09126845587871293	COL17A1;COLEC12;SAR1B;KLHL13;FBXO22;RASGRP1;TRIM4;CTSL;INPP5D;SEC61G;AKT3;KIF5A;SLAMF7;CTSH;AP1S1;CTSF;HLA-DOA;PAK3;CTSC;DYNC1I1;VASP;PDIA3;RAP1GAP2;FGB;ITGA4;SYK;HSPA5;NFATC3;HLA-B;DNM1;RNF41;VAMP8;COL2A1;HECW2;RNF182;TRIM36;KRAS;CALR;HLA-DRB1;CARD11
Post-translational Modification Synthesis of GPI-anchored Proteins	3/93	0.8977098649355021	0.9999956227936566	0	0	0.5628631326744534	0.060737633699754295	CPM;NTM;PIGZ
Presynaptic Phase of Homologous DNA Pairing and Strand Exchange	1/40	0.8996393275720983	0.9999956227936566	0	0	0.43336782798666207	0.04583356355309827	MRE11
Vpr-mediated Nuclear Import of PICs	1/40	0.8996393275720983	0.9999956227936566	0	0	0.43336782798666207	0.04583356355309827	NUP155
Loss of Nlp From Mitotic Centrosomes	2/69	0.9037645446434422	0.9999956227936566	0	0	0.5042203703207482	0.05102025012030446	CNTRL;CDK5RAP2
Loss of Proteins Required for Interphase Microtubule Organization From the Centrosome	2/69	0.9037645446434422	0.9999956227936566	0	0	0.5042203703207482	0.05102025012030446	CNTRL;CDK5RAP2
Defective Homologous Recombination Repair (HRR) Due to BRCA2 Loss of Function	1/41	0.9052505720234457	0.9999956227936566	0	0	0.42251121076233183	0.04205824404984089	MRE11
Diseases of DNA Double-Strand Break Repair	1/41	0.9052505720234457	0.9999956227936566	0	0	0.42251121076233183	0.04205824404984089	MRE11
Dual Incision in GG-NER	1/41	0.9052505720234457	0.9999956227936566	0	0	0.42251121076233183	0.04205824404984089	DDB2
Antimicrobial Peptides	3/95	0.9055587631354972	0.9999956227936566	0	0	0.5505683815774054	0.05461809460629169	ITLN1;CLU;PRSS2
Bacterial Infection Pathways	5/143	0.906470239053947	0.9999956227936566	0	0	0.6113437430699592	0.06003217040542721	SYT2;SV2B;SV2A;CD9;FURIN
Circadian Clock	2/70	0.9080909541216403	0.9999956227936566	0	0	0.4967789629316718	0.04789482527665811	SERPINE1;NR3C1
RHOB GTPase Cycle	2/70	0.9080909541216403	0.9999956227936566	0	0	0.4967789629316718	0.04789482527665811	ARHGEF28;STOM
AUF1 (hnRNP D0) Binds and Destabilizes mRNA	1/42	0.9105483455966307	0.9999956227936566	0	0	0.41218418462211526	0.03862507237299405	PABPC1
Degradation of AXIN	1/42	0.9105483455966307	0.9999956227936566	0	0	0.41218418462211526	0.03862507237299405	AXIN2
Formation of WDR5-containing Histone-Modifying Complexes	1/42	0.9105483455966307	0.9999956227936566	0	0	0.41218418462211526	0.03862507237299405	KAT2B
Regulation of MITF-M-dependent Genes Involved in Pigmentation	1/42	0.9105483455966307	0.9999956227936566	0	0	0.41218418462211526	0.03862507237299405	SMARCA2
Transport of Mature mRNA Derived From an Intronless Transcript	1/42	0.9105483455966307	0.9999956227936566	0	0	0.41218418462211526	0.03862507237299405	NUP155
Base Excision Repair	2/71	0.9122347323431742	0.9999956227936566	0	0	0.4895532485103947	0.04496935296255752	NEIL3;TERF2IP
Transcription of the HIV Genome	2/71	0.9122347323431742	0.9999956227936566	0	0	0.4895532485103947	0.04496935296255752	SUPT16H;POLR2H
Signaling by Rho GTPases, Miro GTPases and RHOBTB3	31/688	0.9122557250817032	0.9999956227936566	0	0	0.79265057621222	0.0727930085193072	CYFIP2;DOCK5;STEAP3;PLXND1;ARHGEF28;STMN2;RHOBTB3;ARHGAP18;TNFAIP1;DOCK10;DOCK11;FGD5;ARHGDIB;KIF5A;EPSTI1;STOM;SRGAP2;PAK3;DYNC1I1;JAG1;LIMK2;PTPN13;RHOC;ARHGAP33;FMNL3;CCDC88A;ARHGEF9;DLG4;RHOU;PDE5A;EPHA2
Anchoring of the Basal Body to the Plasma Membrane	3/97	0.9128586204489565	0.9999956227936566	0	0	0.538796811378104	0.0491244016572057	CNTRL;CEP83;CDK5RAP2
Mitochondrial Translation	3/97	0.9128586204489565	0.9999956227936566	0	0	0.538796811378104	0.0491244016572057	MRPS36;MT-RNR2;MRPL27
Homology Directed Repair	4/122	0.914514315429107	0.9999956227936566	0	0	0.5720643823923912	0.05112090740631945	CCNA1;MRE11;TIMELESS;CLSPN
Activation of Gene Expression by SREBF (SREBP)	1/43	0.9155501455415529	0.9999956227936566	0	0	0.4023489216314328	0.03549930266136351	ACACB
Aggrephagy	1/43	0.9155501455415529	0.9999956227936566	0	0	0.4023489216314328	0.03549930266136351	DYNC1I1
Formation of Incision Complex in GG-NER	1/43	0.9155501455415529	0.9999956227936566	0	0	0.4023489216314328	0.03549930266136351	DDB2
Hh Mutants Are Degraded by ERAD	1/43	0.9155501455415529	0.9999956227936566	0	0	0.4023489216314328	0.03549930266136351	SHH
Homologous DNA Pairing and Strand Exchange	1/43	0.9155501455415529	0.9999956227936566	0	0	0.4023489216314328	0.03549930266136351	MRE11
Interactions of Vpr With Host Cellular Proteins	1/43	0.9155501455415529	0.9999956227936566	0	0	0.4023489216314328	0.03549930266136351	NUP155
Transport of Mature mRNAs Derived From Intronless Transcripts	1/43	0.9155501455415529	0.9999956227936566	0	0	0.4023489216314328	0.03549930266136351	NUP155
AURKA Activation by TPX2	2/72	0.9162027668638798	0.9999956227936566	0	0	0.4825339830725827	0.042230205308034716	CNTRL;CDK5RAP2
Degradation of Beta-Catenin by the Destruction Complex	2/72	0.9162027668638798	0.9999956227936566	0	0	0.4825339830725827	0.042230205308034716	TCF7L2;AXIN2
Interleukin-17 Signaling	2/72	0.9162027668638798	0.9999956227936566	0	0	0.4825339830725827	0.042230205308034716	DUSP4;DUSP6
Signaling by NOTCH4	2/72	0.9162027668638798	0.9999956227936566	0	0	0.4825339830725827	0.042230205308034716	KAT2B;JAG1
Translation	12/302	0.917699795802291	0.9999956227936566	0	0	0.6969265367316342	0.05985550889226107	RPN2;MRPS36;MT-RNR2;SEC61G;MRPL27;RPL35;RPS27L;RPL22L1;PABPC1;RPS4Y1;RPL9;DDOST
Signaling by Rho GTPases	30/672	0.9179021837519129	0.9999956227936566	0	0	0.7849262491179153	0.06724027360496396	CYFIP2;DOCK5;STEAP3;PLXND1;ARHGEF28;STMN2;ARHGAP18;TNFAIP1;DOCK10;DOCK11;FGD5;ARHGDIB;KIF5A;EPSTI1;STOM;SRGAP2;PAK3;DYNC1I1;JAG1;LIMK2;PTPN13;RHOC;ARHGAP33;FMNL3;CCDC88A;ARHGEF9;DLG4;RHOU;PDE5A;EPHA2
RHOA GTPase Cycle	5/149	0.9236659836082275	0.9999956227936566	0	0	0.5856835683568357	0.04650606452549378	FMNL3;ARHGEF28;ARHGDIB;ARHGAP18;STOM
ERCC6 (CSB) and EHMT2 (G9a) Positively Regulate rRNA Expression	1/45	0.9247309879567877	0.9999956227936566	0	0	0.3840195678760701	0.030050455750916583	CHD3
Somitogenesis	1/45	0.9247309879567877	0.9999956227936566	0	0	0.3840195678760701	0.030050455750916583	DLL1
TBC RABGAPs	1/45	0.9247309879567877	0.9999956227936566	0	0	0.3840195678760701	0.030050455750916583	SYTL1
COPI-mediated Anterograde Transport	3/101	0.9259392755470672	0.9999956227936566	0	0	0.5166950877385995	0.03975794245762695	TMED9;TMED3;DYNC1I1
Cellular Response to Heat Stress	3/101	0.9259392755470672	0.9999956227936566	0	0	0.5166950877385995	0.03975794245762695	HSPA5;NUP155;HSPA4L
Host Interactions of HIV Factors	4/126	0.9262440934955191	0.9999956227936566	0	0	0.553190234697488	0.04238404129235424	NUP155;PACS1;ELMO1;AP1S1
Nuclear Envelope (NE) Reassembly	2/75	0.9271183019371239	0.9999956227936566	0	0	0.46263003861193774	0.035009113425805045	NUP155;LMNA
Transcriptional Regulation by Small RNAs	2/75	0.9271183019371239	0.9999956227936566	0	0	0.46263003861193774	0.035009113425805045	NUP155;POLR2H
M-decay Degradation of Maternal mRNAs by Maternally Stored Factors	1/46	0.9289403600398822	0.9999956227936566	0	0	0.37546586945690086	0.027675867175745626	PABPC1
PKMTs Methylate Histone Lysines	1/46	0.9289403600398822	0.9999956227936566	0	0	0.37546586945690086	0.027675867175745626	PRDM16
SUMOylation of DNA Replication Proteins	1/46	0.9289403600398822	0.9999956227936566	0	0	0.37546586945690086	0.027675867175745626	NUP155
Cell Death Signalling via NRAGE, NRIF and NADE	2/76	0.9304482689780983	0.9999956227936566	0	0	0.45635402008831094	0.032898013368596705	ARHGEF9;SQSTM1
Regulation of mRNA Stability by Proteins That Bind AU-rich Elements	2/76	0.9304482689780983	0.9999956227936566	0	0	0.45635402008831094	0.032898013368596705	GPRC5A;PABPC1
DNA Double-Strand Break Repair	5/152	0.9311643664272798	0.9999956227936566	0	0	0.5736389965527166	0.040911628649538324	CCNA1;MRE11;XRCC4;TIMELESS;CLSPN
HIV Transcription Initiation	1/47	0.9329145174011749	0.9999956227936566	0	0	0.3672840709689998	0.025504831575923967	POLR2H
Heme Signaling	1/47	0.9329145174011749	0.9999956227936566	0	0	0.3672840709689998	0.025504831575923967	SLC46A1
RNA Polymerase II HIV Promoter Escape	1/47	0.9329145174011749	0.9999956227936566	0	0	0.3672840709689998	0.025504831575923967	POLR2H
RNA Polymerase II Promoter Escape	1/47	0.9329145174011749	0.9999956227936566	0	0	0.3672840709689998	0.025504831575923967	POLR2H
RNA Polymerase II Transcription Initiation	1/47	0.9329145174011749	0.9999956227936566	0	0	0.3672840709689998	0.025504831575923967	POLR2H
RNA Polymerase II Transcription Initiation And Promoter Clearance	1/47	0.9329145174011749	0.9999956227936566	0	0	0.3672840709689998	0.025504831575923967	POLR2H
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	1/47	0.9329145174011749	0.9999956227936566	0	0	0.3672840709689998	0.025504831575923967	POLR2H
SUMOylation of RNA Binding Proteins	1/47	0.9329145174011749	0.9999956227936566	0	0	0.3672840709689998	0.025504831575923967	NUP155
DNA Repair	12/312	0.9358628536757261	0.9999956227936566	0	0	0.6733333333333333	0.04463280030789497	CCNA1;NEIL3;MRE11;XRCC4;MSH2;USP1;TIMELESS;TERF2IP;ISG15;CLSPN;POLR2H;DDB2
Diseases of Programmed Cell Death	2/78	0.9366811058087784	0.9999956227936566	0	0	0.4442974581876595	0.029062558605230833	APP;LMNA
Defensins	1/49	0.9402089848991372	0.9999956227936566	0	0	0.35194319880418534	0.021698390661794204	PRSS2
Pyruvate Metabolism	1/49	0.9402089848991372	0.9999956227936566	0	0	0.35194319880418534	0.021698390661794204	MPC2
Retrograde Transport at the Trans-Golgi-Network	1/49	0.9402089848991372	0.9999956227936566	0	0	0.35194319880418534	0.021698390661794204	RHOBTB3
HIV Infection	8/227	0.9420368945784634	0.9999956227936566	0	0	0.615366862832369	0.036744071643950105	SUPT16H;XRCC4;NUP155;PACS1;ELMO1;AP1S1;FURIN;POLR2H
Autophagy	5/158	0.9442166880262168	0.9999956227936566	0	0	0.5509668613920216	0.031625275681286036	RRAGD;PRKAB1;RNASE1;SQSTM1;DYNC1I1
HIV Life Cycle	5/158	0.9442166880262168	0.9999956227936566	0	0	0.5509668613920216	0.031625275681286036	SUPT16H;NUP155;XRCC4;FURIN;POLR2H
Synthesis of DNA	3/108	0.9445771130565228	0.9999956227936566	0	0	0.482069054036709	0.027486589729267444	CCNA1;GMNN;MCM6
Centrosome Maturation	2/81	0.9450455272314008	0.9999956227936566	0	0	0.4273572256437061	0.024155160187840603	CNTRL;CDK5RAP2
RNA Polymerase II Pre-transcription Events	2/81	0.9450455272314008	0.9999956227936566	0	0	0.4273572256437061	0.024155160187840603	SUPT16H;POLR2H
RNA Polymerase II Transcribes snRNA Genes	2/81	0.9450455272314008	0.9999956227936566	0	0	0.4273572256437061	0.024155160187840603	POLR2H;POU2F2
Recruitment of Mitotic Centrosome Proteins and Complexes	2/81	0.9450455272314008	0.9999956227936566	0	0	0.4273572256437061	0.024155160187840603	CNTRL;CDK5RAP2
Gene Silencing by RNA	4/134	0.9454511616285372	0.9999956227936566	0	0	0.5189263973436635	0.029108162123307697	NUP155;XPO5;TDRD6;POLR2H
Asymmetric Localization of PCP Proteins	1/51	0.9467109009195243	0.9999956227936566	0	0	0.33782959641255605	0.018500059248986657	FZD7
Formation of TC-NER Pre-Incision Complex	1/51	0.9467109009195243	0.9999956227936566	0	0	0.33782959641255605	0.018500059248986657	POLR2H
Transcriptional and Post-Translational Regulation of MITF-M Expression and Activity	1/51	0.9467109009195243	0.9999956227936566	0	0	0.33782959641255605	0.018500059248986657	AKT3
COPI-independent Golgi-to-ER Retrograde Traffic	1/52	0.9496919173864374	0.9999956227936566	0	0	0.33118790116943636	0.017095139335764283	DYNC1I1
Proteasome Assembly	1/52	0.9496919173864374	0.9999956227936566	0	0	0.33118790116943636	0.017095139335764283	PSMD10
Mitotic Prophase	3/111	0.9511456261237005	0.9999956227936566	0	0	0.46860337426375165	0.023471452057645746	NUP155;ENSA;LMNA
Signaling by the B Cell Receptor (BCR)	5/162	0.9516308969180719	0.9999956227936566	0	0	0.5368148279796132	0.02661422309132087	SYK;NFATC3;KRAS;RASGRP1;CARD11
Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha	1/53	0.9525063078700335	0.9999956227936566	0	0	0.3248016557433598	0.01580437746558736	EGLN3
RHOD GTPase Cycle	1/53	0.9525063078700335	0.9999956227936566	0	0	0.3248016557433598	0.01580437746558736	STEAP3
RUNX1 Regulates Transcription of Genes Involved in Differentiation of HSCs	2/85	0.9545728678160981	0.9999956227936566	0	0	0.4066751746663494	0.018906856483608108	MYB;RUNX1
RHO GTPases Activate Formins	4/139	0.9550094488865388	0.9999956227936566	0	0	0.4995736743938183	0.02299739672226566	FMNL3;SRGAP2;RHOC;DYNC1I1
Activation of NF-kappaB in B Cells	1/54	0.9551633781310828	0.9999956227936566	0	0	0.31865640071072004	0.01461768573367315	CARD11
SARS-CoV-1 Activates Modulates Innate Immune Responses	1/54	0.9551633781310828	0.9999956227936566	0	0	0.31865640071072004	0.01461768573367315	RUNX1
Major Pathway of rRNA Processing in the Nucleolus and Cytosol	6/189	0.9560760446906683	0.9999956227936566	0	0	0.5523851720573032	0.02481194018102945	KRR1;RPL35;RPS27L;RPL22L1;RPS4Y1;RPL9
Ub-specific Processing Proteases	6/190	0.9575495933553924	0.9999956227936566	0	0	0.5493537015276145	0.023829735569851008	CCNA1;IL33;CLSPN;AXIN2;MAT2B;DDB2
Infectious Disease	60/1311	0.9584635573281943	0.9999956227936566	0	0	0.80085931254996	0.033975445444473416	CYFIP2;APP;IRS1;SERPINE1;CHD3;NR3C1;RPL9;CYSLTR2;TRIM4;CTSL;AKT3;AP1S1;RPL35;SUPT16H;ITGA4;SYK;IFNGR1;HLA-B;ATP1B3;TYK2;HSPG2;DDOST;RUNX1;ANO1;PACS1;SNRPG;ELMO1;MASP1;ISCU;RPN2;SAR1B;RPS27L;FURIN;TXN;RPS4Y1;ADCY8;NT5E;GNG2;SV2B;GNG4;SV2A;GPC3;MGAT1;GPC4;POLR2H;DYNC1I1;GSDMD;SYT2;XRCC4;NUP155;STAT1;PLK2;FZD7;ISG15;GNG11;CD9;RPL22L1;CALR;CRB3;BCL2L1
Regulation of PLK1 Activity at G2 M Transition	2/87	0.9587228334286066	0.9999956227936566	0	0	0.39706410391804836	0.01673754724655475	CNTRL;CDK5RAP2
Deadenylation-dependent mRNA Decay	1/56	0.9600402134873073	0.9999956227936566	0	0	0.30703628210354666	0.012520972236968792	PABPC1
Regulation of PTEN Stability and Activity	1/56	0.9600402134873073	0.9999956227936566	0	0	0.30703628210354666	0.012520972236968792	AKT3
RAC2 GTPase Cycle	2/88	0.9606590696945332	0.9999956227936566	0	0	0.3924262034988101	0.015750300039460183	DOCK10;EPHA2
TNFR2 Non-Canonical NF-kB Pathway	2/88	0.9606590696945332	0.9999956227936566	0	0	0.3924262034988101	0.015750300039460183	TNFRSF12A;EDA2R
Macroautophagy	4/143	0.961517199350095	0.9999956227936566	0	0	0.48509393923709954	0.019036457086873553	RRAGD;PRKAB1;SQSTM1;DYNC1I1
Keratinization	7/217	0.9617151875241737	0.9999956227936566	0	0	0.5612864442440637	0.021910902449528806	ST14;KLK13;KRT7;FURIN;PRSS8;DSG3;DSC3
Chemokine Receptors Bind Chemokines	1/57	0.962276107924897	0.9999956227936566	0	0	0.30153747597693786	0.011595278384995546	CXCL6
E3 Ubiquitin Ligases Ubiquitinate Target Proteins	1/57	0.962276107924897	0.9999956227936566	0	0	0.30153747597693786	0.011595278384995546	HLA-B
Meiotic Recombination	1/57	0.962276107924897	0.9999956227936566	0	0	0.30153747597693786	0.011595278384995546	MRE11
SUMO E3 Ligases SUMOylate Target Proteins	5/170	0.963835001553509	0.9999956227936566	0	0	0.5105692387420561	0.018806899209747745	NUP155;XRCC4;NSMCE1;CHD3;NR3C1
ABC-family Proteins Mediated Transport	2/90	0.9642733009432556	0.9999956227936566	0	0	0.38346662314346336	0.013950714136269795	ABCB1;ABCA12
Late Phase of HIV Life Cycle	4/145	0.9644332424768599	0.9999956227936566	0	0	0.4781621511301597	0.017316481485179728	SUPT16H;NUP155;FURIN;POLR2H
Chromosome Maintenance	3/119	0.9652799134441105	0.9999956227936566	0	0	0.4361000092945441	0.015410533169916314	CCNA1;TERF2IP;POLR2H
NRAGE Signals Death Through JNK	1/59	0.96637985486269	0.9999956227936566	0	0	0.2911087057368177	0.009955422143007106	ARHGEF9
RNA Polymerase I Promoter Escape	1/59	0.96637985486269	0.9999956227936566	0	0	0.2911087057368177	0.009955422143007106	POLR2H
TNF Signaling	1/59	0.96637985486269	0.9999956227936566	0	0	0.2911087057368177	0.009955422143007106	SMPD3
tRNA Processing in the Nucleus	1/59	0.96637985486269	0.9999956227936566	0	0	0.2911087057368177	0.009955422143007106	NUP155
Fc Epsilon Receptor (FCERI) Signaling	6/197	0.9666693553499062	0.9999956227936566	0	0	0.5290222159332107	0.01793320257257367	SYK;NFATC3;KRAS;GAB2;RASGRP1;CARD11
CDK-mediated Phosphorylation and Removal of Cdc6	1/60	0.9682612839838203	0.9999956227936566	0	0	0.2861594588432013	0.00922958877884736	CCNA1
Cdc20 Phospho-APC C Mediated Degradation of Cyclin A	1/60	0.9682612839838203	0.9999956227936566	0	0	0.2861594588432013	0.00922958877884736	CCNA1
HDACs Deacetylate Histones	1/60	0.9682612839838203	0.9999956227936566	0	0	0.2861594588432013	0.00922958877884736	CHD3
Recruitment and ATM-med Phosphorylation of Repair and Signaling Proteins at DNA Double Strand Breaks	1/60	0.9682612839838203	0.9999956227936566	0	0	0.2861594588432013	0.00922958877884736	MRE11
rRNA Processing in the Nucleus and Cytosol	6/199	0.9689239450520802	0.9999956227936566	0	0	0.5234841058675256	0.016525952579528203	KRR1;RPL35;RPS27L;RPL22L1;RPS4Y1;RPL9
Cilium Assembly	6/200	0.969997947929274	0.9999956227936566	0	0	0.5207578712733352	0.01586297373403168	IFT20;DYNLT5;CNTRL;CEP83;IFT57;CDK5RAP2
APC Cdc20 Mediated Degradation of Cell Cycle Proteins Prior to Satisfation of the Checkpoint	1/61	0.9700375070009947	0.9999956227936566	0	0	0.28137518684603885	0.008559585469994963	CCNA1
DNA Double Strand Break Response	1/61	0.9700375070009947	0.9999956227936566	0	0	0.28137518684603885	0.008559585469994963	MRE11
Oxidative Stress Induced Senescence	2/94	0.9705676678823484	0.9999956227936566	0	0	0.3667161033486847	0.010955333360709094	CDK6;TXN
Recruitment of NuMA to Mitotic Centrosomes	2/94	0.9705676678823484	0.9999956227936566	0	0	0.3667161033486847	0.010955333360709094	CNTRL;CDK5RAP2
SUMOylation	5/176	0.9710539080649513	0.9999956227936566	0	0	0.49249661808286094	0.014466248027053614	NUP155;XRCC4;NSMCE1;CHD3;NR3C1
Cellular Response to Hypoxia	1/62	0.9717144015548311	0.9999956227936566	0	0	0.2767477762258325	0.007940818939069269	EGLN3
Gap-filling DNA Repair Synthesis and Ligation in TC-NER	1/62	0.9717144015548311	0.9999956227936566	0	0	0.2767477762258325	0.007940818939069269	POLR2H
RHO GTPases Activate PKNs	1/62	0.9717144015548311	0.9999956227936566	0	0	0.2767477762258325	0.007940818939069269	RHOC
Organelle Biogenesis and Maintenance	10/297	0.9717885278490266	0.9999956227936566	0	0	0.5858762152591818	0.016766056054609613	IFT20;DYNLT5;GLUD2;ACSS2;CNTRL;CEP83;ATP5MK;IFT57;PRKAB1;CDK5RAP2
Role of LAT2 NTAL LAB on Calcium Mobilization	2/95	0.9719656959946649	0.9999956227936566	0	0	0.36275361479508117	0.010314814635192068	SYK;GAB2
APC C Cdc20 Mediated Degradation of Mitotic Proteins	1/63	0.973297517632452	0.9999956227936566	0	0	0.27226963691595546	0.0073691056947344236	CCNA1
Dual Incision in TC-NER	1/63	0.973297517632452	0.9999956227936566	0	0	0.27226963691595546	0.0073691056947344236	POLR2H
rRNA Modification in the Nucleus and Cytosol	1/63	0.973297517632452	0.9999956227936566	0	0	0.27226963691595546	0.0073691056947344236	KRR1
Activation of APC C and APC C Cdc20 Mediated Degradation of Mitotic Proteins	1/64	0.9747920951510582	0.9999956227936566	0	0	0.26793366075877284	0.006840632100980724	CCNA1
P75 NTR Receptor-Mediated Signalling	2/98	0.9757856693264368	0.9999956227936566	0	0	0.351361460203471	0.008612683769859573	ARHGEF9;SQSTM1
Mitochondrial Protein Import	1/65	0.9762030815662103	0.9999956227936566	0	0	0.26373318385650224	0.006351918482913573	HSCB
The Role of GTSE1 in G2 M Progression After G2 Checkpoint	1/65	0.9762030815662103	0.9999956227936566	0	0	0.26373318385650224	0.006351918482913573	CDKN1A
Hedgehog 'Off' State	2/99	0.9769432636281018	0.9999956227936566	0	0	0.3477206685298636	0.008111175946058717	IFT57;ADCY8
Viral Infection Pathways	44/1029	0.977214354548604	0.9999956227936566	0	0	0.745848170315933	0.017191241117133133	RPN2;SAR1B;IRS1;SERPINE1;RPS27L;FURIN;CHD3;NR3C1;RPS4Y1;RPL9;TRIM4;CTSL;AKT3;GPC3;AP1S1;RPL35;MGAT1;GPC4;POLR2H;DYNC1I1;SUPT16H;ITGA4;XRCC4;SYK;NUP155;STAT1;IFNGR1;HLA-B;ISG15;ATP1B3;TYK2;HSPG2;DDOST;RUNX1;ANO1;PACS1;SNRPG;ELMO1;RPL22L1;CALR;MASP1;ISCU;CRB3;BCL2L1
Neddylation	7/234	0.9783726875798381	0.9999956227936566	0	0	0.5187790723078696	0.01134290229525425	CUL9;SOCS2;CDKN1A;KLHL13;FBXO22;SQSTM1;DDB2
G2 M Transition	5/184	0.9786114028365949	0.9999956227936566	0	0	0.47028445861345913	0.010167854740240474	CCNA1;CDKN1A;CNTRL;PHLDA1;CDK5RAP2
RNA Polymerase II Transcription Termination	1/67	0.9787927051756533	0.9999956227936566	0	0	0.25571409158853103	0.005481333906757797	SNRPG
Assembly of the Pre-Replicative Complex	2/101	0.9790998829816343	0.9999956227936566	0	0	0.34065973922347353	0.007195284245676783	GMNN;MCM6
Regulation of APC C Activators Between G1 S and Early Anaphase	1/68	0.9799799169258997	0.9999956227936566	0	0	0.25188407737099255	0.005093902189420687	CCNA1
Mitotic G2-G2 M Phases	5/186	0.9801888684173985	0.9999956227936566	0	0	0.4650382165288352	0.009305416113107192	CCNA1;CDKN1A;CNTRL;PHLDA1;CDK5RAP2
Epigenetic Regulation of Adipogenesis Genes by MLL3 and MLL4 Complexes	2/103	0.9810604293495184	0.9999956227936566	0	0	0.3338784506816929	0.006384163832696992	ACSL1;PHLDA1
Epigenetic Regulation of Gene Expression by MLL3 and MLL4 Complexes	2/103	0.9810604293495184	0.9999956227936566	0	0	0.3338784506816929	0.006384163832696992	ACSL1;PHLDA1
MLL4 and MLL3 Complexes Regulate Expression of PPARG Targets in Adipogenesis and Hepatic Steatosis	2/103	0.9810604293495184	0.9999956227936566	0	0	0.3338784506816929	0.006384163832696992	ACSL1;PHLDA1
HDR Through Homologous Recombination (HRR)	1/69	0.9811007150150729	0.9999956227936566	0	0	0.24816671063044052	0.004735060303259269	MRE11
Chromatin Modifying Enzymes	7/238	0.9811659026592101	0.9999956227936566	0	0	0.509686586332213	0.009691036946839933	KAT2B;CCND1;PRDM16;JADE1;CHD3;SMARCA2;WDR77
Chromatin Organization	7/238	0.9811659026592101	0.9999956227936566	0	0	0.509686586332213	0.009691036946839933	KAT2B;CCND1;PRDM16;JADE1;CHD3;SMARCA2;WDR77
TCF Dependent Signaling in Response to WNT	5/189	0.9823519783317969	0.9999956227936566	0	0	0.45738269479121824	0.008143975494501111	PYGO1;TCF7L2;SFRP1;CTNNBIP1;AXIN2
Epigenetic Regulation by WDR5-containing Histone Modifying Complexes	3/135	0.9828075118013513	0.9999956227936566	0	0	0.38291268479947727	0.006640469903062572	KAT2B;ACSL1;PHLDA1
Translocation of SLC2A4 (GLUT4) to the Plasma Membrane	1/71	0.9831577108660389	0.9999956227936566	0	0	0.24105060858424088	0.004094421370037923	PRKAB1
RHO GTPase Effectors	9/291	0.9836723331226894	0.9999956227936566	0	0	0.5362970650983105	0.008828754061964834	CYFIP2;FMNL3;DLG4;LIMK2;KIF5A;RHOC;PAK3;SRGAP2;DYNC1I1
G2 M Checkpoints	3/137	0.9842795343335177	0.9999956227936566	0	0	0.37715733998471257	0.005976187290912124	MRE11;CLSPN;MCM6
Deubiquitination	8/268	0.9843404065653728	0.9999956227936566	0	0	0.5171896695362399	0.008163063212437902	KAT2B;IL33;CCNA1;TRIM4;CLSPN;AXIN2;MAT2B;DDB2
HATs Acetylate Histones	2/108	0.9852128554429563	0.9999956227936566	0	0	0.3180447816808374	0.004738092572398886	KAT2B;JADE1
Nucleotide Excision Repair	2/108	0.9852128554429563	0.9999956227936566	0	0	0.3180447816808374	0.004738092572398886	POLR2H;DDB2
Complement Cascade	3/139	0.9856303676972665	0.9999956227936566	0	0	0.37157127001744095	0.005378076225952735	MASP1;F2;CLU
Transport of Mature mRNA Derived From an Intron-Containing Transcript	1/74	0.985831404485154	0.9999956227936566	0	0	0.23110756188955095	0.003297888352963074	NUP155
Maternal to Zygotic Transition (MZT)	2/109	0.98592985420428	0.9999956227936566	0	0	0.3150556217386198	0.004464359801473813	UHRF1;PABPC1
FCERI Mediated Ca+2 Mobilization	2/110	0.9866129639307439	0.9999956227936566	0	0	0.31212181661014693	0.0042066062590460866	SYK;NFATC3
APC C-mediated Degradation of Cell Cycle Proteins	1/75	0.986624809508394	0.9999956227936566	0	0	0.2279723669858199	0.003069749147477813	CCNA1
Regulation of Mitotic Cell Cycle	1/75	0.986624809508394	0.9999956227936566	0	0	0.2279723669858199	0.003069749147477813	CCNA1
Immunoregulatory Interactions Between a Lymphoid and a non-Lymphoid Cell	6/223	0.9869839388827445	0.9999956227936566	0	0	0.4649894133765102	0.006092064538677781	COL17A1;COLEC12;COL2A1;ITGA4;HLA-B;SLAMF7
FCERI Mediated MAPK Activation	2/111	0.9872637294770824	0.9999956227936566	0	0	0.3092418427684351	0.003963884244191048	SYK;KRAS
Regulation of Endogenous Retroelements	2/111	0.9872637294770824	0.9999956227936566	0	0	0.3092418427684351	0.003963884244191048	CHD3;SMARCA2
NoRC Negatively Regulates rRNA Expression	1/76	0.9873738149321301	0.9999956227936566	0	0	0.22492077727952167	0.0028579722125004724	POLR2H
Regulation of Endogenous Retroelements by KRAB-ZFP Proteins	1/76	0.9873738149321301	0.9999956227936566	0	0	0.22492077727952167	0.0028579722125004724	CHD3
Transcription-Coupled Nucleotide Excision Repair (TC-NER)	1/76	0.9873738149321301	0.9999956227936566	0	0	0.22492077727952167	0.0028579722125004724	POLR2H
FCGR3A-mediated Phagocytosis	3/142	0.9874498397411843	0.9999956227936566	0	0	0.36349357171944385	0.004590770669441103	CYFIP2;SYK;ELMO1
Leishmania Phagocytosis	3/142	0.9874498397411843	0.9999956227936566	0	0	0.36349357171944385	0.004590770669441103	CYFIP2;SYK;ELMO1
Parasite Infection	3/142	0.9874498397411843	0.9999956227936566	0	0	0.36349357171944385	0.004590770669441103	CYFIP2;SYK;ELMO1
DNA Replication	3/143	0.9880055299948338	0.9999956227936566	0	0	0.3608779360800924	0.004354708312811094	CCNA1;GMNN;MCM6
Regulation of Actin Dynamics for Phagocytic Cup Formation	3/143	0.9880055299948338	0.9999956227936566	0	0	0.3608779360800924	0.004354708312811094	CYFIP2;SYK;ELMO1
G2 M DNA Damage Checkpoint	1/77	0.9880809033196071	0.9999956227936566	0	0	0.22194949256549446	0.002661329477704133	MRE11
Protein Ubiquitination	1/77	0.9880809033196071	0.9999956227936566	0	0	0.22194949256549446	0.002661329477704133	HLA-B
PTEN Regulation	3/145	0.9890467493587282	0.9999956227936566	0	0	0.3557571846171368	0.00391819548857382	AKT3;RRAGD;CHD3
PCP CE Pathway	1/79	0.9893785730415203	0.9999956227936566	0	0	0.2162354835000575	0.002309013727778917	FZD7
MAPK6 MAPK4 Signaling	1/80	0.9899734564834167	0.9999956227936566	0	0	0.21348697281035364	0.00215133978817334	PAK3
DNA Replication Pre-Initiation	2/118	0.9910298728818628	0.9999956227936566	0	0	0.2904723580758992	0.002617330498945867	GMNN;MCM6
Negative Epigenetic Regulation of rRNA Expression	1/82	0.9910651897453433	0.9999956227936566	0	0	0.20819354481536842	0.0018685297850848772	POLR2H
Transport of Mature Transcript to Cytoplasm	1/83	0.9915656599929695	0.9999956227936566	0	0	0.2056436618177841	0.0017418245037295528	NUP155
Global Genome Nucleotide Excision Repair (GG-NER)	1/84	0.9920381120591787	0.9999956227936566	0	0	0.20315522178399698	0.0016239726678223283	DDB2
FCGR3A-mediated IL10 Synthesis	2/121	0.9922879093052245	0.9999956227936566	0	0	0.2831042650453359	0.0021917883086084384	SYK;ADCY8
Sensory Perception	23/640	0.9926869429325771	0.9999956227936566	0	0	0.6230024274112111	0.004572793308600594	CLIC5;RETSAT;LRP1;USH1C;EBF1;PCDH15;MSN;ESPN;HSPG2;GRM4;SCNN1A;OTOG;GPC3;LRAT;EPS8L2;SLC17A8;APOE;GPC4;PPEF1;BSN;LRP10;RGS9;TRPM4
Regulation of Complement Cascade	2/128	0.994589572668947	0.9999956227936566	0	0	0.2672765096463481	0.0014500062562161611	F2;CLU
Amplification of Signal From Unattached Kinetochores via a MAD2 Inhibitory Signal	1/94	0.995526694673491	0.9999956227936566	0	0	0.18121413761512126	8.124446814143711E-4	DYNC1I1
Amplification of Signal From the Kinetochores	1/94	0.995526694673491	0.9999956227936566	0	0	0.18121413761512126	8.124446814143711E-4	DYNC1I1
FCGR Activation	1/94	0.995526694673491	0.9999956227936566	0	0	0.18121413761512126	8.124446814143711E-4	SYK
Antigen Activates B Cell Receptor (BCR) Leading to Generation of Second Messengers	1/95	0.9957773311359369	0.9999956227936566	0	0	0.17927678656616736	7.586293546018808E-4	SYK
Creation of C4 and C2 Activators	1/96	0.9960139274133002	0.9999956227936566	0	0	0.17738022185508615	7.08463372899531E-4	MASP1
Fcgamma Receptor (FCGR) Dependent Phagocytosis	3/168	0.9962225139477079	0.9999956227936566	0	0	0.30579106428163033	0.0011573087177898884	CYFIP2;SYK;ELMO1
Cell Cycle Checkpoints	6/261	0.9970182071240915	0.9999956227936566	0	0	0.3948913619501855	0.0011792432544231763	CCNA1;CDKN1A;MRE11;CLSPN;MCM6;DYNC1I1
mRNA Splicing - Major Pathway	4/204	0.9970456411918566	0.9999956227936566	0	0	0.3360431654676259	9.942615126938533E-4	SNRPG;POLR2H;HTATSF1;SRSF8
Epigenetic Regulation of Gene Expression	7/291	0.9973244131006992	0.9999956227936566	0	0	0.4133910768488297	0.0011075460790015324	KAT2B;ACSL1;UHRF1;CHD3;POLR2H;SMARCA2;PHLDA1
Initial Triggering of Complement	1/104	0.9974869083962409	0.9999956227936566	0	0	0.16353345813923115	4.114918357638569E-4	MASP1
Antigen Processing Ubiquitination & Proteasome Degradation	7/296	0.997796305283664	0.9999956227936566	0	0	0.4061297780662151	8.959736352451329E-4	TRIM4;HECW2;RNF182;TRIM36;KLHL13;FBXO22;RNF41
Role of Phospholipids in Phagocytosis	1/107	0.9978860898230661	0.9999956227936566	0	0	0.15887976986208646	3.362130498473181E-4	SYK
FCERI Mediated NF-kB Activation	2/147	0.9979562159497961	0.9999956227936566	0	0	0.23201882003343033	4.746816024754114E-4	RASGRP1;CARD11
mRNA Splicing	4/215	0.9981925402363592	0.9999956227936566	0	0	0.3183367997545092	5.759015732299541E-4	SNRPG;POLR2H;HTATSF1;SRSF8
Mitotic Spindle Checkpoint	1/111	0.9983214448524381	0.9999956227936566	0	0	0.1530697105584998	2.571518327889437E-4	DYNC1I1
EML4 and NUDC in Mitotic Spindle Formation	1/116	0.9987417166252197	0.9999956227936566	0	0	0.14637551179567168	1.8429784675726415E-4	DYNC1I1
Resolution of Sister Chromatid Cohesion	1/126	0.9992925977165856	0.9999956227936566	0	0	0.13459372197309416	9.524559870730093E-5	DYNC1I1
Mitotic Prometaphase	3/203	0.9992933305377072	0.9999956227936566	0	0	0.2518059299191375	1.7800646437471284E-4	CNTRL;DYNC1I1;CDK5RAP2
HCMV Early Events	3/205	0.9993588403765541	0.9999956227936566	0	0	0.24928611459528702	1.598834522501339E-4	NUP155;IRS1;DYNC1I1
HCMV Late Events	2/171	0.9994129382506589	0.9999956227936566	0	0	0.19881444339392138	1.1675062820120184E-4	NUP155;IRS1
Cell Cycle, Mitotic	14/516	0.9994392821824368	0.9999956227936566	0	0	0.4651954794253115	2.6091655108118647E-4	CDKN1A;NUP155;GMNN;CCNA1;CDK6;CCND1;AKT3;ENSA;CNTRL;LMNA;MCM6;PHLDA1;DYNC1I1;CDK5RAP2
Processing of Capped Intron-Containing Pre-mRNA	5/285	0.9996874202183326	0.9999956227936566	0	0	0.299022759418799	9.348308007437576E-5	NUP155;SNRPG;POLR2H;HTATSF1;SRSF8
Mitotic Anaphase	3/221	0.9997065708117564	0.9999956227936566	0	0	0.23079205717253146	6.773106361075889E-5	NUP155;LMNA;DYNC1I1
Mitotic Metaphase and Anaphase	3/222	0.9997205954448896	0.9999956227936566	0	0	0.2297259043188224	6.419543275939595E-5	NUP155;LMNA;DYNC1I1
Cell Cycle	18/649	0.9998106917254669	0.9999956227936566	0	0	0.47421475150035075	8.978127480194596E-5	CDKN1A;MRE11;NUP155;GMNN;CCNA1;CDK6;CCND1;AKT3;ENSA;CNTRL;LMNA;TERF2IP;MCM6;POLR2H;CLSPN;PHLDA1;DYNC1I1;CDK5RAP2
Metabolism of RNA	21/761	0.9999413259862865	0.9999956227936566	0	0	0.4702258422806368	2.75908469592035E-5	NUP155;MT-CO1;KRR1;RPS27L;CDKAL1;RPS4Y1;HTATSF1;MT-ND3;RPL9;MT-ND1;WDR77;GPRC5A;MT-RNR2;SNRPG;TRMT12;RPL35;MT-CO2;RPL22L1;POLR2H;PABPC1;SRSF8
HCMV Infection	3/259	0.9999533039505066	0.9999956227936566	0	0	0.19613376010781672	9.15888561286694E-6	NUP155;IRS1;DYNC1I1
Separation of Sister Chromatids	1/177	0.9999599008536039	0.9999956227936566	0	0	0.09533224622910721	3.822818344201643E-6	DYNC1I1
M Phase	6/372	0.999970792626508	0.9999956227936566	0	0	0.2734898833259489	7.988037823951904E-6	NUP155;CNTRL;ENSA;LMNA;DYNC1I1;CDK5RAP2
Olfactory Signaling Pathway	1/422	0.9999955962790313	0.9999956227936566	0	0	0.03933193442902336	1.7320724576151318E-7	EBF1
Expression and Translocation of Olfactory Receptors	1/414	0.9999956227936566	0.9999956227936566	0	0	0.04011118470341698	1.7557531638952604E-7	EBF1
